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ABSTRACT 
 
The research project presented in this thesis deals with the development of the 
alkylation of protected aldimines using organoaluminium and organozinc 
compounds as alkylating agents. To this end, efforts have been focused into 
the methylation reaction using trimethylaluminium and dimethylzinc. It was 
hoped to establish promising conditions using the methylate group and then to 
extend the catalytic system to other interesting nucleophiles. In the case of 
organoaluminium alkylation the reaction was extended to other nucleophiles, 
namely to the allyl and propargyl groups. The identificaton of suitable metal 
catalysts as well as diphosphine ligands was carried out by means of 
extensive high throughput screening. On the one hand [IrCl(COD)]2 proved to 
be very efficient when associated to AlMe3 or DABAL-Me3 in the non-
enantioselective 1,2-addition reactions to aldimines (100% conversion in 3 h). 
On the other hand, [RhCl(COD)]BF4 was found to be able to efficiently 
catalyse the enantioselective 1,2-addition of Me2Zn to aldimine substrates 
(100% conversion in 3 h  - up to 99% e.e.).  
A preliminary screening of a range of aldimines bearing different protecting 
groups aimed at selecting the most interesting substrate in terms of reactivity 
and ease of cleavage of the protecting group. Once this substrate had been 
identified, a range of derivatives was synthesised in order to appraise the 
scope of the newly developed reaction. The diphenylphosphinoyl (dpp) 
protecting group turned out to be the best activating group for aldimines 
tested within the framework of this study. In addition to being easy to 
introduce, the dpp group can also be removed easily under mild conditions. 
viii  
What is more, the presence of a phosphorus atom on this protecting group is a 
feature which was used to determine the enantiomeric excess by 31P NMR 
spectroscopy, thus providing a novel and efficient screening tool at disposal. 
In the course of this investigation, various issues were faced and tackled. One 
of them was the unexpected non-reproducibility taking place in the Rh-
catalysed Me2Zn addition reaction; however, a deeper thinking of the reaction 
mechanism enabled us to solve this problem to eventually get a more robust 
catalytic system. Another one was the formation of a reduction product as a 
by-product of the Rh-catalysed Me2Zn addition reaction. 
Finally, several interesting attempts (Et2Zn addition, aliphatic imine 
synthesis), findings (effect of ligand bite angle) and hypotheses (testing of the 
BPM ligand) made during this study deserve to be studied further for 
improvement and optimisation. 
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1.1  Metal-catalysed asymmetric synthesis 
 
1.1.1  Introduction 
Asymmetric syntheses of organic molecules are important in the 
pharmaceutical, agrochemical,1 fragrance and flavour2 industries. For 
example, chirality-control in pharmaceuticals can be significant in terms of 
safety; often only one of the enantiomers of a pharmaceutical has desirable 
biological activity, while the other enantiomer is often inactive or even, in the 
worst case, has adverse effects.3 Thus, it is highly desirable to produce 
medicinal compounds in enantiomerically pure forms. Examples of property 
differenciation within enantiomer pairs are numerous and often dramatic. 
Examples such as Ethambutol4 (1, 2) and Thalidomide (3, 4) emphasise the 
reasons for commercial interest and the incentive for producing 
enantiomerically pure materials (Figure 1). 
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Figure 1: Differences in the properties of enantiomers. 
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The production of optically pure materials has generally presented significant 
challenges. Several methods for obtaining optically active compounds can be 
utilised:5 
- use of naturally occuring chiral pool materials: amino acids, hydroxyl 
acids, carbohydrates, terpenes, alkaloids. 
- separation of racemates: classical resolution, resolution by direct 
crystallisation, kinetic resolution. 
- creation from prochiral compounds: asymmetric synthesis (enzymic 
methods and non-enzymic methods). 
 
Of the many possible approaches to synthesise enantiomerically pure 
compounds, enantioselective catalysis is arguably the most elegant method. 
Asymmetric catalysis is an ideal method for synthesising optically active 
compounds in large quantity. Tremendous effort has been devoted to 
developing new asymmetric catalysis reactions and to improving the 
enantioselectivity and reaction efficiency of existing asymmetric catalysis 
reactions.6 To realise maximum chiral multiplication, such catalysts should 
efficiently differentiate enantiotopic groups or faces of prochiral molecules. 
For that purpose, homogeneous metal complexes have come to be one of the 
most powerful and general tools available. Indeed, metal-mediated 
asymmetric catalysis has been intensively studied in the four decades since 
the first report of homogeneous Cu-catalysed asymmetric cyclopropanation.7 
Although at first only modest enantioselectivities were realised, notable 
advances have been achieved during the last three decades. Rh-phosphine 
complex catalysed asymmetric hydrogenation of dehydro amino alcohols8,9 
4  
and Ti-tartrate complex catalysed asymmetric epoxidation of allylic 
alcohols10 were early milestones in metal-catalysed asymmetric catalysis, 
realising high enantioselectivity and broad substrate scope. These reactions 
demonstrated the high practicality of asymmetric catalysis and this was 
notably recognised in the award of a Nobel Prize to Profs. Knowles, Noyori 
and Sharpless for their seminal work on chirally catalysed hydrogenation and 
oxidation reactions.11  
 
1.1.2  Design of asymmetric catalysis 
In metal-catalysed asymmetric catalysis, high selectivity and reactivity can be 
realised by selecting the proper catalyst, substrate, and reaction conditions. 
Catalytic function is typically determined by the central metal used, while 
reactivity and enantioselectivity are more finely tuned by chiral organic 
ligands coordinated to the central metal. A delicate balance of electronic and 
steric factors determines the efficiency of a chiral metal catalyst. The proper 
choice of chiral ligands is crucial to realising efficient intermolecular chirality 
transfer from catalyst to substrate. Ligands with central chirality, axial 
chirality and/or planar chirality have proven to be effective. The diverse 
catalytic activities of metallic species combined with the virtually infinite 
availability of chiral organic ligands have so far made possible a broad 
spectrum of asymmetric reactions. Given the countless possible combinations 
of metal and chiral ligands, future prospects in this area seem bright. 
On the basis of the tremendous accumulated knowledge of organometallic 
compounds brought to us through mechanistic study, rational design and 
optimisation of catalyst is sometimes possible. For well-precedented 
5  
reactions, rational design can be considered appropriate. On the other hand, 
for unprecedented asymmetric reactions, the screening of suitable metals, 
chiral ligands and reaction conditions is still required during early 
development.  
Currently, both screening and rational optimisation through mechanistic 
studies are often required to achieve highly enantioselective metal-catalysed  
asymmetric methods. Either random screening or rational design alone rarely 
lead to superior chiral catalysts. 
 
1.2  Asymmetric synthesis of α-methyl amines 
   
 
1.2.1  Importance of chiral amines 
Asymmetric preparations of α-substituted chiral amines are a very important 
process due to the predominant role that α-chiral amines play in several drugs 
and natural products. Moreover, such chiral amines often possess pronounced 
biological activity in their own right, and hence are of increasing commercial 
value in the fine chemical and pharmaceutical areas in view of their 
application as resolving agents, chiral auxiliaries/chiral bases and catalysts for 
asymmetric synthesis. Examples of these amines (Figure 2) are Mexitil 5 
(antiarrhythmic agent), Rivastigmine 6 (anti-Alzehimer) and Indanorex 7 
(amphetamine). 
 
 
O
NH2
     
Me
NMe2
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O
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 5  6  7  
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Figure 2: Examples of chiral amines used as pharmaceuticals. 
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1.2.2  Overview of the synthesis of α-substituted chiral amines 
The preparation of α-substituted chiral amines can be carried out via several 
synthetic methods. The non exhaustive overview presented in Scheme 1 
highlights some of the most important asymmetric and non asymmetric 
reactions available to date. 
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Scheme 1: Overview of the synthesis of α-substituted chiral amines. 
 
 
If the starting material utilised in the transformation is an imine, two 
approaches may be considered depending on its nature: reduction (Equ. 9) or 
the 1,2-addition  of a nucleophile (Equ. 3-8). The reduction of ketimines 
which is a powerful method including a range of reactions such as 
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hydrogenation, transfer hydrogenation, hydrosilylation and borohydride 
reduction is developed later in this chapter (cf. 1.3.1 - Table 1). These 
reduction reactions can also be applied to oximes (Equ. 1, R1 = OH).12 
Another attractive approach is the direct reductive amination (Equ. 1) which 
corresponds to the direct reduction of an imine resulting from the reaction of 
the corresponding ketone and amine. This reaction has been carried out in an 
asymmetric fashion with metal catalysts13 and organocatalysts.14 
Another popular synthetic route starting from aldimine substrates is the 
alkylation. Indeed, the literature is abundant with procedures enabling the 
introduction of a variety of nucleophiles onto aldimines. Resulting products 
of these alkylation reactions include propargyl amines15 and allylamines (cf. 
5.1.2.1.1 - Table 1) among many other examples. As with the reduction of 
ketimines, this transformation can be carried out in an asymmetric fashion. 
The chirality can be induced here by adding an external chiral auxiliary. For 
example, the addition of organolithium reagents work successfully on  
N-(4-methoxyphenyl) protected imine in the presence of stoichiometric 
amounts of the specific chiral amine16 or bis-isoxazoline17 used as an 
auxilary.  
The chirality can also be induced by using an internal chiral auxiliary on the 
substrate itself (Equ. 7-8). This strategy was used in the addition of allylic 
metal compounds18 and organocuprate reagents19 to aldimines derived from  
1-(R)-phenylethylamine. Similarly, several allylic metal reagents based on 
Al/Ti,20 Zn21 and Mg/Cu21 above have been added with excellent 
diastereoselectivity to imines derived from (S)-valine. Turning away from 
imines, SAMP-hydrazones (SAMP: (S)-1-amino-2-methoxymethyl 
8  
pyrrolidine) are also very useful for highly asymmetric additions of 
organolithium,22 and organocerium reagents23 to yield optically active 
hydrazines that can be subsequently converted to the amine (reduction with 
Raney-Ni) without loss of optical purity. α-substituted chiral amines can also 
be prepared by alkylation of nitrone substrates which affords the 
hydroxylamine that can be subsequently converted to the amine. This can be 
done either asymmetrically (Equ. 8)24 or racemically (Equ. 2).25 Finally,  
α-substituted chiral amines can be prepared from azide substrates via a 
Staudinger reaction (Equ. 4);26 the azide substrate can be prepared 
enantioselectively via a Mitsunobu reaction (Equ. 5).27 
 
 
1.3  Asymmetric synthesis of amines from imines 
 
Preparation of chiral amines can be attained from imines substrates via two 
main different approaches: asymmetric reduction of ketimines and 
asymmetric 1,2-addition to aldimines; and it is the latter method which has 
been studied in this thesis. 
 
1.3.1  Asymmetric reduction of ketimines 
Reduction of prochiral ketimines is the most commonly used route to obtain 
optically active amines and this covers a broad field of reactions using metal 
catalysed processes. Some of the most interesting results reported in the 
literature are those that utilise acetophenone-based imines as substrates, and 
are listed below (Table 1). 
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Table 1: Enantioselective reduction of acetophenone-based imines. 
N
R
Me
HN
R
Mecatalytic complex
*
 
Entry R Conditions Catalytic complex Results 
 
128 
 
PPh2
O
 
 
NaBH2(OEt) 
(O-CH2-THF)  
0 °C, 4 h
 
N
O
Co
N
O OO
 
 
90% 
yield, 
97% e.e. 
 
229 
 
Me 
 
PhSiH3, 
pyrrolidine, 
MeOH, 
RT, 12 h 
 
TiH
 
 
95% 
yield, 
99% e.e. 
 
 
 
330 
 
Ph 
 
HCOOH, 
Et3N, 
CH2Cl2, 28 °C, 
36 h 
 
Cl
Ru
N SO2H2N
 
 
72% 
yield, 
77% e.e.  
 
 
431 
PPh2
O
 
 
H2, 25 bar, 
pyridine, 
toluene, RT, 
120 h 
 
 
[Ir(COD)Cl]2 / 
 
P
O
HPh
tBu
 
 
100% 
conv, 
70% e.e. 
531 Ph 100% 
conv, 
0% e.e. 
631  
CH2-
Ph 
 
100% 
conv(a), 
76% e.e. 
732  
CH2-
Ph 
 
H2, 100 bar, 
phthalimide 
toluene, 5 °C, 
24 h 
 
[Ir(COD)Cl]2 / 
 
N
P(C6H11)2
OO
PPh2
tBu
 
 
95% 
conv., 
85-93% 
e.e. 
 
(a) Time = 168 h. 
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The examples of Table 1 reflect the most developed enantioselective 
processes for reductions of ketimines known so far: borohydride reduction 
(Entry 1), hydrosilylation (Entry 2), transfer hydrogenation (Entry 3), and 
hydrogenation (Entries 4-7). 
Another important example in the field of enantioselective hydrogenation is 
the one developed by Bläser and Spindler33,34 during the course of the 
synthesis of a precursor of (S)-metolachlor, a popular herbicide sold all over 
the world. This molecule which is from the chloroacetanilide family is a 
 N-chloracetylated, N-alkoxy alkylated ortho disubstituted aniline (Scheme 2). 
 
N
O
H2
chiral catalyst
H
N
O
H
4 h, 25 bar, 25 °C
79 % e.e. (S)
TOF = 396 h-1
Fe PPh2
CH3
P(Xyl)2
H
Ir IrClCl
99 % conv.
S/C = 800
AcOH, TBAI8 9
 
 
Scheme 2: Preparation of (S)-metolachlor by enantioselective 
     hydrogenation. 
 
It is obtained by hydrogenation of the corresponding imine in presence of a 
catalyst generated in situ from [Ir(COD)Cl]2 and (R,S)-PPF–P(3,5-Xyl)2 
(xyliphos). This catalyst shows a high catalytic activity (396 h-1) and a 
moderate, but industrially acceptable, enantioselectivity (79% e.e.). 
At production scales, this transformation is carried out on a 10 m3 reactor, at 
80 bars and 50 °C. At the time when this transformation was reported, these 
results set a new standard concerning catalyst activity and productivity for a 
homogeneous enantioselective hydrogenation. 
11  
 
As can be seen in Table 1, the range of catalysts used in these processes 
involves various metals such as cobalt(II), titanium(III), ruthenium(II), and 
iridium(I), with e.e. values reaching 99% (Entry 2). 
Many advantages can be found to these reactions. For example, transfer 
hydrogenation (Entry 3) using stable organic hydrogen donors (HCO2H) is an 
attractive route in view of the low hazardous properties of such reducing 
agents and operational simplicity. However, these reactions require either 
expensive catalysts, harsh conditions (Entries 4-7) or offer insufficient 
reaction rates (Entries 2-7). These drawbacks have directed the study 
presented in this thesis to a second focus for the synthesis of chiral amines: 
the asymmetric 1,2-addition of carbanions to aldimines. 
 
1.3.2  Asymmetric 1,2-addition of carbanions to aldimines 
1.3.2.1  Nucleophilic attack reaction on protected aldimines 
Although imines are versatile intermediates for the synthesis of chiral 
α-branched amines, primarily due to the ready availability of a wide range of 
aldehyde and ketone starting materials, their use is not without problems. For 
the vast majority of aldehyde and ketone precursors, N-substitution is 
required to prevent oligomerization or other decomposition pathways. In 
addition to play a stabilising role, N-substitution can also be used to activate 
the imine. Many imines are hydrolytically unstable, depending both upon the 
steric and electronic properties of the aldehyde or ketone precursor, and upon 
the nitrogen substituent. In addition, imines are poor electrophiles and, upon 
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treatment with basic carbanion nucleophiles, are prone to competitive  
α-deprotonation, resulting in aza-enolate formation (Scheme 3). 
 
N
H
PG
R
N
Nu
PG
R
H
N
H
PG
R
N
H
PG
RNu +
1,2-addition
+
deprotonation reduction
 
 PG: protecting group 
 Nu: nucleophile 
   
Scheme 3: Problems encountered in the 1,2-addition to aldimines. 
 
To avoid these potential issues, studies in this thesis have been restricted to 
1,2-additions of carbanions to benzaldimines N-substituted with groups that 
make them more resistant to hydrolysis (Scheme 4). 
 
N
H
PG HN
Nu
PG
O
PPh2
Nu
Catalyst / ligand
PG =         , tosyl, benzyl, anisyl
  
 
 Scheme 4: Nucleophilic attack on protected imines. 
 
1.3.2.2  Catalytic systems for the methylation 
1.3.2.2.1  Nickel catalysed asymmetric methylation 
Nickel-catalysed methylation of aldehydes using trimethylaluminium as an 
alkylation reagent was reported by Fujisawa et al.35 in 1998. It was found that 
the addition of a phosphine ligand, such as triphenylphosphine, improved the 
reactivity of the catalyst and considerably increased the product yield. The 
reaction was carried out in THF at 0 ºC and affords the methylated alcohol 
with a range of yields exceeding 83% (Scheme 5). 
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Ar
O
H Ar
OH
Me
Me3Al (1 equ)
Ni(acac)2 (0.5 mol%)
THF, 0 oC
PPh3 (1 mol %)
90-92 %
Ar = Ph, 4-Cl-Ph,
4-Br-Ph, 4-OMe-Ph
 
    
 Scheme 5: Nickel catalysed methylation of aryl aldehydes. 
 
It can be suggested that this methylation of imines proceeds as follows 
(Scheme 6): the reaction of nickel acetylacetonate and triphenylphosphine in 
presence of trimethylaluminium gives rise to a Ni0 catalytic species that will 
coordinate with the C=N bond. An excess of trimethylaluminium activates 
the imine by coordination to the nitrogen which enables a methyl transfer 
process from nickel. Finally, the Ni0 catalytic species is released and the 
subsequent addition of acid affords the N-tosyl protected methylated amine. 
 
AlMe3 + Ni(acac)2 + 2 L
L2Ni0
N
TsH
Ph
Ph
N Ts
AlMe3
reduction
Ni0
LL
N
AlMe2H
Ph
NiII
LMe
Ts
Ph Me
N TsMe2Al
Ph Me
HN Ts
(L = PPh3)
H+
 
 
Scheme 6: Proposed catalytic cycle for the 1,2-addition of AlMe3  to N-tosyl 
   protected benzaldimine. 
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1.3.2.2.2  Copper catalysed asymmetric methylation 
The copper-catalysed addition of dialkylzinc reagents to electrophiles, which 
proceeds via an organocopper intermediate, is a well established process 
which has been used in many asymmetric processes such as conjugate 
addition36,37 and nucleophilic addition reaction.38 Charette et al.39,40,41 have 
reported the copper-catalysed addition of diorganozinc reagents to  
N-phosphinoylarylimines. This reaction proceeds with high yields and 
enantioselectivities in the presence of a catalytic amount of (R,R)-Me-
DuPHOS monoxide (BozPHOS) chiral ligand (Scheme 7). 
 
N
P
O
Ph
Ph
Ph HN
P
O
Ph
Ph
Ph
MeToluene, RT, 48 h
Me2Zn (3 eq.)
(CuOTf)2.toluene (5 mol%)
 (5 mol%)
87% yield, 97% e.e.
10 11
60
P
P
O
60
 
  
 Scheme 7: Copper-catalysed methylation of 
      N-phosphinoylbenzaldimine. 
 
Although this transformation is highly efficient, it should be noted that it has 
two drawbacks that cannot be neglected: the high sensitivity of the CuI 
catalyst (which requires handling in a glove box) and a long reaction time  
(48 h). 
 
1.3.2.2.3   Rhodium catalysed asymmetric methylation 
The observation that rhodium complexes coordinated with chiral diene 
ligands are highly active and enantioselective catalysts for the asymmetric 
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addition of arylboron reagents to imines42,43 as well as to α,β-unsaturated 
carbonyl compounds44 (Scheme 8), led Hayashi’s group to conduct the first 
example of a rhodium-catalysed methyl-transfer reaction. 
 
(Ar2BO)3 KOH/H2O
dioxane, 60 °C, 6 h
+
[RhCl(C2H4)2]2 / L* (3 mol% Rh)
L* =
(R,R)-Ph-bod*
R = 3-OMe-Ph, 4-OMe-Ph, 
3-Cl-Ph, 4-F-Ph
(1)
(2)
O
+ (RBO)3
Ph
PhL* =
[RhCl(C2H4)2]2 / L* (3 mol% Rh)
L*/Cat. = 1.1
KOH (50 mol %)
dioxane/H2O (10:1)
30-50 °C, 1 h
*
O
R
Ar1 H
N Ts
Ar1 Ar2
HN Ts
88-96 % yield
93-99 % e.e.
Ar1, Ar2 = Ph, 4-Cl-Ph,
4-CF3-Ph, 4-NMe2-Ph
94-97 % yield
95-98 % e.e.
13
 
 
Scheme 8: Use of rhodium with chiral diene ligands in the asymmetric addition 
  of aryl boroxines reported by Hayashi. 
 
 
Indeed, as shown on Scheme 8, a range of arylboroxines (and/or boronic 
acids) can be successfully added to electrophiles such as N-tosyl protected 
aldmines (Equ. 1) and α,β-unsaturated enones (Equ. 2) in an enantioselective 
fashion. These transformations are catalysed by a chiral Rh(I) catalytic 
species formed by reaction of [RhClbis(ethylene)] dimer with the appropriate 
chiral diene ligand. The reported conditions were then used by Hayashi to 
perform the addition of another type of nucleophile: dimethylzinc. It was 
found that under these conditions dimethylzinc was a better methylating 
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reagent than methylboronic acid. Therefore, in 2006, Hayashi et al.45 reported 
the asymmetric addition of dimethylzinc to N-tosylarylamines catalysed by a 
chiral rhodium-diene complex, with high yield and enantioselectivity 
(Scheme 9).  
 
 
 
dioxane, 50 °C, 3-12 h
[RhCl(C2H4)2]2 / L* (3 mol% Rh)
L* =
(R,R)-Ph-bod*
Ar1 H
N Ts
Ar1
*
Me
HN
Ts
Me2Zn (1.5 eq.)
61-82% yield 94-98% e.e.
Ar = Ph, 4-Cl-Ph, 
3-OMe-Ph, 2-naphthyl
L*/Cat. = 2.0
 
Scheme 9: Rhodium catalysed asymmetric methylation of aryl aldimines. 
 
The methylation of several N-tosylarylimines having different substituents on 
the aromatic nuclei was perfomed; electron-withdrawing substituents such as 
chloro, fluoro, and trifluoromethyl groups, smoothly give the corresponding 
amines in high yields (83-84%) with high e.e. values (94-98% e.e.).  On the 
other hand, in the reaction of imines with electron-donating substituents, a 
longer reaction time (6 h) is required to complete the reaction. The 
methylation of imines with an ortho substituent and 2-naphthylimine is 
sluggish, and the increase of the catalyst loading is needed to acquire the 
corresponding products sufficiently. 
Regarding the reaction mechanism (Scheme 10), this rhodium-catalyzed 
methylation may proceed via a methylrhodium species which is formed by 
the reaction of [RhCl(diene)] with dimethylzinc. Methyl rhodium complexes 
such as [RhMe(COD)]2 and [RhMe(COD)L] are known,46,47 the former of 
17  
which is thermally unstable. Addition of the methylrhodium 1’ to the C=N 
bond of imine 2’ forms the aminorhodium species 4’, which undergoes the σ-
bond metathesis with Me2Zn to regenerate the methylrhodium species 1’ and 
to produce the methylated product 5’ as a zinc amide.   
 
Rh Me Rh
Me
H
N
S
S
N
O
O
H
O O
Rh
S
N
O
O
H
Me
si-face
H2O (S)
R
R
R
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N
O
O
H
Me
R
MeZn
S
H
N
O
O
H
Me
R
1'
2'
3'
4'
5' 6'
Me2Zn
 
 
Scheme 10: Mechanism of the Rh-catalysed Me2Zn addition to N-tosyl 
      protected aryl imines, suggested by Hayashi. 
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The existence of 4’ is supported by the evidence provided by Hartwig et al. 48  
who reported the insertion of imines into an aryl-rhodium bond to form the 
resulting amido complex. The S configuration of the product 6’ obtained with 
(R,R)-Ph-Bod* is rationalized by the coordination of imine 2’ to a rhodium on 
its si-face, the coordination with the other face being much less favourable 
due to the steric repulsions caused by both of two phenyl groups on the diene 
ligand. This phenomenon is also observed in the arylation of imine catalysed 
by a very similar catalytic system.49 
In spite of the high efficiency of this reaction, one should note that the choice 
of the tosyl fragment as a protecting group can be problematic. Indeed, the 
fact that it requires harsh conditions to be removed may cause significant side 
reactions. For example, within the framework of the investigation mentioned 
above, the reductive deprotections of phenyl(4-chlorophenyl)methylamine 
tosylamide were  attempted with Li/NH3 and SmI2/HMPA. These reductions 
resulted in the formation of a significant amount of diphenylmethylamine, 
thus making the efficient access to the free amine difficult. 
 
 
1.3.2.2.4   Other recent systems in literature 
A) Addition of trialkyl aluminium reagents to N-phosphinoylketimine 
A noteworthy example of synthesis of α-trisubstituted amines from ketimines 
and using trialkyl aluminium reagents was reported by Bräse in 2008.50 In 
contrast to the well established 1,2-addition of organozinc reagents to 
aromatic ketones,51 the application of ketimines as alkyl or aryl group 
acceptors under similar conditions has proved much more challenging. For 
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that reason, the conditions developed by Bräse (Scheme 11) are of great 
interest. 
 
N
P
O
Ar
Ph
Ph HN
P
O
Ar
Ph
Ph
R1
(rac)
AlR23
toluene, 25 oC
R2 =  Me, EtAr = 4-Cl-Ph, 4-OMe-Ph
4-NO2-Ph, 2-OMe-Ph
7-99% yield
0.5-24 h
(3-6 equ.)
R1 R2
R1 = Me, Et, Ph
 
Scheme 11: Synthesis of α-trisubstituted by 1,2-addition to ketimines. 
 
This reaction proceeds at room temperature without the use of any additional 
reagents and enables the preparation of the desired protected amine in 
excellent yields up to 99%. Furthermore, this procedure is adapted to a range 
of acetophenone- and benzophenone-derived ketimines as shown by the 
electron withdrawing and electron releasing group aryl substituents tolerated. 
 
 
B) Addition of aryl groups to N-phosphinoylimines   
Although arylboronic acids are poor nucleophiles, rhodium(I) phosphine 
complexes can efficiently catalyse their addition to N-arene sulfonyl 
imines.52,53 Ellman et al.54 reported a highly enantioselective addition of 
arylboronic acids to N-diphenylphosphinoyl imine (Scheme 12). While the 
deprotection of the p-toluenesulfonyl protecting group can be problematic and 
costly (e.g. use of SmI2), the cleavage conditions of the diphenylphosphinoyl 
group are much easier39,55 thus making it more desirable. 
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Ph
Ph
Ph
Ar
Ar =  Ph, 4-OMe-Ph,
Rh(acac)(COE)2 (5 mol%)
(R,R)-DeguPHOS (5.5 mol%)
Et3N (1 equ.)
MS (3 A)
o
dioxane, 50 oC, 24 h
ArB(OH)2
4-Cl-Ph
(2 equ.)
46-97% yield
88-96% e.e.
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(R,R)-DeguPHOS
 
 
Scheme 12: Addition of aryl boronic acids to N-phosphinoylimines. 
 
 
When the reaction is performed in presence of activated powdered MS 3Å 
and one equivalent of Et3N (to prevent imine hydrolysis) the amine product 
could be obtained in good yield and good enantioselectivity. Furthermore, 
these reaction conditions with slight modifications could be applied 
successfully to alkylimines56 which are known for being challenging 
substrates. 
 
C) Direct allylation of N-phosphinoylimines   
Methodologies used to carry out allylation of imines include the use of allyl 
boronates,57 allyl stananes58 and chiral silanes.59 An interesting  nucleophilic 
addition of allyl groups to N-phosphinylimines  has been reported by Porco et 
al. (Scheme 13).60 
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O
Ar
Ph
Ph HN
O
Ar
Me CO2Me
SiMe2Ph
La(OTf)3.nH2O
TFAA
(0.2 equ.)
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CH3CN, 3 h
CO2Me
Me
CF3
Ar Yield (%) dr er
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2-naphthyl
87 15:1 89:11
99 15:1 96:4
 
 
Scheme 13: Allylation of N-phosphinoylimines with organosilanes. 
 
 
This reaction corresponds to the addition of a chiral organosilane by rare earth metal 
trilfate/trifluoroacetic anhydride activation and affords the trifluoroacetamide 
product. It should be noted that the resulting product of this reaction which is formed 
via an in situ derivatisation step was unexpected by the authors. A screening of 
different rare-earth metal triflates was carried out and led to the identification of 
La(OTf)3nH20 as an efficient catalyst. Furthermore this reaction affords moderate to 
good yields and is tolerant towards a range of aryl substituents. 
 
D) Direct addition of TMS-acetylene to aldimines 
Carbanion addition to N-alkyl aldimines typically prescribes the use of Lewis 
acid additives (i.e. BF3Et2O) as a means of activating the aldimine substrate. 
Moreover imine addition reactions typically require the use of  stoichiometric 
quantities of alkali, alkaline earth, or transition metal carbanions, or 
alternatively organoboranes, -silanes, or -stannanes. In 2001, Carreira et al.15 
reported a novel process which was considerably simplified over previously 
documented C=N addition reactions, proceeding at room temperature and 
requiring only N-alkyl or N-aryl aldimines, trimethylsilylacetylene and 
catalytic amounts (4-5 mol%) of [IrCl(COD)]2 (Scheme 14). 
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N
PG
R
HN
R
PG
PG = Bn, p-Anisyl
R = alkyl, aryl
[IrCl(COD]2 (4-5 mol%)
THF, 23 oC
54-85% yield
SiMe3
H SiMe3 (1.5 equ.)
 
 
Scheme 14:  Addition of TMS-acetylene to aldimines. 
 
The main advantages of this process are the fact that the Ir(I) catalyst which is 
used is commercially available and that the reaction can be carried out in the 
absence of solvent thus providing for a highly atom-economical process. 
 
E) Separation of racemates 
Most of the chiral synthetic methods presented in this thesis focus on 
asymmetric synthesis; however, it should be noted that other chiral methods 
of synthesis can be utilised, notably the separation of racemates. The 
separation of racemates include a range of methods: classic resolution, 
resolution by direct recrystallisation and kinetic resolution. 
Despite its “low technology” image, classical resolution via diastereoisomer 
crystallisation is widely used industrially and in particular furnishes a large 
proportion of optically active drugs which are not derived from natural 
products. In 1992, the examination of a representative group of optically 
active drugs61 showed that 65% owed their optical activity to classical 
resolution. Classical resolution can be very useful provided there is suitable 
functionality in the molecule through which to form a diastereoisomer, and 
usually, access to both enantiomers. There are clearly many instances where 
resolution is both economically viable and the method of choice.62,63 
Kinetic resolution was first discovered by Marckwald and McKenzie in 
189964 in the esterification reaction of racemic mandelic acid. This process is 
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based on the difference of reaction rates of two enantiomers in a chemical 
reaction, thereby creating an excess of the less reactive enantiomer. 
Finally, resolution by direct crystallisation is also an attractive method since 
auxiliairies and reagents other than solvent are not required. In simple terms, 
the principle of this method65 depends on the occurence of some substances 
as crystalline conglomerates (racemic mixtures) rather than racemic 
compounds. Although in bulk a conglomerate is optically neutral, individual 
crystals contain only one enantiomer, whereas in a racemic compound 
individual crystals contain equal amounts of both enantiomers.  
 
1.4  Methylating reagents 
 
 
1.4.1  Organoaluminium compounds 
Although known as a highly reactive species for more than a century, it is 
only since the 1950s that organoaluminium compounds have attained 
widespread use, triggered by the pioneering work of Karl Ziegler (Nobel 
prize laureate in 1963). Compared with the organometallic compounds of 
groups 1 and 2, aluminium organyls excel in the ease of their addition to 
alkenes and alkynes. The regio- and stereoselectivity of these 
carbaluminations, as well as of the related hydroaluminations with R2AlH, are 
an additional asset. Organoaluminium compounds, which are derivatives of 
the cheapest of the active metals, may gradually substitute organolithium and 
organomagnesium compounds as more-economical reducing and alkylating 
agents. 
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1.4.1.1  AlMe3 as a methylating reagent 
1.4.1.1.1  Use and applications of AlMe3 
Trimethylaluminium (TMA) is a pyrophoric colourless liquid that is perhaps 
the most industrially important organoaluminium compound. It is mainly 
used for the production of methylaluminoxane, an activator for Ziegler-Natta 
catalysts for olefin polymerisation.66,67 TMA is also employed as a 
methylation agent. Tebbe's reagent, which is used for the methylenation of 
esters and ketones, is prepared from TMA. TMA also forms a complex with 
the tertiary amine DABCO, which is safer to handle than TMA itself.68 In 
combination with Cp2ZrCl2 (zirconocene dichloride), TMA participates in 
carboalumination reactions of alkynes to give vinyl aluminium species which 
are useful in organic synthesis in a reaction known as carbozirconation69,70 
(Scheme 15). 
 
AlMe3
Cp2ZrCl2
(2 equ.)
Me2Al
Cl
ZrCp2
Me
Cl
Me2Al
Cl
ZrCp2
Cl
Me
R H
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R H
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Cl AlMe2Cl
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Me2
ClCl
Me AlMe2
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Zr
Cp2
ClCl
Cp2ZrCl2
Me AlMe2
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Scheme 15: Negishi zirconium-mediated carboalumination reaction. 
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1.4.1.1.2  Preparation 
Alkylaluminium compounds were originally prepared on a laboratory scale 
by transmetallation of mercury compounds (Figure 3 - route i). Later on, 
many other methods were developed by different groups, some of which are 
reported in Figure 3. 
Na
Me3Al2X32 Al + 3 MeX
+ 3 MeXAl MgMe3Al2I3 + AlR3
Et3Al + 3 MeI
AlMe3
2 Al + 3 HgMe2
(i)
(ii)
(iii)(iv)
(v)
14
 
Entry Route Conditions Yield (%) 
171 (i) /a /a 
272 (ii) 30-170 °C, 30 h 70-80 
373 (iii) 92 °C, 18 h 95 
474 (iv) X = Cl, autoclave, reflux, 25 h 63 
575 (v) R = Et, 100 °C,  6.5 h 90 
676 R = Et : ultrasonic, RT, 2.5 h 86 
 
(a)  Not reported. 
 
Figure 3: Preparations of trimethylaluminium reported for a laboratory scale. 
 
As it can be seen, trimethylaluminium (and other trialkylaluminium reagents) 
can be prepared from either aluminium metal (routes i, iv) or other aluminium 
derivatives (routes ii, iii, v). Often, the ease of the reaction depends on the 
nature of the solvents and the method of the activation of the aluminium 
metal; the latter can be done by grinding aluminium with Et3Al (to remove 
surface oxides) and/or by other means such as ultrasonic irradiation (route v) 
or addition of iodine. On an industrial scale, trimethylaluminium is prepared 
by the reaction of aluminium metal with chloromethane to give Al2Cl2Me4, in 
a reaction commonly known as the Ziegler direct process. This intermediate 
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is then reduced with sodium and the product Al2Me6 is removed by fractional 
distillation (Scheme 16). 
 
2 Al + 6 MeCl + 6 Na Al2Me6 + 6 NaCl
14
 
 
  Scheme 16: Industrial preparation of trimethylaluminium. 
 
Triethylaluminium and higher alkyl compounds can be prepared from the 
metal, an appropriate alkene and hydrogen gas at elevated temperatures and 
pressures (Scheme 17). This route is relatively cost-effective and, as a result, 
these alkylaluminium compounds have found many commercial applications. 
 
2 Al + 3 H2 + 6 CH2 CH2 Al2(CH2CH3)660-110 °C
15
10-20 MPa
 
 
Scheme 17: Preparation of higher alkyl aluminium compounds. 
 
 
1.4.1.1.3  Structure and bonding 
Steric factors have a powerful effect on the structures of alkylaluminiums. 
Where dimers are formed the long weak bridging bonds are easily broken. 
This tendency increases with the bulkiness of the ligand. The species AlMe3 
which features an aluminium atom bonded to three methyl groups can only be 
observed in the gas phase in an equilibrium with Al2Me6. As for the solid and 
solution states, the dimeric form is exclusive. 
Alkylaluminium dimers are similar in structure to the analogous dimeric 
halides but the bonding is different. In the halides, the bridging Al-Cl-Al 
bonds are 2c,2e bonds (2-center-2-electron bonds); that is each Al-Cl bond 
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involves an electron pair. In the alkyl aluminium dimers the Al-C-Al bonds 
are longer than the terminal Al-C bonds (214 and 197 pm, respectively for 
AlMe377), which suggests that they are 3c,2e bonds, with one bonding pair 
shared across the Al-C-Al unit, somewhat analogous to the bonding in 
diborane, B2H6 (Figure 4).  
C
Al
C
CH3
CH3
Al
H3C
H3C
260
75 °
H3
H3
197214
123 °
      
Figure 4: Structure of trimethylaluminium (distances in pm). 
 
 The Al-Al distance in Al2Me6 (260 pm) which has a 2e3c Al-C-Al bridge is 
significantly shorter than in Al2Cl6 (340 pm) which has a 2e2c Al-X-Al 
bridge. The short distance in Al2Me6 is indicative of a direct Al-Al interaction 
as this length only marginally surpasses the sum of the covalent radii of two 
Al atoms (2 × 126 ppm). In an extreme representation that involves an Al-Al 
σ bond, Al(sp2) hybridization rather than Al(sp3) is assumed78 (Figure 5). 
Al
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H3C Al
CH3
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Al Al
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Figure 5: Extreme formulations of the dimeric structure of 
   trimethylaluminium. 
 
δ+ 
δ- 
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The case of structure A is in agreement with the considerable increase in the 
Cterminal-Al-Cterminal angle beyond 109.5 °. The smaller bond angle Al-Cbonded-
Al reflects a compromise between optimal orbital overlap and tolerable 
Alδ+/Alδ- repulsion. The actual situation probably lies between the alternatives 
of structures A and B. 
 
1.4.1.1.4  DABAL-trimethyl 
Attempts to realise stabilised reagents derived from trimethylaluminium 
through the formation of Lewis acid/base pairs have been reported first by 
Schumann, Blum and co-workers.79 Recently, it has been reported by 
Woodward68 that a remarkably air-stable AlMe3 adduct (AlMe3)2DABCO, 
called DABAL-Me3 (Figure 6), could be applied to the asymmetric 
methylation of aldehydes. 
N
N
AlMe3
AlMe3
Al
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NMe2
Al
O
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Al
Me2N
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DABAL-Me3 Schumann-Blumm reagents
16 17 18 19
 
 
Figure 6: Intramolecularly stabilised alkylaluminium reagents. 
 
DABAL-Me3, which is now commercially available, can be readily prepared 
in one step from DABCO and neat AlMe3. Although somewhat moisture 
sensitive it can be easily handled without the need for an inert atmosphere 
(unlike AlMe3 which is pyrophoric). In comparison to the Schumann-Blumm 
reagents (1780, 1881, 1982) DABAL-Me3 16 is prepared directly from 
inexpensive, commercially available materials and is an extremely convenient 
source of carbanions. 
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1.4.2  Organozinc compounds 
1.4.2.1  General features 
Organozincs have been known since the preparation of diethylzinc by 
Frankland83 in 1849 at Marburg (Germany). These organometallic reagents 
were often used to form new carbon-carbon bonds until in 1900 Grignard84 
discovered a convenient preparation of the equivalent organomagnesium 
compounds. These reagents were found to be more reactive species toward a 
broad range of electrophiles and afforded generally higher yields compared to 
organozincs. However, some reactions were still performed with zinc 
organometallics such as the Reformatsky reaction85 and Simmons-Smith 
cyclopropanation.86 The intermediate “organometallics” (a zinc enolate and a 
zinc carbenoid) were easier to handle and more selective than the 
corresponding magnesium organometallics. The functional-group tolerance of 
organozinc reagents87 remained largely ignored by synthetic chemists and it 
only became clear in the 1980s that organozinc compounds are able to undergo 
a large range of transmetallations with transition metals due to the presence of 
empty low-lying d-orbitals leading to highly reactive intermediates. Thus, 
unreactive zinc reagents can produce highly reactive organometallic 
intermediates capable of reacting with many electrophiles that are otherwise 
unreactive toward organozincs. This behaviour can be explained by the 
presence of d-orbitals at the transition-metal center that makes a number of 
new reaction pathways available that were not accessible to the zinc precursors 
since the empty d-orbitals of zinc are too high in energy to participate to most 
organic reactions. It is the combination of the high tolerance of functionalities 
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of organozinc derivatives with a facile transmetallation to many transition 
metal complexes, which makes organozincs such valuable reagents. 
 
1.4.2.2  Reactivity of organozinc reagents 
There are three important classes of organozinc reagents: (i) organozinc halides 
of the general formula  RZnX (ii) diorganozincs of the general formula R1ZnR2 
in which R1 and R2 are two organic groups and (iii) zincates of the general 
formula R1(R2)(R3)ZnMet in which the metal (Met) is usually Li or MgX. The 
reactivity of these zinc reagents increases with the excess of negative charge of 
the zinc center (Figure 9). 
 
alkynyl < alkyl < alkenyl ≤ aryl < benzyl < allyl 
 
RZnX < R2Zn < R3ZnMgX < R3ZnLi 
 
Figure 9: Reactivity order of zinc organometallics. 
 
The high covalent degree of the carbon-zinc bond together with its low polarity 
leads to a moderate reactivity for these organometallics towards many 
electrophiles. Only reactive electrophiles react in the absence of a catalyst. In 
general, a direct reaction of organozincs with carbon electrophiles is not 
efficient and low yields are obtained. The addition of a catalyst is usually 
needed. The presence of empty p-orbitals at the zinc center facilitates 
transmetallations and a number of transition metal organometallics can be 
prepared in this way. These reagents can be highly reactive towards organic 
electrophiles since the low-lying d-orbitals are able to coordinate and activate 
many electrophilic reagents. 
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Because this thesis focuses mainly on diorganozincs only these will be 
considered in detail in the following introduction. 
 
1.4.2.3  Dimethylzinc 
Dimethyl- and diethylzinc were the first main group organometallic 
compounds to be synthesised and characterised; the events and deliberations 
leading up to their preparation by Frankland more than 150 years ago have 
recently (2001) been reviewed by Seyferth.83 Dimethylzinc or 
“zincmethylium” as first named by Frankland, Zn(CH3)2 is a colourless liquid 
originally prepared by the action of methyl iodide on zinc (or zinc sodium 
alloy) at elevated temperature (Figure 7 - entry 1). Since the discovery of this 
process (1884), most of the literature procedures reporting in the synthesis of 
Me2Zn rely mainly either on the same approach with slightly modified 
conditions (Entry 2) or on reacting zinc bromide (or chloride) with methyl 
organometallics (Entries 3-4). Both approaches work efficiently and afford the 
product often in very good yields. 
ZnMe2 ZnX2 + MeYZn + MeX
(i) (ii)
20
 
 
  
 (a)  Not reported. 
 
      Figure 7: Selected preparations of dimethylzinc from the literature. 
 
Entry Route Conditions Yield 
(%) 
183,83 (i) X = I, 
150-160 °C 
/a 
288 X = halogens, 
DMF, 50-60 °C 
90 
389 (ii) X = Br, Y = halogens,  
Li, ultrasonic, toluene/THF, 0 °C, 10-20 min  
100 
490 X = Cl, Y = Li, 
THF, RT, 5 min 
100 
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Regarding the structural data (Figure 8), 83,91,92 several studies of the vibrational 
spectrum of Me2Zn have made it clear that the valence angle C-Zn-C is 180° 
and that the barrier to internal rotation is negligeable.93 Additionaly, 
computational population analyses94 indicate that the 3d electrons of Zn must 
be regarded as non-bonding and the Zn-C bond as a pure σ-bond. 
 
CZnC
H
H
H
H
H
H
180 ° 112,5 °
193
110
  
 
Figure 8: Structure of dimethylzinc (distances in pm). 
 
Binary organozinc compounds such as Me2Zn are monomeric. The molecules 
are linear and have low melting and boiling points. Whereas self-association 
through Zn-R-Zn 2e3c bridges is apparently disfavoured, Zn-H-Zn 2e3c 
bridges are formed readily. Dimethylzinc has been used for a long time to 
introduce methyl groups into organic molecules or to synthesise organometalic 
compounds where a very mild methylation source is required. The Grignard 
reagents MeMgX, which are easier to handle and less inflammable have, 
however, replaced dimethyl zinc in most of the laboratory synthesis.  
 
1.4.2.4  Preparation of diorganozincs 
1.4.2.4.1  I/Zn exchange 
Diorganozincs ZnR2 are usually more reactive toward electrophiles than 
organozinc halides RZnX. However, a wide range of methods is available for 
the preparation of the latter, the oldest being the direct insertion of zinc to an 
alkyl halide (usually an alkyl iodide) leading to an alkylzinc intermediate that, 
σ 
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on distillation, provides the liquid diorganozinc (R2Zn).83,95 This method is 
applicable only to non-functionalized diorganozincs bearing lower alkyl chains 
(up to hexyl) due to the thermic instability of higher homologues.  
The I/Zn exchange reaction using Et2Zn allows the preparation of a broad 
range of diorganozincs. The ease of the exchange reaction depends on the 
stability of the newly produced diorganozincs. Thus, diiodomethane smoothly 
reacts with Et2Zn in THF at -40 °C providing the corresponding mixed 
ethyl(iodomethyl)zinc reagent with quantitative yield. The I/Zn exchange is 
catalysed by the addition of CuI (0.3 mol%). After the evaporation under 
vacuum of excess Et2Zn and ethyl iodide formed during the reaction, the 
resulting diorganozincs are obtained in excellent yields (Scheme 18).96 
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Scheme 18: Diorganozincs obtained by I/Zn exchange. 
 
A more reactive exchange reagent (i-Pr2-Zn) can be used instead of Et2Zn. This 
organometallic has to be free of salts if optically active diorganozincs need to 
be prepared. However, the presence of magnesium salts has a beneficial effect 
on the rate of exchange and a range of mixed zinc reagents of the type  
RZn(i-Pr) can be prepared under mild conditions.97 
34  
Since the isopropyl group is also transferred in the reaction with an electrophile 
at a comparable rate as the second R group, an excess of electrophile has to be 
added and tedious subsequent separations may be required. A more 
straightforward approach is possible for diarylzincs. In this case, the I/Zn 
exchange is catalysed by lithium salts and can be performed under very mild 
conditions (Scheme 19).98 
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Scheme 19: Li(acac) catalysed synthesis of diarylzincs. 
 
The intermediate formation of a zincate enhances the nucleophilic reactivity of 
the substituents attached to the central zinc atom and makes it more prone to 
undergo an iodine-zinc exchange reaction. Thus, the addition of catalytic 
amounts of Li(acac) to an aryl iodide and i-Pr2Zn allows the transfer of the two 
i-Pr groups with the formation of Ar2Zn and i-PrI (2 eq.). This method allows 
the preparation of highly functionalised diarylzinc reagents that undergo 
typical reactions of diorganozincs. 
 
1.4.2.4.2  B/Zn exchange 
Various organoboranes react with Et2Zn or i-Pr2Zn providing the 
corresponding diorganozinc. Pioneered by Zakharin and Okhlobystin99 and 
Thiele and co-workers,100 the method provides a general entry to a broad range 
of diorganozincs. Remarkably, functionalised alkenes bearing a nitro group or 
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an alkylidenemalonate function are readily hydroborated with Et2BH prepared 
in situ and converted to diorganozinc reagents (Scheme 20). 
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   Scheme 20: Preparation of functionalized diorganozincs using  
            B/Zn exchange. 
 
The exchange reaction proceeds usually under mild conditions and tolerates a 
wide range of functional groups. It is applicable to the preparation of allylic 
and benzylic diorganozincs as well as secondary and primary dialkylzincs101 
and dialkenylzincs.102 
 
1.4.2.4.3  Hydrozincation of alkenes 
Diorganozincs can also be prepared by a nickel-catalysed hydrozincation. The 
reaction of Et2Zn with Ni(acac)2 may produce a nickel hydride that adds to an 
alkene leading after transmetallation with Et2Zn, to a dialkylzinc. This reaction 
proceeds in the absence of solvent and at temperatures between 50-60 °C. A 
number of functionalised olefins, like allylic alcohols or amines can be directly 
used. They afford the expected products in 60-75% yield (Scheme 21).103 
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Scheme 21: Ni-catalysed hydrozincation of alkenes. 
 
This method is especially well suited for the preparation of functionalised 
diorganozincs for the asymmetric addition to aldehydes. 
 
1.4.2.5  Preparation of organozinc halides 
The reactivity of organozinc halides strongly depends on the electronegativity 
of the carbon attached to zinc and on the aggregation of the zinc reagent. A 
stabilisation of the negative carbanionic charge by inductive or mesomeric 
effect leads to a more ionic carbon-zinc bond and to a higher reactivity. 
The oxidative addition of zinc dust to functionalised organic halides allows the 
preparation of a broad range of polyfunctional organozinc iodides (Scheme 
22). 
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THF
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FG = CO2R, CN, halide, (RCO)2N, (TMS)2N, RNH, NH2, 
             RCONH, (RO)3Si, (RO)2PO, RS, RSO, RSO2, PhCOS 
 
Scheme 22: Functionalised organozinc compounds prepared 
          by oxidative addition. 
 
As a general rule, both the nature of the zinc and its activation are important. 
Finely cut zinc foil or zinc dust can be used. Zinc slowly oxidises in air and is 
covered by an oxide layer. Its activation which is of great importance is done 
by removing the oxide layer via chemical methods.104 
 
 
1.5  Aims and objectives 
 
The aim of the research project presented herein is to develop a new 
enantioselective catalytic system for the 1,2-addition of alkyl nucleophiles to 
aldimines. The methyl group was chosen as the first nucleophile to be tested, 
therefore trimethylaluminium and dimethylzinc were used as primary 
alkylating agents. Even though a few processes have already been reported in 
the literature in this field, they present some shortcomings, thus allowing room 
for better systems to be developed. Unlike Charette’s39,40,41 and Hayashi’s44 
metal-catalysed Me2Zn addition reactions, we aimed to identify a novel 
reaction that would ideally fulfill the following criteria: relatively short 
reaction time, commercial availability of all reagents including ligand and 
catalyst, easy handling of the ligand and catalyst under air. 
Since no antecedent of this type of imine chemisty existed within the 
laboratory, we embarked on this totally new project based exclusively on 
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literature reports. Consequently, modern high throughput screening was an 
essential tool that we aimed to take advantage of to identify leads. 
The ultimate goal of the development of this methodology is to expand the 
newly discovered methylation system in hand by further elaboration to useful 
targets such as biologically active molecules or their precursors. 
 
39  
 
 
 
 
Chapter II 
Synthesis of substrates 
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2.1  Synthesis of the substrates 
 
At the project’s inception five benzaldimines with different steric and 
electronic properties were synthesised in order to observe the effect of the 
nature of the protecting group on potential imine alkylation reactions. Thus, 
various protecting groups such as the diphenylphosphinoyl, the tosyl and the 
tert-butyl carbamate as electron withdrawing groups, the benzyl as an aliphatic 
group, and finally the anisyl as a coordinating group, have been used in imine 
methylation reactions (Figure 10). 
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Figure 10:  Synthesised imines used as substrates. 
 
The synthesis of benzylidene N-tosylimine 28 was achieved by condensation of 
benzaldehyde and the corresponding amine, in presence of trifluoroacetic 
anhydride in refluxing CH2Cl2105 or by using a Dean-Stark trap with refluxing 
toluene.106 On the other hand, a third method involving the use of the Lewis 
acid TiCl4 in a basic solution of triethylamine in CH2Cl2 at room temperature 
41  
afforded the N-tosylimine with a good yield (71%) in a single step. Likewise, 
imines 27, 29 and 30 were synthesised using the same method. 
Dropwise addition of TiCl4 to a solution of triethylamine, benzaldehyde and 
the corresponding amine in CH2Cl2 at 0 ºC, provided imines 27-30 in 71-89% 
yield (Table 2). All the amines used in the synthesis were commercially 
available. 
 
 
Table 2: Synthesis of benzaldimines. 
 
O
H H2N PG H
N
PG
+
TiCl4 , Et3N
CH2Cl2, 0 °C, 30 min
(+ RT, overnight)
 
Entry Imine PG   
(protecting group) 
Yield (%)a 
1 27169 POPh2 71 
2 28107 SO2-Tol 71b 
3 29162 CH2-C6H5c 89d 
4 30107 2-OMe-C6H4 85d 
  
(a) Isolated yield. Purified by flash chromatography on silica gel. 
(b) Yield valid when purification is carried out on a 3 mmol scale. 
(c) Synthesis of this imine under simpler conditions (CH2Cl2, 
  molecular sieves, RT, overnight) afforded the product with the 
  same yield. 
(d) No purification required. 
 
The mechanism of formation of these imines is quite simple (Figure 11). After 
activation of the aldehyde by titanium (IV) chloride (Lewis acid), attack of the 
amine at the carbonyl occurs. Proton transfer generates an oxonium ion that 
can eliminate to give the iminium cation which can be quenched to lead to the 
desired imine. 
 
42  
H
O
H
O
TiCl4
PGH2NTiCl4 O
TiCl4
H
O
TiCl4
H
H
N
H
PG
H
N
PGH
H
N
PG
..
+
+
-
-
-
+
N PG
H
+
PT
H
 
 
 Figure 11: Mechanism for the formation of benzaldimines promoted by TiCl4. 
 
As illustrated in the mechanism, the presence of titanium chloride is crucial for 
the success of the reaction since it compensates the lack of nucleophilicity of 
the amide. However, since the benzylidene N-benzylamine (Entry 3) is rather 
nucleophilic, it was possible to synthesise 29 with a more convenient route 
involving only the use of dichloromethane and molecular sieves at room 
temperature, with an identical yield (89%). Finally, tert-butyl 
benzylidenecarbamate 31 was synthesised in a completely different way.108 
Synthesis of 31 (Scheme 23) was achieved in two steps via a sulfone 
intermediate. In the first step, benzaldehyde, tert-butylcarbamate and sodium 
benzenesulfinate react together with formic acid to generate the corresponding 
sulfone. Treatment of the crude sulfone with the weak base K2CO3 in refluxing 
THF afforded the pure imine with a 66% overall yield. 
 
43  
O
H
H2N
O
O HN
SO2Ph
O
O
N
O
O
H
PhSO2Na, HCO2H
H2O/MeOH (2:1), RT, 24 h
THF, reflux, 24 h78%
85%
66% overall yield
K2CO3
31
 
 
Scheme 23: Synthesis of tert-butyl benzylidenecarbamate. 
 
The need to use a sulfone as an intermediate can probably be explained by the 
instability of product 31 in the presence of acids and strong Lewis acids. 
Precipitation of the insoluble SO2Ph adduct provides an alternative driving 
force. 
 
 
2.2  Synthetic routes of access to diphenylphosphinoyl protected 
   imines 
 
During the course of our investigation, the most useful protecting group turned 
out to be the diphenylphosphinoyl group (cf 4.2). Therefore, we investigated 
other ways of preparing diphenylphosphinoyl protected aldimines, in the most 
efficient and convenient way possible. An overview of the literature enabled us 
to distinguish three main synthetic routes (Scheme 24), including one we 
already used, all using an aldehyde as a starting material. 
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Scheme 24: Synthetic routes for the preparation of diphenylphosphinoyl 
              protected aldimines. 
 
The first route (Equ. i)109,39 consisted in forming a sulfonyl adduct of the 
amine, by reacting the aldehyde with toluenesulfinic acid and 
diphenylphosphinic amide at room temperature. The resulting adduct can then 
be deprotected with a base such as potassium carbonate to afford the desired 
imine. Although this method may seem attractive, it should be noted that long 
reaction times are required (3 days in total to achieve the crude imine). 
Furthermore, in our hands the isolation of the sulfonyl adduct intermediate 
turned out to be problematic and this method was deemed not viable for future 
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syntheses. The second route (Equ. ii),169 the titanium (IV) chloride promoted 
condensation between the aldehyde and diphenylphosphinic amide, in the 
presence of triethylamine (traps the free HCl in the reaction mixture) afforded 
the desired imine in 21-88% yield. Finally, a third method (Equ. iii)110 which 
consists in making an oxime intermediate (in quantitative yield) that 
subsequently undergoes a reaction with chlorodiphenylphosphine at a low 
temperature (-45 °C) in CH2Cl2, reportedly affords the desired imine. However, 
the second step involving the introduction of the phosphorus containing group 
turned out to be impossible to achieve in our hands. The reasons for this are not 
clear since other groups have used this route. It should be noted that the 
primary literature suggests the involvement of a radical mechanism in that step 
and also reports occasional unexplained failures of the reaction, thus 
demonstrating the high sensitivity of the reaction conditions. A low 
temperature 31P NMR investigation in deuterated dichloromethane was carried 
out in an attempt to get a better understanding of the reaction but this did not 
prove helpful. Indeed, it was found that the reaction between the oxime and 
chlorodiphenylphosphine occurred instantly to generate a substantial range of 
peaks in the 31P NMR spectrum and in a wide range of chemical shifts. No 
evolution could be observed at all in the 31P NMR spectrum even after several 
hours of reaction. The particular asset of that method is that it could potentially 
give access to aliphatic imines, which are challenging substrates since they are 
enolisable compounds. 
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We eventually opted for the initial TiCl4 promoted condensation (Equ. ii) 
because of the simple conditions required: single step synthesis, short reaction 
time and simple purification (filtration through Celite + flash chromatography).  
One major advantage of this synthesis is the fact that both of the starting 
materials are commercially available. However, as the price of 
diphenylphosphinic amide is quite high (5 g for £100 from Sigma Aldrich) we 
thought it was necessary to prepare this compound in the laboratory. It can be 
synthesised by reacting diphenylphosphinic chloride (5 g for £8 from Sigma 
Aldrich) with liquid ammonia169 in CH2Cl2 (-78 °C to RT, overnight) to give 
rise to the precipitation of a white crystalline solid (92% yield) that was used 
without further purification for the synthesis of 27. Interestingly, no report in 
the literature was found for a version of this reaction using the safer standard 
aqueous ammonia solution instead of liquid ammonia which requires cautious 
handling because of the hazard known for this chemical (corrosive and 
extremely irritating). Consequently, we ran the reaction using aqueous 
ammonia at room temperature for two hours and were very pleased to see that 
it was as efficient as liquid ammonia at -78 °C to afford diphenylphosphinic 
amide with an identical yield. 
While using the TiCl4 promoted condensation method, we were also pleased to 
find that a simple scale-up of the reaction could increase the chemical yield 
(Figure 12). For instance, in the synthesis of 27 the initial 71% yield (Table 2 – 
entry 1) could be increased to 88% (Figure 12) by scaling up the reaction by a 
factor of two. 
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Figure 12: Range of diphenylphosphinoyl protected aryl imines prepared in  
          21-88% isolated yield. 
 
 
A wide range of substrates with aryl substituents was prepared. The chemical 
yield of their synthesis is quite variable (21-88%) depending on the hydrolytic 
stability of the imine which is obtained. Therefore, one of the least stable imine 
turned out to be imine 38 bearing the m-chlorophenyl substituent while one of 
the most stable was imine 27. From a practical point of view, each of these 
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imines could be stored for several weeks under an inert atmosphere, at room 
temperature and in the absence of light, without any significant hydrolysis. 
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Chapter III 
Measurement of the 
enantiomeric excess 
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3.1  Synthesis of the racemates 
 
In order to gather the data of the imine methyl addition compounds (for future 
e.e. assays), it was required first of all to synthesise the racemates. These can 
be prepared in two different ways. The first method consists in reacting  
(±)-α-methylbenzylamine with a suitable electrophile introducing the 
protecting group on the nitrogen (Scheme 25). 
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Scheme 25: Synthesis of the racemates. 
 
In the case of amines 44 and 45, simple basic conditions were required. In the 
case of 46 in which the halide is an aryl halide, use of the chemistry of 
Buchwald111 was necessary to afford the amine. Finally, 47 was prepared by  
simply using Boc anhydride (di-tert-butyl dicarbonate) in a basic solution of a 
mixture Et3N/DMAP in dichloromethane. 
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The second method of preparation of these racemates consisted in reacting the 
imine with MeMgBr thus reducing the aldimine into an α-methylated amine 
(Table 3). 
 
  Table 3: Synthesis of racemates using methyl Grignard reagent. 
 
R
N
PPh2
O
Me MgBr
CH2Cl2/THF
0 °C RT
1-3 h
(3 equ)
R
HN
PPh2
O
Me
(rac)
 
Entry R Product Yield 
(%) 
1 Ph 44 92 
2 4-Me-Ph 48 83 
3 3-Me-Ph 49 98 
4 2-Me-Ph 50 93 
5 4-Cl-Ph 51 96 
6 4-Ph-CF3 52 89 
7 4-F-Ph 53 93 
8 4-Cl-Ph 54 96 
9 4-CF3-Ph 55 91 
10 3-Cl-Ph 56 94 
11 2-Cl-Ph 57 91 
12 4-Br-Ph 58 87 
13 4-OMe-Ph 59 94 
14 2-naphthyl 60 92 
15 1-naphthyl 61 90 
 
Unlike the first method, this second method can be generalised and used with 
any aromatic aldimine. The reaction is run in THF and a minimum amount of 
dichloromethane to solubilise the imine. In addition to being an inexpensive 
nucleophile, the high reactivity of methyl Grignard reduces substantially the 
reaction time. Therefore the reaction conditions make this method very 
attractive for its simplicity and cost-effectiveness. 
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3.2  Measurement of the enantiomeric excess 
 
3.2.1  Phosphorus NMR assay 
The most time consuming aspect of (L*)M promoted asymmetric catalysis is 
often the identification of an optimal ligand. High throughput screening where 
the e.e. value of a large number of reactions can be determined quickly is 
highly desirable. Various methods are available to determine the e.e. values of 
chiral molecules, including chiroptical, spectroscopic and chromatographic 
techniques, each finding preference in certain circumstances. It was quickly 
realised that measurement of the e.e. of 44 using HPLC was quite time 
consuming, partly because of the non-availability of an autosampler in our 
HPLC unit. An alternative to HPLC could be the use of G.C. (which was 
available locally with an autosampler) but the high molecular weight of the 
diphenylphosphinoyl group could not make GC viable. 
It was decided that the use of chiral shift reagents in NMR spectroscopy could 
be a solution to these difficulties. Indeed, although enantiomers cannot be 
distinguished in NMR spectroscopy in an achiral medium, since the resonances 
of enantiotopic nuclei are isochronous, chiral shift reagents may be able to 
form complexes that can be distinguished because their resonances are 
anisochronous. Of the several types of NMR experiment available to assay 
enantiopurity, chiral derivatisation relies upon conversion of substrate 
enantiomers to diastereomers upon interaction with a chiral probe compound. 
For example, Mosher’s acid112 - MTPA (α-methoxytrifluorophenylacetic acid) 
is one of the most commonly used (Scheme 26).  
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Scheme 26: α-methoxytrifluorophenylacetic acid 
    commonly known as Mosher’s acid. 
 
However, any derivatisation for NMR assay would entail a deprotection step of 
the diphenylphosphinoyl group to get the free amine. Such lengthy procedures 
would then favour the use of GC instead of NMR (GC often gives a better 
resolution than NMR). Consequently the use of NMR could be advantageous 
if, and only if, a direct determination of the e.e. value carried out in a single 
step could be done. Chiral lanthanide NMR probes113,114 such as Yb(III) and 
Eu(III) β-diketonate complexes are well known organic chiral chelates that 
have the ability to form diasteromeric complexes that induce variations of the 
chemical shifts of different enantiomers. These reagents function by acting as 
Lewis acids, forming a complex with the substance under analysis, which acts 
as a nucleophile. Induced shifts with this type of complexes are attributed to a 
pseudo-contact or dipolar interaction between the reagent and the nucleophile. 
We undertook a study in which different chiral additives were tested with the 
hope of finding one that could enable us to determine the e.e. by NMR 
spectroscopy. The fact that imine 27 could be detected by 31P NMR 
spectroscopy, pushed us into making use of this feature to our advantage. 31P 
NMR offered a larger range of resonance than 1H and greater sensitivity than 
13C making the probability of finding an observable and measurable difference 
of chemical shifts between the R and the S enantiomers higher. Four chiral 
additives were tested in CDCl3 (Table 4): L-(+)-tartaric acid, D-(-)-tartaric acid, 
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Europium tris[3-(heptafluoropropylhydroxymethylene)-(+)-camphorate] and 
(1S)-10-camphorsulfonic acid. 
 
Table 4: Testing of various chiral additives in 31P NMR spectroscopy. 
Me
HN
PPh2
O
Chiral additive 31P NMR analysisCDCl3
filtration
44
(rac)
 
Entry Chiral additive Observation in  
31P NMR 
1 L-(+)-tartaric acid none 
2 D-(-)-tartaric acid none 
3 Europium chelate complex 
O
CF2CF2CF3
O Eu
3
 
none 
4 (1S)-10-camphorsulfonic acid 
OHO3S
 
split  
 
We found that neither tartaric acid (which has a very poor solubility in CDCl3) 
nor the Eu chiral complex, had an effect on the amide 31P NMR signals of 44. 
However, we were pleased to see that camphorsulfonic acid  
(Figure 13) which has better solubility, was able to split the amide 31P NMR 
signal, thus allowing direct determination of the e.e. of 44. Indeed, in the 31P 
NMR spectrum, under normal circumstances, both the R and the S enantiomers 
have the same chemical shift and appear as a singlet. By addition of a sufficient 
amount of (1S)-10-camphorsulfonic acid to the amine (beforehand dissolved in 
CDCl3) followed by a filtration, analysis of the sample by 31P NMR showed the 
amide under the form of two signals corresponding to the two enantiomers 
(Figure 13). 
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Figure 13: (1S)-10-camphorsulfonic acid used as a chiral shift reagent in  
  
31P NMR spectroscopy. 
 
Although the cause of the split of the NMR signal has not been entirely 
delineated, we suggest that the complexation of the amide with the acid is due 
to a hydrogen bonding interaction (P=Oamide---HO3Sacid and NHamide---O=Cacid). 
An optimisation of the quantity of acid required was carried out on a racemic 
sample (Figure 14). 
31P NMR 
signal 
(R) (S) 
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Figure 14: Effect of (1S)-10-CSA on the amide 31P NMR signal. 
 
(a) Resolution in ppm calculated according to the formula R = (2xZ) / (WA+WB) where 
Z is the separation between peaks A and B, WA and WB the widths at the base of 
peaks A and B respectively. 
 
a 
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When increasing the amount of (1S)-10-CSA, a clear change of both the 
chemical shift (deshielding of the phosphorus nucleus) and the resolution could 
be observed. It turned out that the best resolution was attained with 1.5 
equivalents of acid. Above that limit, the lack of solubility of (1S)-10-CSA in 
CDCl3, confirmed by a plateau of the chemical shift, resulted in a reduction of 
the resolution. In order to measure how accurate this method was and also to 
make sure that the split generated was genuinely due to the two enantiomers, 
the e.e. values of standard solutions made of the two enantiopure synthesised 
amides were measured (Graph1). 
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Graph1: Reliability of the method. 
 
From Graph 1, we can deem this unusual and innovative method as being fairly 
reliable (± 4%), albeit not being as accurate as HPLC. This method was used 
during screenings as a preliminary means to select the samples deserving to be 
analysed by HPLC, thus saving a considerable amount of time. 
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3.2.2  GC assay 
During the course of the investigation, while the 31P NMR technique was used 
to identify samples reaching a reasonable enantioselectivity, more accurate 
assay methods had to be utilised for samples having good e.e. values. To this 
end, three methods were used: chiral HPLC, chiral SFC and chiral GC. 
Although HPLC assays are highly accurate, SFC was temporarily preferred 
later on as it turned out that highly UV absorbant impurities could co-elute 
with the enantiomer of the injected sample and thus making the analysis 
irreproducible and erroneous. The nature and the source of these impurities 
have not been identified yet; however perplexing cases of irreproducible 
analytics in HPLC is a known phenomenon which can have multiple sources 
such as the solvent grade, the mobile phase or the temperature and lengthy 
investigations are usually required to solve them when they occur. A 
remarkable recent finding in this field was reported by Hintermann115 who 
found that adventitious trace amounts of water in the eluant affected 
dramatically the analysis in a normal-phase chiral HPLC system. Furthermore, 
he found that if this amount of water was controlled and added deliberately, it 
could improve substantially the peak resolution. Advantages of SFC over 
HPLC are numerous: lower fluid viscosity, higher efficiencies per unit time, 
ease of control of the solvent power (via pressure and temperature), etc. 
Finally, a method of choice for the e.e. assay was identified and focuses on GC 
analysis. While the protected diphenylphosphinoyl amide could be injected 
directly into the HPLC or SFC system, a removal or change of the heavy 
P(O)Ph2 protecting group (MW = 201 g mol-1) was necessary for a GC assay. It 
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should be noted that one the great advantage of the diphenylphosphinoyl group 
over other protecting groups is its facile removal under mild conditions. This is 
due to the lack of interaction of the nitrogen lone pair with phosphorus as 
shown by a X-ray data116 that indicates nitrogen in the diphenylphosphinamide 
group to be tetrahedral, as opposed to the trigonal nitrogen often observed in 
the sulfonamide unit. 
Our first approach consisted in getting the free amine by carrying out a 
dephosphinylation in a Lewis acid-promulgated methanolysis (Scheme 27).117 
The phosphinamide protecting group was treated with excess boron trifluoride 
etherate in methanol. Different MeOH/BF3·Et2O ratios were investigated (10:1, 
5:1 and 2.5:1) and ratio 2.5:1 where the amount of methanol is minimised gave 
a slightly better isolation of the free amine. Acid washing with 2M HCl of the 
reaction product allows removal of the phosphinate by-product by a simple 
extraction and furnishes the amine in aqueous solution as the hydrochloride 
salt. Finally, the free amine was obtained by basification with 6M NaOH. 
Other similar literature procedures were employed but were either less 
efficient118 or required a lengthier protocol119 than the BF3 promoted 
methanolysis deprotection. 
As expected, a test injection of the free amine 45 in GC (without special 
modification to the column) proved to be unsatisfactory owing to the 
adsorption of the solute, resulting in peak tailing. Therefore it was necessary to 
convert this free amine into a suitable derivative prior to analysis. 
Derivatisation of amines is employed not only to reduce the polarity but also to 
improve the volatility, selectivity, sensitivity, and separation of the amine 
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signals. A wide range of derivatisation reactions are available.120 Silylation, 
permethylation and acylation were tried as representative examples. 
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Si
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Cl Cl
crude mixtureCH2Cl2, RT, 4h
Et3N
0 °C to RT, 60 min
N
HCHO, HCO2H
reflux, 24 h
CH2Cl2, RT, 15 min
K2CO3
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CF3O
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F3C
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(pure)
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Scheme 27: Deprotection and derivatisation reactions of the methylated products. 
 
The amino group is not very reactive to silylating reagents, and its conversion 
into a silyl derivative is normally difficult. However, by using literature 
conditions,121,122 silyl derivative 46 could be prepared by reaction of 45 with 
Stabase chloride (1,2-bis(chlorodimethylsilyl)ethane) in the presence of 
triethylamine, in dichloromethane. Unfortunately, the Stabase adduct 46 was 
obtained as a crude mixture that required an inconvenient purification step 
(distillation) that rendered this method unattractive as we were aiming for an 
ideal quick derivatisation procedure. 
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Permethylation, carried out with the Eschweiler-Clark reaction123,124 was 
performed on free amine 45 to prepare tertiary amine 47. Although the reaction 
time is fairly long, it has the advantage of being straightforward, easy to 
perform and clean since it gives the pure desired amine without any 
purification. Unfortunately, this reaction failed to afford the product when 
carried out in situ, even after removal of the methanol used to provide 45. 
Finally, acylation which is one of the most popular derivatisation reactions for 
primary and secondary amines was carried out. Reaction of trifluoroacetic 
anhydride with primary amine 45 in presence of potassium carbonate, in 
dichloromethane at room temperature were found to be the optimal conditions 
to obtain trifluoroacetamide derivative 227. Use of a base such as triethylamine 
in this reaction was attempted and proved unsuccessful; on account of the 
nucleophilic feature of triethylamine, the reaction affords in this case the 
trifluorocetamide as a minor product and Et3N·TFA and Et3N·HCl (HCl 
workup) as major products that could not be isolated. As with the Eschweiler-
Clark reaction product 47, the reaction did not work when carried out in situ. 
The fact that the preparation of a derivative systematically failed when the free 
amine used as a starting material was not properly isolated in the presence of 
excess BF3 and traces of methanol pushed us into considering another strategy: 
a straight permutation of the protecting groups from 44 to 227 or in other 
words a trans-acylation. A single example of such a transformation in the 
literature125 consists in reacting N-diphenylphosphinoyl protected compound 
with trifluoroacetic acid at room temperature for 2 hours to afford a crude 
product which needs to be purified by distillation. Such a protocol could 
obviously not be suitable for our derivatisation since it requires a distillation, a 
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time-consuming step. Consequently, the latter was modified and it was found 
that treatment of 44 with a large excess of TFAA and no other reagents could 
give the desired trifluoroacetamide 227. Interestingly, monitoring of the 
reaction by 1H NMR spectroscopy suggested that two amides are formed in this 
reaction: the monoamide and the diamide, the diamide being converted 
progressively to the monoamide in time. Different reaction conditions were 
tried and it was found that the amount of monoamide was increased if the 
reaction was carried out at room temperature instead of reflux (Table 5). 
 
Table 5: Effect of the temperature on the derivatisation reaction. 
 
HN
PPh2
O
HN
O
CF3F3C
O
O
O
CF3
+
N
PPh2
OO
F3C
227 49
(100 equ.)
2-3.5 h
44
 
 
Entry Temp. Ratio 227:49 a  
1 reflux 63 : 37 
2 RT 82 : 18 
 
(a) Determined by 1H NMR spectroscopy. 
 
 
A mass spectrometry monitoring of that derivatisation reaction was carried out 
in order to confirm formation of products 227 and 49. The detection of  
compound 44 (which amount decreases in time) and detection of by-product 
diphenylphosphinic acid P(O)Ph2OH (which amount increases in time) did 
confirm the progressive deprotection of the starting material and possibly of 
diamide 49. 
TFAA was present in a large excess since it was used both as a reagent and a 
solvent. It should be noted that this reaction was performed under “wet” 
conditions since it was carried out in an open vessel. The fact that compound 
63  
49 could be converted into 227 made us think that a third reagent was involved 
and we supposed that it was water coming from atmospheric moisture. The 
hypothesis seemed very sound since it could explain why the amount of 49 was 
decreasing in time. To verify it, we decided to observe the effect of the addition 
of a small amount of water in the reaction mixture. It turned out that not only 
this (exothermic) addition was beneficial to the reaction because it could 
dissolve entirely the reaction mixture, but it has also a catalytic effect in the 
conversion 49→227 thus confirming the hypothesis. The reaction taking place 
with water seems to be a simple acid-catalysed mono-hydrolysis of the diamide 
(Scheme 28). 
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Scheme 28: Reaction mechanism of the mono-hydrolysis of diamide 49. 
 
 
The mechanism proceeds via protonation of one of the carbonyl of diamide 49 
to give activated species 50 that undergoes a nucleophilic attack by water. The 
result of that attack gives intermediate 51. Finally, a proton transfer is followed 
by the departure of the monoamide moiety to give compound 227 and 
diphenylphosphinic amide. These new conditions using TFAA at room 
temperature followed by a catalytic amount of water afforded successfully the 
desired trifluoroacetamide albeit with a low yield (c.a. 50%). This procedure is 
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attractive in many ways since it is carried at room temperature, is solvent free, 
is carried out in an open vessel and requires a simple purification (filtration 
through Pasteur pipette of silica to remove Ph2P(O)OH). 
The influence of other parameters was evaluated (Table 6): the reaction time, 
the amount of TFAA and the amount of solvent. It was found that the 
conditions in which no diamide is formed were the ones found precedently, 
that is to say 100 equivalents of TFAA and no solvent (Entry 1). The addition 
of dichloromethane was tested because the reaction mixture is heterogeneous in 
TFAA; we found that the presence of dichloromethane, regardless of its 
amount (Entries 2-3 and 4-5), was not favourable for the removal of 49. 
Finally, the decrease of the amount of TFFA from 100 equivalents to 10 
equivalents was attempted and gave almost an equal ratio between 49 and 227 
(Entries 4-5). 
 
Table 6: Optimisation of the derivatisation reaction. 
HN PPh2
O
HN
O
CF3F3C
O
O
O
CF3
+
N PPh2
OO
F3C
227 49
H2O (cat)
overnightRT, 30 min
(open flask)44
 
 
Entry Eq. of 
TFAA 
V CH2Cl2 
(mL) 
Results 
Ratio 227:49  a Observation b 
1 100 0 100 : 0  no impurities 
2 100 1.0 >90 : 10 minor 
impurities 
3 100 4.0 >90 : 10 minor 
impurities 
4 10 1.0 53 : 46 major impurity 
5 10 4.0 54 : 47 major impurity 
     
  (a) Determined by 1H and 31P NMR spectroscopy. 
  (b) Qualitative analysis of the 31P NMR spectrum. 
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It should be noted that this trans-acylation reaction does not racemise or alter 
the enantiopurity of the starting material which makes the derivatisation 
process safe. To check this, an enantiopure sample was derivatised and GC 
analysis confirmed complete retention of enantiopurity. 
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Chapter IV 
Catalyst discovery 
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Within this thesis, a series of ligands and catalysts were screened in order to 
identify novel asymmetric catalytic systems for the synthesis of chiral amines. 
To this end, a commercially available ligand supplied by an industrial 
collaborator, (R,R)-Me-DuPHOS, has played a major role in this investigation. 
 
4.1  Ligands 
 
4.1.1  DuPHOS ligand 
4.1.1.1  Methyl-DuPHOS 
Asymmetric phosphine ligands play a dominant role in novel transition metal-
catalysed enantioselective syntheses; for that reason, they have been subject to 
continuous development. The design of the DuPHOS ligand was initiated by 
Burk126 in 1993. Burk and co-workers prepared a homochiral series of  
C2-symmetric 1,2-bis(phospholano)-benzene ligands (Figure 15) that afforded 
efficient catalysts for the highly enantioselective hydrogenation and 
hydrosilylation of various unsaturated substrates. More particularly, use of 
DuPHOS in the rhodium-catalysed hydrogenation of α-(N-acylamino) acrylates 
showed enantioselectivities approaching 100% e.e. 
P
P
R
R
R
R
R = Me, Et, n-Pr, i-Pr
 
  Figure 15: (R,R)-DuPHOS ligand series developed by Burk. 
 
Preparation of the Me-DuPHOS ligand (Scheme 29) is carried out in three 
steps from the 1,2-phenylbisphosphine 53. An initial basic treatment of the 
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bisphosphine with n-BuLi generates the dilithium species and subsequent 
reaction with the cyclic sulphate 57 leads to nucleophilic opening of one cyclic 
sulphate by each phosphide. Finally, the second n-BuLi addition allows 
deprotonation of each remaining P-H and induces smooth closure to the five-
membered phospholane rings. In line with the SN2 character of the reaction, 
complete inversion of stereochemistry occurs at the stereogenic carbon centers 
of the cyclic sulphate to provide phosphines of opposite absolute configuration. 
 
OO S
Me Me
O
P
P
Me
Me
Me
Me
Me
Me
OH
OH
OO S
Me Me
O O
PH2
PH2
OO S
Me Me
O O
RuCl3 / NaIO4
1. n-BuLi
2. (2 equ.)
3. n-BuLi
(1)
(2)(0.1 mol %)
(R,R)-Me-DuPHOS
53
55 56 57
SOCl2
54
 
Scheme 29: Synthesis of the (R,R)-Me-DuPHOS ligand. 
 
Synthesis of sulfate 57 is performed in two steps from the chiral 1,4-diol 55. 
The crystalline diol 55 is readily converted to the corresponding 1,4-diol cyclic 
sulphate 57 by reaction with thionyl chloride, followed by ruthenium-catalysed 
oxidation (RuCl3/NaIO4) of the intermediate cyclic sulfite 56 which is not  
isolated. 
 
4.1.1.2  Me-DuPHOS monoxide (BozPHOS) 
A recent use of the Me-DuPHOS ligand in the metal-catalysed enantioselective 
synthesis was reported by Charette40 in the addition of dialkylzinc to imines. In 
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his investigation, Charette reported the enantioselective addition of diethylzinc 
to N-diphenylphosphinoylimines. In order to identify the optimal ligand in 
terms of both conversions and enantiomeric ratios, numerous mono- and 
bidentate phosphines were screened and the investigation disclosed that the 
(R,R)-Me-DuPHOS 54 was the best ligand (96% conversion, 93% e.e.) using 
these conditions [Cu(OTf)2, Et2Zn, toluene, 0 °C, 18 h]. In a later investigation 
with Me2Zn,41 Charette demonstrated that the use of a modified version of the 
Me-DuPHOS ligand, in which only one of the two phosphorus atoms is 
oxidised (Me-DuPHOS monoxide or BozPHOS), gave better results than the 
non-oxidised version of the ligand (Table 7). 
 
Table 7: Comparative results of (R,R)-Me-DuPHOS and (R,R)-Me-DuPHOS 
    monoxide. 
 
Ph
N
P
O
Ph
Ph
Ph
HN P
O
Ph
Ph
Me
Me2Zn (x equ)
(CuOTf)2 toluene (y mol %).
Ligand (z mol %)
Toluene, RT, 48 h
27 44
 
 
 
Ligand 
Loadings Results 
x y z yield 
(%) 
e.e. 
(%) 
 
(R,R)-Me-DuPHOS 54 
 
 
10 
 
9.5 
 
10 
 
51 
 
90 
 
(R,R)-Me-DuPHOS monoxide  60 
 
 
3 
 
5 
 
5 
 
87 
 
97 
 
 
 
Even with the best loadings which were found with (R,R)-Me-DuPHOS, the 
BozPHOS ligand gives better results with lower loadings. Nevertheless, in both 
cases the reaction is very slow. The BozPHOS ligand is synthesised in three 
steps from (R,R)-Me-DuPHOS with a 83% yield (Scheme 30). The mono-
P
P
o
P
P
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oxidation which is carried out is possible due to the protection of one of the 
two phosphorus atoms with a borane in the first step. Then, the remaining 
phosphine is oxidised by use of hydrogen peroxide, and finally deprotection 
occurs with the addition of DABCO in the third and last step. 
 
P
P
P
P
P
P
H3B
O
N
N
P
P
O
BH3.DMS
THF, 0 °C, 45 min
THF, RT, 45 min
R,R-Me-DuPHOS monoxide
(BozPHOS)
Toluene, 50 °C, 5 h
83 %
H2O2
H3B
54 58
5960
 
 
Scheme 30: Synthesis of the (R,R)-Me-DuPHOS monoxide ligand (BozPHOS). 
 
It has been noted that for ZnMe2/Cu(I) additions to imines, BozPHOS is a 
better ligand than Me-DuPHOS. Moreover, it has the advantage of being less 
air sensitive. 
 
4.1.2  Feringa’s ligand 
Feringa and co-workers have described the synthesis of a variety of 
phosphoramidites and their application as ligands in the copper catalysed 
conjugate addition of dialkylzinc reagents to assess the effect of ligand 
variation in the asymmetric catalysis. Their study led to the design of a new 
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effective group of phosphoramidite ligands (Figure 16) that was tested in 
conjugate addition reactions.  
 
O
P
O
N
R
R
 
  Figure 16: Monodentate phosphoramidite ligand developed by Feringa.  
 
This phosphoramidite is made of two parts, one chiral binaphthol core of S 
configuration and an exocyclic chiral secondary amine.  
It is prepared in a two step sequence (Scheme 31). This one pot procedure 
consists in mixing together a warm solution of phosphorus trichloride PCl3 and 
chiral binaphthol in a Et3N solution in toluene to generate the phosphoryl 
chloride. Then, treatment of the mixture with the chiral secondary amine in 
presence of n-BuLi in THF leads to the formation of the phosphoramidite. 
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Scheme 31: Synthesis of (S,S,S)-Feringa’s ligand. 
 
Numerous NR2 groups have been tested in the enantioselective copper-
catalysed diethylzinc addition to the model substrate cyclohexenone. There is 
no straightforward relation between the molecular architecture of the 
phosphoramidite ligand, for instance steric requirements, and the 
enantioselectivities observed. It was also observed a major influence of the 
nature of the amine part of the ligand whereas the effects of variation in the 
binaphthol unit are less prominent. However, a delicate balance seems to exist 
between the increase of steric hindrance and the chirality of the amine moiety. 
The best ligand has proved to be a phenylethyl group (Scheme 32).127 
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   Scheme 32: Efficiency of the (S,R,R) Feringa’s ligand in the  
       1,4-addition of diethylzinc to cyclohexenone. 
 
 
It is interesting to note that the mismatched ligand with the absolute 
configuration (S,S,S) gives a lower 75% e.e.  
It is suggested that the mechanism of the reaction proceeds from a 
transmetallation of the Cu(I)-complex and diethylzinc via an ethyl group 
transfer to the copper. The enone coordinates to the ethyl copper species by  
π-complexation of the olefinic bond. The Lewis acidic Zn(II) centre probably 
activates the enone through complexation to the carbonyl oxygen (zinc is a 
slightly more electronegative than copper). This substrate binding and 
activation is likely to involve a bimetallic complex. Finally, the remaining sites 
in the tetrahedral coordination sphere of the copper ion are occupied by two 
phosphoramidite ligands providing a favourable pathway for π-face selective 
ethyl transfer. 
 
4.2  Screening of reaction conditions 
 
4.2.1  High throughput screening 
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Once the chiral ligands previously mentioned (R,R-Me-DuPHOS 54, R,R-
BozPHOS 60 and S,S,S-Feringa 64) were prepared, we undertook an initial 
screening in which several conditions using different nucleophiles, catalysts 
and ligands were tested. A high throughput screening approach using a 
carousel multireactor unit allowing the simultaneous run of up to twelve 
reactions under inert atmosphere was employed (Figure 17a). The 
enantioselectivity reached in these reactions was determined and analysed with 
a range of powerful analytical methods at our disposal: 31P NMR spectroscopy, 
HPLC, SFC and GC (Figure 17b); each one being respectively used at the most 
appropriate time depending on how advanced the study was. 
 
 
 
 
Figure 17: High throughput screening tools.  
(a)  A heated carousel multireactor running 12 reactions 
simultaneously under inert atmosphere. 
(b) Modern computer-controlled chiral GC machines equipped 
  with autosamplers. 
 
(a) 
(b) 
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4.2.2  Exploration of Fujisawa’s and Charette’s conditions 
Conditions described in the literature for methylation of imines were trialled 
(Table 8). On the one hand, we were pleased to see that the Fujisawa’s 
conditions (Conditions A) using nickel(II) as a catalyst were reproducible and 
gave an excellent result not only for 28 but also for 27. On the other hand, we 
were surprised to see the poor results obtained in the reproduction of Charette’s 
conditions (Conditions B) and more especially in the case of substrate 27 (26% 
conversion) that was expected to give an 87% yield according to Charrette’s 
report (Table 7). 
 
Table 8: Results obtained for the methylation reactions using Charettte’s and 
     Fujisawa’s conditions.35,41 
 
H
N PG Nu
Cat., Ligand Me
HN
PG
PG
P(O)Ph227
28
29
30
Ts
Bn
2-OMe-Ph
 
 
Cond. 
 
 
Nu 
 
 
Catalyst 
 
Ligand 
Solvent, 
Temp., 
Time 
Conversion (%)a 
 
27 28 29 30 
 
Ab 
 
AlMe3 
 
Ni(acac)2 
 
PPh3 
THF 
0 °C 
overnight 
 
97 
 
100 
 
nd 
 
nd 
 
   
 
  
  
 
Bc 
 
Me2Zn 
 
(CuOTf)2 
 
BozPHOS 
Toluene 
RT 
48 h 
 
26 
 
14 
 
nd 
 
4 
 
(a) Estimated by 1H NMR spectroscopy. 
(b) Fujisawa’s conditions.35 
(c) Charrette’s conditions.41 
 
 
However, the only difference that can be reported between conditions B and 
the original Charette’s conditions is the form of Me2Zn used in the reaction. In 
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Charette’s original report, neat Me2Zn was used, but because of its 
unavailability in our lab we opted for the use of a 2 M Me2Zn solution in 
toluene as an alternative. Initial attempts at measurement of the conversion 
were problematic as the measured values were erroneous due to decomposition 
of the unreacted starting imine into benzaldehyde and the corresponding amide. 
Obviously, this decomposition was the result of the acidic workup which 
highlights the sensitivity of aldimines. Thereby, to remedy this problem, 
several different quenching reagents were tried and slightly alkaline NH4Cl 
turned out to be better than MeOH, TMSCl or a saturated aqueous solution of 
NaHCO3. 
 
4.2.3  Screening of copper and iridium catalysts 
Screening of several catalysts associated either with BozPHOS or Feringa’s 
ligand were carried out in order to find some first reaction conditions that could 
be optimised later on. All initial reactions were carried out for 24 h for 
convenience. Monitoring the reaction by TLC was quite inefficient because of 
the poor separation between the imine and the corresponding methylated 
amine. 
 
4.2.3.1  Screening of copper catalysts 
Screening of different Cu(I) catalysts-based with BozPHOS  was carried out 
and their effects on imines 27-30 noted (Table 9). They were all carried out in 
THF, at room temperature, for one day. 
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Table 9: AlMe3 addition catalysed by copper. 
 
 
H
N PG
Cat.
Me
HN PGAlMe3
BozPHOS
THF, RT, 24 h
27-30
 
 
 
Cond. 
 
 
Catalyst 
Conversion (%) a 
 
27 28 29 30 
 
C 
 
(CuOTf)2 
 
26 
 
nd 
 
2 
 
2 
 
D 
 
CuTC 
 
17 
 
9 
 
nd 
 
nd 
 
E 
 
[Cu(MeCN)4] 
BF4 
 
65 
 
5 
 
nd 
 
nd 
 
  (a) Estimated by 1H NMR spectroscopy. 
 
Apart from the change of nucleophile (Me2Zn vs AlMe3), conditions C and B 
differ only in the solvent (toluene vs THF) and afford essentially the same 
results which shows that the solvent is not playing a key role here. Then, in 
conditions D and E, more stable copper(I) catalysts were tested. The main 
drawback of copper(I) triflate is its high air sensitivity (it requires handling in a 
glove box) and we found it useful to test sources such as copper(I) thiophene-
2-carboxylate (D) and tetrakis acetonitrile copper(I) tetrafluoroborate (E) not 
only because they are less sensitive to air but also to observe the effects of their 
ligands. Conversions obtained in these conditions are quite poor on the whole 
and the only substrate that stands out is 27 within conditions E (65% 
conversion). 
 
79  
4.2.3.2  Screening of iridium catalysts 
Three sources of iridium catalysts, associated with the (S,S,S)-Feringa ligand 
were tested in this screening: one source of Ir(III), [Ir(acac)3], and two sources 
of Ir(I) [ [Ir(Cl)COD]2, [Ir2(Cl)(OMe)(COD)2] ]. Similarly to the screening of 
copper catalysts, reactions were all carried out in THF, for one day (Table 10). 
 
Table 10: AlMe3 addition catalysed by iridium. 
 
H
N PG
Cat.
Me
HN PGAlMe3
(S,S,S)-Feringa
27-30
 
 
 
Cond. 
 
 
Cat. 
Solvent, 
Temp., 
Time 
Conversion (%)(a) 
 
27 28 29 30 
 
F 
 
Ir(acac)3 
THF 
RT,  
24 h 
 
 
13 
 
nd 
 
nd 
 
nd 
 
G 
 
Ir(acac)3 
THF 
50 °C,  
24 h 
 
 
11 
 
2 
 
1 
 
nd 
 
H 
 
[Ir(Cl)COD)]2 
THF 
50 °C,  
24 h 
 
 
96 
 
1 
 
2 
 
nd 
 
I 
 
[Ir2(Cl)(OMe)(COD)2] 
THF 
50 °C,  
24 h 
 
> 99 
 
2 
 
2 
 
nd 
 
(a) Estimated by 1H NMR spectroscopy. 
 
Under conditions F and G, Ir(acac)3 gave quite poor results, and an increase in 
temperature from room temperature (F) to 50 °C (G) barely changed the 
conversion for 27. In conditions H, use of dichloro-bis(1,5-cyclooctadiene)-
diiridium(I) gave an excellent conversion that reached 96% for 27. Finally, in 
conditions I, use of chloromethoxy-bis(1,5-cyclooctadiene)-diiridium(I) gave 
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results even better than with H as conversion reached with 27 exceeds  
99%. With regard to the enantiomeric excess, only amines resulting from 
reactions in which conversion was higher than 25% (conditions C, E, H, I) 
were analysed by chiral HPLC. Unfortunately, e.e. values were all lower than 
10% which means that there was no enantoselectivity in these reactions and 
that the development of an appropriate ligand was required. 
 
4.2.4  Development of the new iridium(I) catalysed AlMe3 addition 
   reaction 
Once we identified a suitable nucleophile and catalyst to carry out the methyl 
addition to the diphenylphosphinoyl imine, namely trimethylaluminium and 
chlorobis(cyclooctadiene) iridium(I) dimer, we studied the scope of these two 
elements to check if the reaction conditions could be improved. 
 
4.2.4.1  Synthesis of di-µ-chlorotetrakis (cyclooctene) diiridium(I) 
The effect of other sources of iridium(I) were screened to check whether the 
presence of the cyclooctadiene in the iridium catalyst is crucial to the success 
of the reaction. Thus, di-µ-chlorotetrakis (cyclooctene) diiridium(I) was 
prepared (Scheme 33) in a reasonable yield (66%). 
 
IrIr Cl
Cl
+ iPrOH/H2O
reflux, 3 h
66 %
42 IrCl3
67
 
Scheme 33: Synthesis of di-µ-chlorotetrakis (cyclooctene) diiridium(I). 
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Reaction of iridium (III) chloride with cyclooctene refluxed within a degassed 
mixture water/isopropanol afforded the bright yellow complex. Although being 
light sensitive and requiring storage at a low temperature (cold room), this 
complex is much easier to prepare than its cyclooctadiene analogues. We 
observed that the activity of this  iridium catalyst, in terms of conversion, is 
identical to the ones we previously observed with other iridium(I) based 
catalyst, namely [Ir(Cl)COD]2 and Ir2(Cl)(OMe)(COD)2 (Figure 17). Indeed 
using any one of these three catalysts affords the methylated amine with a  
complete conversion after reflux in THF for 3 hours. 
 
IrIr Cl
Cl
IrIr O
Cl
Me
IrIr Cl
Cl
65 66 67
 
    
Figure 17: Iridium(I) based catalysts tested in the methyl addition reaction with 
    AlMe3. 
 
4.2.4.2  Importance of the cyclooctadiene group 
The fact that the efficiency of the reaction does not depend only on iridium 
precursors 65 and 66 indicates that the presence of the COD coligand is not 
crucial to the success of the reaction. This argument is supported by one 
observation made in an earlier experiment in which Ir(acac)3 and 1,5-COD 
were used together as a catalyst (Scheme 34). 
82  
H
N
P
AlMe3
27-30
(2 equ)
Ir(acac)3
(5 mol%)
(5 mol%)
THF, reflux, 3 h
O Ph
Ph
Me
HN
P
O Ph
Ph
44
1,5-COD
+
   . 
 
Scheme 34: Use of 1,5-COD and Ir(acac)3 as a catalyst in the methyl addition. 
 
Failure of this experiment made clear that the cyclooctadiene group does not 
strongly promote the reaction. 
 
4.3  Screening of ligands and preformed catalysts 
 
4.3.1  Screening of ligands 
Once the best reaction conditions had been identified (imine 27, AlMe3, 
[IrCl(COE)]2 and a suitable method for the measurement of the enantiomeric 
excess attained, the next goal was to increase the enantioselectivity of the 
reaction. To this end, a wide range of ligands having different skeletons, 
functionalities, and electronic and steric properties was screened. 
The first set of ligands tested in the different screenings (Figure 18), which 
comprises 10 ligands, mostly chiral diphosphines, includes 6 families: 
DuPHOS, BPE, Trost, PhanePHOS, Chiraphite and Kelliphite. Chiral 
diphosphines play a pivotal role as ligands in metal-catalyzed asymmetric 
hydrogenation. In particular C2-symmetric 1,2-bisphospholanes form highly 
enantioselective catalysts for the hydrogenation of a range of different 
prochiral olefins. Due to their excellent and versatile catalytic performance in 
asymmetric hydrogenation,128 we were very keen to test some of them in 1,2-
addition reactions of imines to see if related performance could be observed. 
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Figure 18: First set of ligands tested in the series of screening. 
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However, before proceeding to the screening in itself, we thought it was 
necessary to carry out a very basic kinetic study of the reaction. Consequently 
the conversion of the reaction was monitored using benzaldimine 27, 
trimethylaluminium, [Ir(Cl)(COD)]2 and THF. The kinetic influence of three 
ligands (68, 74 and 77) was observed at room temperature (Graph 2). 
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Graph 2: Monitoring of the conversion in the methyl addition reaction. Reactions 
      carried out at room temperature. 
 
Surprisingly, it was observed that the three ligands tested responded quite 
differently in terms of kinetics. We could observe two phenomena resulting 
from the nature of the ligand bound to the metal center: a ligand-accelerated 
catalysis (LAC) and a ligand-decelerated catalysis (LDC); phenomena that 
affect the rate (Graph 2) and selectivity (Graph 3) of the transformation. When 
the ligand is bound, the rate of product formation can either be slowed down 
(υML < υM where υML is the overall rate of product formation in presence of the 
// 
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ligand, and υM is the rate of the reference reaction in the absence of the ligand 
in question), remain the same (υML = υM), or be increased (υML > υM). 
Therefore we found that in the case of S,S,S-Feringa 68 a LAC was exhibited, 
while in the case of 74 and 77 a LDC was observed. According to Sharpless,129 
the likely explanation of a LDC phenomenon is the creation of an effective 
chiral environment that often results in extra steric crowding around the 
binding/catalytic site, which eventually leads to a rate deceleration (case of 74 
and 77). 
  
Using this kinetic study, initial reaction temperature of 50 °C and a reaction 
time of 24 h could be optimised so that completion could be reached in only 3 
hours at reflux temperature (67 °C in THF). 
Ligands (71-80) were screened under the conditions identified (Graph 3). 
While ligands 71 to 73 were screened with Ir2Cl(OMe)(COD)2, ligands 74 to 
80 were screened with both [IrCl(COD)]2 and [IrCl(COE)2]2 in order to 
observe possible differences of activities between the two catalysts. Results of 
the screening revealed that the two iridium catalysts can show a substantial 
difference in terms of enantioselectivity depending on the chiral ligand which 
is used. Indeed, one good example which exemplify this behaviour is ligand 
75; with 75, [IrCl(COD)]2 gave only 6% e.e. while [IrCl(COE)2]2 gave 34% 
e.e.  
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Graph 3: Screening of ligands in the AlMe3 addition reaction using Ir (I) based 
      catalyst. 
 
 
Th e.e. values obtained with ligands 68-80 are quite low as a whole (0-36% 
e.e.) which shows a poor enantioselectivity is engendered with this range of 
ligands. However, among them, four ligands stand out as their e.e. values 
exceed 30%: 75, 76, 77 and 78. The highest e.e. value in this screening (36%) 
was reached with ligand 78 while using [IrCl(COD)]2. Since quite poor 
enantioselectivity was observed we speculated a racemisation process was 
occurring in the reaction, as if it was the case that would explain the very low 
e.e. values reached. To check this hypothesis the enantiopure product prepared 
from the corresponding commercially available amine was exposed to the 
reaction conditions (Scheme 35). Two possibilities were considered:  
Cat.: Cat.: Cat.: 
IrIr
Cl
Cl
65
IrIr
O
Cl
Me
66 IrIr Cl
Cl
67
Ph
N PPh2
O
THF, reflux, 3 h
Cat / L*
AlMe3 HN PPh2
O
Ph Me
27 44100 % conv.
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- presence of a racemisation in the catalytic process which would give an 
equal mixture of the two enantiomers of the amine as a product 
- absence of a racemisation in the catalytic process which would give the 
starting material with the same absolute configuration 
 
HN
P
O
Ph
Ph
Ph
Me
HN
P
O
Ph
Ph
Ph
Me
IrIr ClCl
THF, reflux, 3 h
Cat.,  no ligand
(S) enantiomer exclusively
AlMe3
(S)-44 (S)-44
67
 
 
Scheme 35: Absence of racemisation in the catalytic process. 
 
It was apparent there was a complete absence of racemisation in the reaction as 
no change was noticed in the absolute configuration of the amine. Therefore, 
the hypothesis of product racemisation was eliminated. 
 
4.3.2  Screening of preformed catalysts 
Once the ligands had been tested in the chemistry of Graph 3, other 
possibilities were considered as only poor enantioselectivity had been realised. 
One drawback in not using preformed catalysts is the possibility of a racemic 
reaction promoted by unligated iridium species. With preformed catalysts, 
which are preferred in asymmetric hydrogenation, ligand free background 
reactions are minimised.  
Both iridium and rhodium preformed catalysts were tested with AlMe3 (Figure 
19). These preformed catalysts are both BF4 salts of Ir or Rh(COD) DuPHOS. 
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 81: R=Me  (R)  83 
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Figure 19: Iridium and rhodium DuPHOS preformed catalysts tested. 
 
In respect of the enantioselectivity the highest e.e. value was reached with 83 
which gave only 32% e.e. (Table 11). 
 
 
 Table 11: Screening of preformed catalysts with trimethylaluminium. 
 
N P
O
Ph
Ph
Ph HN
P
O
Ph
Ph
Ph
Me
THF, 3 h, reflux
Cat. / L*
AlMe3
27 44
 
 
Entry Ligand Conversiona 
(%) 
e.e. b 
(%) 
1 81 65 12 
2 82 100 6 
3 83 100 32 
 
(a) Determined by 1H NMR spectroscopy. 
(b) Determined by Supercritical Fluid Chromatography. 
 
 
The fact that the best results (albeit poor) were obtained with a rhodium 
preformed catalyst drew our attention to this metal. For this reason, our next 
studies focused on the screening of many other rhodium preformed catalysts 
for imine methylation. 
 
4.4  Optimisation and scope of the iridium(I)-catalysed AlMe3 
addition reaction 
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4.4.1  Use of DABAL-Me3 as a methylating agent  
The air stable trimethylaluminium DABAL-Me3 was also tested in the methyl 
addition reaction (Table 12). As expected we found that as with AlMe3, 
presence of the iridium catalyst was crucial to the success of the reaction 
(Entries 1-2). Two different ligands (71, 74) were tested, and although they 
showed a slightly higher enantioselectivity compared with AlMe3, they gave 
very low e.e. values (Entries 3-4). 
 
Table 12: Results obtained with DABAL-Me3 as a methylating agent. 
 
N P
O
Ph
Ph
Ph HN
P
O
Ph
Ph
Ph
Me
THF, reflux
N N AlMe3Me3Al
27 44
16
Cat.
L*
(5 mol% Ir)
(5 mol%)
  
P
P Me
Me
Me
Me
P
Me
Me
P
Me
Me
71 74
 
 
Entry Catalyst L* Time Conversiona 
(%) 
e.e.
b
 
(%) 
1 none / 3 h 1 / 
2 67 / 3 h 98 / 
3 67 71 overnight 100 14 
4 67 74 overnight 100 10 
 
(a) Determined by 1H NMR spectroscopy. 
(b) Determined by 31P NMR spectroscopy. 
 
 
Iridium and rhodium preformed catalysts previously tested with AlMe3 (cf. 
4.4.1.2) were also tested with DABAL-Me3 to see if any difference of 
reactivity would be observed between the two analogues. Interestingly, 
although in the absence of ligand both AlMe3 and DABAL-Me3 performed 
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with the same efficiency, in this new system, DABAL-Me3 was found to be a 
much less active nucleophile (Table 13). Indeed, the maximum conversion 
reached with DABAL-Me3 was only 4%, and it is known for sure that this loss 
of activity cannot be entirely due to the preformed catalyst given that AlMe3 
gave with the same preformed catalysts moderate to very good conversions 
(65-100% conversion).  
 
Table 13: Screening of preformed catalysts with DABAL-Me3. 
 
N
P
O
Ph
Ph
Ph HN P
O
Ph
Ph
Ph
Me
THF, 24 h, reflux
Preformed cat.
N N AlMe3Me3Al
27 44
16
(5 mol%)
 
 
 
P RR
P RR
Ir
BF4
     
P MeMe
P MeMe
Rh
BF4
 
 81: R=Me  (R)  83 
 82: R=Et   (R) 
 
Entry Preformed 
cat. 
Conversion a 
(%) 
e.e.b  
(%) 
1 81 4 / 
2 82 0 / 
3 83 4 / 
 
 (a) Determined by 1H NMR spectroscopy. 
(b) Determined by Supercritical Fluid Chromatography. 
  
 
The proposed methylation mechanism with AlMe3 and DABAL-Me3 is 
identical (Scheme 36). In the first step, the Ir catalyst 1' reacts with the 
organoaluminium reagent to generate the active catalytic species LnIr-Me 2'. 
Then, the imine substrate 3' which is activated by Lewis acidic AlMe3, 
undergoes a methyl transfer from the newly formed catalytic species 2'. This 
results in the formation of a methylated protected amine 4' which bears a chiral 
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centre α to the Me group. Finally, another equivalent of AlMe3 intervenes and 
introduces a N-Al bond that replaces the former N-Ir bond, to give 5'. 
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Scheme 36: Suggested mechanism of the Ir(I)-catalysed methylation reaction. 
 
Finally, in the last step compound 5' is quenched by water to afford the desired 
methylated protected amine 6'. 
 
4.4.2  Addition of other nucleophiles 
Having seen the results obtained in the addition of the methyl group to imines, 
we were keen to try new types of nucleophiles other than the alkyl. Thus, we 
tried successively the addition of an alkenyl group and the addition of an 
alkynyl group. 
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4.4.2.1  Ir (I)-catalysed addition of alkenylaluminium 
4.4.2.1.1  Allylamine synthesis 
Allylamines are fundamental building blocks in organic chemistry and their 
synthesis is an important industrial and synthetic goal. The allylamine fragment 
can be encountered in natural products, but often it is transformed to a range of 
products by functionalization, reduction, or oxidation of the double bond. Thus 
allylamines have been used as starting materials for the synthesis of numerous 
compounds such as amino acids, different alkaloids and carbohydrate 
derivatives. Several ways to synthesize allylamines130 have been developed and 
aldimines are one potential starting material. Methods described in the 
literature for this way of synthesis of allylamines use exclusively 
hydrozirconation of alkynes to generate the nucleophile that reacts with the 
imine. Some of the results reported in the literature that have drawn our interest 
are reported below (Table 14). 
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Table 14: Syntheses of allylamines from benzaldimines reported in the literature. 
 
N
PG
HN
PG
R1
R2
R1H+
PG: protecting group
 
 
Entry Conditions R1 R2 PG Yield (%) 
 
1131 1) Cp2ZrHCl 
2) [RhCl(COD)]2     (2 mol%) 
    dioxane, RT, 1 h 
 
t-but H Ts 99 
2131 t-but H PO(OEt)2 63 
3132 1) Cp2ZrHCl            (1.5 eq.) 
2) Me2Zn                 (1.5 eq.) 
     toluene, RT, 2 h 
 
n-but H POPh2 76 
4132 1) AlMe3                 (2 eq.) 
    Cp2ZrHCl            (0.03 eq.) 
    H2O                     (1 eq.) 
    CH2Cl2, 
    0 °C, 40 min 
2) -15 °C, 20 h  
    (addition of imine) 
n-hex Me SO(p-Tol) 80 
 
 
In these three examples, in the first step, alkenylzirconocene complexes were 
readily generated by use of the Schwartz reagent Cp2ZrHCl. Then, additives 
such as [RhCl(COD)]2 (Entries 1-2), Me2Zn (Entry 3) or – more surprising – 
water (Entry 4) act as catalysts and enable to afford the addition product with 
respectable yields when the amine is activated by an electron withdrawing 
group. 
 
4.4.2.1.2  Addition of alkenylaluminium 
A similar approach in which an alkenylaluminium nucleophile is generated was 
used (Scheme 37). Hydroalumination of dec-1-yne by using neat DIBAL-H 
(Equ. 1) generates the aluminium reagent which is directly used to react as a 
nucleophile with the imine (Equ. 2). The allylamine which is formed is 
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obtained with a quite poor yield (36%) but it should be noted that this reaction 
has not been optimized yet. 
 
H C8H17
N P
O
Ph
Ph
Ph
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P
O
Ph
Ph
Ph
C8H17
hexane, 55 °C, 4 h
(1.2 equ.)
THF, 55 °C, overnight *
36 %
(1)
(2)[IrCl(COE)2]2
C8H17
(i-Bu)2Alneat (i-Bu)2AlH
84 85
27 86
85
(5 mol% Ir)
(2 equ.)
 
Scheme 37: Alkenylaluminium addition to diphenylphosphinoyl benzaldimine. 
 
By analogy to the mechanism proposed by Taguchi133 in the addition of 
alkenylzirconocene chlorides to aldimine derivatives, it can be suggested that 
our reaction involves the transfer of an alkenyl group from aluminium to 
iridium metal (transmetalation) giving an alkenyliridium species 87 and the 
following insertion of the carbon-nitrogen double bond of the benzaldimine 
into the Ir-carbon bond to afford 88 (Scheme 38). 
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Scheme 38: Suggested catalytic cycle for the formation of the allylic amine. 
 
 
4.4.2.2  Ir (I)-catalysed addition of alkynylaluminium 
4.4.2.2.1  Propargylamine synthesis 
Similarly to allylamines, propargylamines can serve as important building 
blocks for organic synthesis; they have broad applications and are often used as 
intermediates in preparation of complex natural products and pharmaceuticals. 
While the addition of acetylenes to carbonyl compounds has been the subject 
of a large number of publications, the use of imines and related C=N 
electrophiles as substrates has been much less developed, mostly as a result of 
the reduced reactivity of these compounds compared to aldehydes and 
ketones.134 
Table 15 reports some interesting results found in recent publications. These 
selected results incude only non-enantioselective reactions. 
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Table 15: Syntheses of propargylamines from benzaldimines reported in the 
        literature. 
 
N PG
+ H R
HN PG
R
PG: protecting group
 
 
Entry Conditions R PG Yield (%) 
1135  Me2Zn  (1.5 eq.) 
 toluene, 50 °C, 24 h 
Ph Ts 80 
2132 Ph P(O)Ph2 69 
3132 n-hexyl Ts 67 
4136 [IrCl(COD)]2 (5 mol%) 
THF, RT, 24 h 
TMS C6H5-p-(OMe) 85 
 
 
4.4.2.2.2  Addition of alkynylaluminium 
An alkenyl addition to benzaldimine 27 was carried out, again using an 
organoaluminium nucleophile (Scheme 39). This nucleophile was generated by 
a nucleophilic substitution of the acetylinic proton of heptyne by AlMe3  
(Equ. 1). Then, in a second step, the alkenyl aluminium complex (crude 
mixture) was used in our catalytic system to finally obtain the propargylic 
amine (Equ. 2). 
 
H C5H11
AlMe3 (in toluene) (0.9 equ.)
(0.1 equ.)Et3N
toluene, 60 oC, 6 h
Me2Al C5H11 (1)
Ph
N PPh2
O
27
90 91
91 (2 equ)
[IrCl(COE)2]2  67 (5 mol% Ir)
THF, reflux, 3 h
64%
Ph
HN PPh2
O
92 C5H11
(2)
 
Scheme 39: Alkenylaluminium addition to diphenylphosphinoyl benzaldimine. 
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Unfortunately, when this reaction was carried out without the presence of 
catalyst, the chemical yield was found to be essentially quantitative. However, 
this method could be utilised in an enantioselective reaction providing that the 
high background reaction could be successfully minimised. 
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Chapter V 
Catalyst enhancement and 
reaction optimisations 
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5.1  Optimisation of the rhodium catalytic system 
 
5.1.1  Addition of Et2Zn 
Although this project has been essentially focused on the methyl addition, it 
should be noted that this rhodium catalysed dimethylzinc addition reaction 
offers a potential great scope of nucleophiles. It can theoretically be extended 
to various other alkyls (diorganozincs, or alternatively organozinc halides), 
aryls137 or functionalised groups. 
 
As the addition of the methyl group to imine 27 was efficient under conditions 
we had developed, it was of interest to check if the addition of another alkyl 
group such as the ethyl group would be effective. An important feature of 
Et2Zn when compared to its homologue Me2Zn is its lower C-Zn bond 
dissociation enthalpy; values of these enthalpies are 374 and 312 kJ.mol-1 for 
Me2Zn and Et2Zn respectively,138 which corresponds to a difference of  
62 kJ mol-1. 
Addition of diethyl zinc was then carried out (Scheme 40), but disappointingly 
it wasn’t the chiral ethyl addition product which was obtained, but the 
reduction product resulting from a β-hydride elimination reaction. 
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Scheme 40: Rhodium catalysed Et2Zn addition to diphenylphosphinoyl imine 27. 
 
100  
In an undesirable β-hydride elimination, the ethyl group which is bonded to the 
rhodium metal centre is converted into the corresponding metal-bonded 
hydride and ethylene. This could not occur without the presence of hydrogens 
on the beta carbon to rhodium and the presence of a vacant site cis to the ethyl 
group. The mechanism shown (Scheme 41) indicates a four-center transition 
state in which the hydride is transferred to the metal. 
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Scheme 41: Beta-hydride elimination occurring with diethylzinc and 83. 
 
 
5.1.2  Screening of solvents 
Before going further in the new rhodium preformed catalyst screening, an 
optimisation of the reaction conditions was required. Thereby a range of 
organic solvents was screened in the addition of Me2Zn to imine 27. The 
results of this screening (Graph 4) suggest that there is a correlation between 
the polarity of the solvent and the effectiveness of the reaction.  
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β 
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Graph 4: Screening of solvents in the Rh catalysed Me2Zn addition reaction. 
 
In Graph 4, in which solvents are sorted from the most to the least polar from 
left to right (based on dipole moment), two general trends can be observed. On 
the one hand, from acetonitrile to THF, conversion and e.e. increase; on the 
other hand, from THF to toluene, conversion and e.e. decrease. These two 
trends point towards THF which gives at the same time the highest conversion 
(99%) as well as the highest e.e. (85%). Consequently, THF was the solvent 
used as an optimal solvent from then on. It should be noted that no correlation 
between catalyst solubility in the solvent and outcome could be established. 
 
5.1.3  Further screening of preformed catalysts 
A wide range of preformed rhodium and iridium catalysts bearing different 
types of chiral bisphosphines were tested in the Me2Zn imine addition reaction. 
Note:   * Conversion measured by 1H NMR spectroscopy 
             * e.e. measured by Supercritical Fluid Chromatography 
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Families of ligands tested include DuPHOS, BPE, FerroTANE and  
5-Ferrocenyl (Figure 19). 
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Me2Zn
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 Ir – DuPHOS  
 
Figure 19: Preformed catalysts tested in the ligand screening with dimethylzinc. 
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The results of this screening (Table 16) identified two main families of ligands 
giving good enantioselectivities: Rh-DuPHOS and Rh-BPE. The highest 
enantioselectivity (Entry 2) was reached with 83 which gave 94% e.e. In the 
presence of 7% dichloromethane in the reaction solvent (Entries 3-4), solubility 
of 83 is complete but the e.e. and conversion go down slightly. With 95, 97 and 
98, e.e. slightly decreases but remains moderately good (75-82%). 
Interestingly, when the substituent in the bisphosphine is an isopropyl group 
(96 and 99) no reaction occurs at all. This clearly shows that steric hindrance is 
a key factor to the success of the reaction. When rhodium-BPE is substituted 
with a phenyl group (100), a dramatic drop of the enantioselectivity is observed 
(36% e.e.); this observation leads to the conclusion that the reaction is favoured 
by a ligand moiety in which the substituent is a small alkyl group. 
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Table 16: Results obtained in the ligand screening with dimethylzinc. 
 
Entry Ligand Time Conv.a (%) e.e.b (%) 
1 83 2 h 74 92 
2 overnight 100 94 
3 83(c) 2 h 49 89 
4 overnight 98 84 
5 95 2 h 61 82 
6 overnight 99 80 
7 96 2 h nd nd 
8 overnight nd nd 
 9 97 1 h 37 76 
10 3 h 93 75 
11 98 1 h 49 80 
12 3 h 84 80 
13 99 1 h nd nd 
14 3 h nd nd 
15 100 1 h 35 36 
16 3 h 95 31 
 17 101 3 h 42 38 
18 102 3 h 15 0 
19 103 3 h 18 0 
20 104 3 h 69 0 
 21 105 3 h 26 32 
22 106 3 h nd nd 
23 107 3 h 15 7 
 24 81 3 h ndd nd 
25 108 3 h nd nd 
 
(a) Determined by 1H NMR spectroscopy. 
(b) Determined by Supercritical Fluid Chromatography. 
(c) Solvent: THF/dichloromethane (93/7). 
(d) Formation of an unidentified compound. 
 
In the case of the rhodium-BPE catalyst 97, Burk139 who first reported the 
synthesis and application of this family of catalyst, highlighted the large 
dihedral angle (24° for the SbF6- version of 97) between the P-Rh-P plane and 
the plane defined by the COD olefin midpoints and Rh (CM-Rh-CM). Strong 
steric interactions between the asymmetric phosphine ligand and COD are 
responsible for this distortion from the expected square-planar geometry. 
Similar distortions are seen in ligands of this family bearing different 
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substituents as well as in a related Rh-complex bearing the chiral ligand 
BINAP140 and indicate a highly asymmetric environment that should strongly 
influence π-facial selectivity during binding of prochiral unsaturated substrates. 
In fact, an extensive crystallographic study of five-membered Rh-
bisphosphine–diolefin complexes of the type [Rh(PP)(diolefin)]+ carried out by 
Heller et al.141 demonstrated that most crystal structures of this type of catalyst 
show a deviation from the ideal square-planar arrangement. A more detailed 
consideration of the structures shows that there are also other deviations from 
the square-planar structure occurring than the tetrahedral distortion. If one 
defines the ideal square-planar arrangement according to Figure 20 as the x/y 
plane with rhodium in the point of origin, the tetragonal distortion corresponds 
to the rotation of the diolefin around the y-axis. The similarly possible rotation 
around the x-axis results in a square-pyramidal arrangement with the rhodium 
atom at the top of the pyramid.142 
 
   
Figure 20: Square-planar [Rh(PP)(diolefin)]+ complex in the x/y-plane, 
   with  rhodium in the point of origin. 
 
  rotation leading to dissimilarity of 
  P-Rh-CM angles 
rotation leading to square 
pyramidal arangement 
tetragonal distortion 
  bite angle 
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The tetrahedral distortion, a “twist” of the diolefin, is generally explained by 
steric demands of the diphosphine ligand. Comparison of the dihedral angles 
(P-Rh-P/CM-Rh-CM) for cataysts [(S,S)-Me-DuPHOS Rh(COD)]BF4 (S,S-83) 
and [(R,R)-Et-DuPHOS Rh(COD)]BF4 (S,S-95), 16.4° and 21.1° respectively,  
confirms this assumption. Finally, a rotation of the diolefin around the z-axis is 
also imaginable, it leads to a situation in which the two P–Rh–CM angles 
become dissimilar. All three disturbances influence and depend on each other. 
 
To conclude, the steric demand fixed by the alkyl substituents on the ligand 
moiety generates geometrical distortions on the cationic rhodium complex 
which result in an increase or decrease of the enantioselectivity as proven by 
our experimental evidence. Therefore, a small group such as the methyl is 
preferred to the ethyl which is preferred to the phenyl or isopropyl group. 
 
There is a clear correlation between the chelation bite angle143 (P-Rh-P) that is 
determined crystallograhically for the diphosphine ligand backbone and the 
outcome of the addition reaction in terms of enantioselectivity. For example, 
the Rh-BPE family (97, 98) gives a good enantioselectivity; but not as good as 
the Rh-DuPHOS (83, 95); this difference could be explained by the fact that 
the degree of ring strain is more important with the Rh-DuPHOS family since 
it has a smaller bite angle due to the phenyl group of the DuPHOS moiety. As a 
comparison, [(S,S)-Me-DuPHOS Rh(COD)]SbF6 and [(R,R)-Me-BPE 
Rh(COD)]SBF6 have bite angles of 84.8° and 85.1° respectively;143 analogous 
complexes tested, e.g. (R,R)-Me-DuPHOS Rh(COD)]BF4 83 (Table 15, entry 
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2, 93% e.e.) and [(R,R)-Me-BPE Rh(COD)]BF4 97 (Table 5, entry 10, 75% 
e.e.) support our theory. 
Similarly, total or partial collapse of the enantioselectivity in the Rh-
FerroTANE and Rh-5-Ferrocenyl (101-107) catalysed reactions can be 
explained by the wide bite angle existing in these ligands (98.3° for analogous 
[Rh(NBD)(Et-FerroTANE)]BF4 complex144). Indeed, X-ray structures of 
FerroTANE complexes highlight some peculiar structural features that may 
affect on their catalytic behaviour: the large bite angle and the high tilting of 
the phosphetane moieties relative to each other, which is enforced by the bulky 
ferrocene backbone.144,145 However the possible implications of these peculiar 
geometric features have not been fully rationalised yet. 
 
An interesting Rh-preformed catalyst to try would be Rh-BPM 109146,147 
(Figure 21) because of its smaller bite angle (74.10o for (R,R)-Ph-BPM 
Rh(acac) complex148). If the theory is true, enantioselectivity which could be 
reached with this preformed catalyst could exceed that achieved with 83. 
 
BF4
P RR
P RR
Rh
109
 
 
Figure 21: [BMP Rh(COD)]BF4 preformed catalyst. 
 
Obviously this is only a general trend since not all the preformed catalysts 
tested follow the rule and it should be borne in mind that this theory can only 
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give a partial explanation since other factors such as the steric and electronic 
properties of the preformed catalysts also intervene. 
 
Finally, screening of two Ir-DuPHOS ligands (Entries 24-25) was unsuccessful 
as no addition product was formed. In the case of 81 a certain amount of 
unidentified compound was detected by thin layer chromatography; isolation 
and characterisation of this compound was carried out but did not enable clear 
identification of this compound. 
 
A second set of other rhodium preformed catalysts was tested (Figure 22). This 
new set comprises two families: PhanePHOS and PhePHOS. 
 
BF4
P
R2
R2
P
Rh
P RR
Ph
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Rh
BF4
 
 R = i-Pr (R)   110  R = Me (R)     114 
 R = Ph (S)     111 R = Et (R)      115 
 R = 4-F-Ph    112 
 
 Rh – PhanePHOS  Rh - PhePHOS 
 
Figure 22: Second set of preformed catalysts tested in the ligand screening with 
  dimethylzinc. 
 
Results obtained with these preformed catalysts (Table 17) show that the 
PhanePHOS and PhePHOS family do not seem to be very enantioselective  
(0-36% e.e.).  
 
 
109  
Table 17: Results obtained with the second set of preformed catalysts in the 
 ligand screening with dimethylzinc. 
 
Entry Ligand e.e.a (%) 
1 110 0 
2 111 11 
3 112 4 
4 114 0 
5 115 36 
  
 (a) Determined by Supercritical Fluid Chromatography. 
  
Indeed, neither the the PhanePHOS ligands (Entries 1-3, 0-11% e.e.) nor the 
PhePHOS ligands (Entries 4-5, 0-36% e.e.) gave high e.e. values. 
 
Graph 5 summarises the enantioselectivities obtained with the preformed 
catalysts screening thus giving a good visual comparison. As it can be seen, the 
most efficient preformed catalyst discovered was [(R,R)-Me-DuPHOS) 
Rh(COD)][BF4] 83.  
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Graph 5: Comparison of the different catalysts tested in the screening 
   with Me2Zn. 
 
It was considered that a tuning of this catalyst by different alterations could 
lead to an enhancement of its efficiency either in terms of activity or more 
importantly in enantioselectivity. Therefore, two minor alterations were carried 
out on 83: a change of the counteranion and a change of the leaving group. As 
mentioned earlier, an attempt to make this preformed catalyst more soluble in 
THF wasn’t entirely successful (Table 15 – entries 3-4) as although it was 
managed to make it totally soluble in the presence of dichloromethane a drop 
in the enantioslectivity was observed. 
Rh – DuPHOS 
Rh- BPE 
 
Rh – FerroTANE 
 
Rh – 5-Fc 
 Ir – DuPHOS 
 
Rh – PhanePHOS 
 Rh – PhePHOS 
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Another solution to achieve this goal was to modify a part of the preformed 
catalyst so that it becomes more soluble in THF while keeping the same 
activity at the same time. Consequently, it was decided to prepare and test a 
homologue of 83 having the tetrafluoroborate counteranion replaced by a 
triflate counteranion, 117. Preparation of the preformed catalyst 117 is a 
straightforward two step synthesis from commercially available 
[Rh(COD)(acac)] (Scheme 42). Addition of trific acid into a warm solution of 
[Rh(COD)(acac)] in a mixture of donor solvent causes the displacement of the 
acetylacetonate group in order to form a solvato species.  
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O
O TfOH Rh
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solv.
Donor solvent
P
Me
Me
P
Me
Me
P MeMe
P MeMe
Rh
OTf
OTf
(IPA/THF/MTBE)
88 %
50 °C
117
54
116
 
 
Scheme 42: Synthesis of [(R,R)-Me-DuPHOS) Rh(COD)]OTf. 
 
Then, neat addition of (R,R)-Me-DuPHOS to the solvato species causes 
precipitation of the desired preformed catalyst in a good yield (88%). The 
hypothesis that the triflate salt of the preformed catalyst would be more soluble 
was verified experimentally; furthermore it was found that equal levels of 
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acitivity and enantioselectivity were reached with the two salts ({Table 16, 
entry 2} vs {Table 18, entry 1}). 
Given that the change of the counteranion was not successful in increasing the 
efficiency of 83, another alteration was carried out: replacement of the COD 
leaving group by a NBD group with 119 (Table 18, entry 2). 
 
 Table 18: Results obtained with catalysts 118 and 119 in the ligand 
    screening with dimethylzinc. 
 
P MeMe
P MeMe
Rh
BF4
P MeMe
P MeMe
Rh
OTf
 
  118  119 
 
Entry Ligand e.e.a (%) 
1 118 93 
2 119 93 
  
 (a) Determined by Supercritical Fluid Chromatography. 
  
 
Although COD and NBD may seem to be very similar, they cause slight 
structural differences in Rh-bisphosphine-diolefin complexes such as a shorter 
CM-Rh bond length and a smaller CM-Rh-CM with NBD.149 
One attractive advantage of NBD precatalysts over COD complexes is its 
lower cost which in turn can make costs of ligands and catalysts significantly 
reduced. One other element that pushed us into trying the NBD group (119) is 
the fact that in a reported study carried out in the field of hydrogenation,150 the 
time required for conversion of half of one same substrate ((Z)-N-
benzoylaminocinnamate) with the COD complex is six times as long as with 
the NBD complex.  
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This type of NBD precatalyst can be easily prepared following the procedure of 
Schrock and Osborn151 by the reaction of Rh(NBD)acac with the chiral ligand 
and subsequent addition of HBF4. Another quite general methodology 
developed by Heller152 consists in the treatment of the relevant COD 
complexes with an excess of NBD (Scheme 43). 
  
[Rh(COD)(P-P*)]BF4 NBD [Rh(NBD)(P-P*)]BF4
 
 
 Scheme 43: Synthesis of Rh complexes with a NBD counter ligand  
             developed by Heller. 
 
The mechanism of the Me2Zn addition reaction (Scheme 40) is similar to the 
mechanism proposed for the Ir(I)-catalysed AlMe3 addtion reaction presented 
earlier (Scheme 44). 
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Scheme 44: Suggested mechanism for the Rh(I) catalysed Me2Zn addition 
  reaction. 
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In the first step, reaction between Rh catalyst 1' and diorganozinc reagent 
generates the active catalytic species LnRh-Me 2'. Then, this species carries out 
a methyl transfer to the imine substrate 3' which is activated by Lewis acidic 
Me2Zn. This results in the formation of compound 4' which bears a chiral 
center α to the Me group. Finally, intervention of another equivalent of Me2Zn 
replaces the former N-Rh bond by a N-Zn bond to give 5'. In the last step 
compound 5' is quenched by water to afford the desired methylated protected 
amine 6'. 
 
5.2  Problem of reproducibility 
The different screenings led to the conclusion that the best preformed catalyst 
for our catalytic system using solely benzaldimine 27 as substrate was 83; the 
next move was then to evaluate and compare the tolerance of the newly found 
system towards different aryl substituents. Therefore nine substrates bearing 
different substituents at different positions were tested (Table 19).  
Substituents such as the p-methoxy phenyl group (Entry 7) seemed to perform 
poorly both in terms of activity and enantioselectivity, thus showing a limited 
tolerance towards electron donating groups. This observation that an electron 
donating substituent on the aromatic ring decreases the rate of the reaction was 
equally observed in Cu(II)-catalysed Me2Zn addition developed by Charette et 
al.40 
In the case of the 1-naphthyl group (Entry 8), the reaction does not proceed at 
all while it runs smoothly with the 2-naphthyl group (Entry 9), highlighting 
here a non-tolerance of excessively sterically hindered substrates. All other 
substrates gave a reasonable enantioselectivity (Entries 1-6). 
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  Table 19: Substrate tolerance of the Me2Zn addition reaction. 
 
Ar
N P
O
Ph
Ph Me2Zn
THF, reflux,  3 h
83 (5.8 mol% Rh) Ar
HN P
O
Ph
Ph
Me
 
P MeMe
P MeMe
Rh
BF4
83
 
Entry Ar e.e.a (%) 
1 Ph 27 74-94 
2 4-F-Ph 36 80 
3 4-Cl-Ph 37 84 
4 4-Br-Ph 40 62 
5 4-CF3-Ph 35 76 
6 4-Me-Ph 32 70 
7 4-OMe-Ph 43 50 b 
8 1-naphthyl 42 / c 
9 2-naphthyl 41 74 
 
(a) Measured by HPLC (OD-H column, 95:5 hexane/IPA,1.0 ml/min). 
(b) Low conversion. 
(c) No reaction occurred. 
   
 
Surprisingly, while it was previously found that use of benzaldimine 27 as a 
substrate could reach an enantioselectivity of up to 94% e.e. (cf. Table 15), we 
were disappointed to realise that this enantioselectivity could be significantly 
variable (Entry 1), going in the worst cases down to 75% e.e. This gap was 
obviously not acceptable and an investigation was undertaken to identify the 
source of the problem and to make the system more robust. 
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5.2.1  Effect of the ligand/metal ratio 
This problem of reproducibility was thought to be related to the formation of 
an undesired achiral catalytic species, generated in random amounts, each time 
the reaction was run. This achiral species has to compete with the active chiral 
species which we aim to generate between the Rh precursor and Me2Zn. 
If one considers the reaction between Me2Zn and the Rh catalyst 83, the 
transfer of the nucleophilic methyl group from Me2Zn can occur through two 
different approaches that may compete with another. The first one is an attack 
of the Rh centre of 83 by the methyl group that leads to the displacement of the 
COD coligand, in which case species 120 is formed (Scheme 45). The second 
one is the same nucleophilic attack that results this time in the displacement of 
the DuPHOS ligand, in which case species 121 is formed. 
 
BF4
P MeMe
P MeMe
Rh
P MeMe
P MeMe
Rh RhMe Me
COD (R,R)-Me DuPHOS
MeZn Me
83120 121
MeZn Me
COD
(R,R)-Me DuPHOS
 
 
Scheme 45: Chiral and achiral species competing as a nucleophile. 
 
In other words, two different catalytic species are formed according to a 
pathway differing only in the nature of the leaving group. The rhodium-
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ethylene bond dissociation energy being estimated to only ca. 130 kJ mol-1,153 
the ratio 121/120 should be fairly small. Nevertheless, species 121 being 
catalytically more active than 120, even a small amount can be very 
detrimental to the enantioselectivity. The Rh-Me bond energy being fairly low  
(52.0 kJ mol-1,154 so lower than Rh-ethylene) one can say that formation of 
compounds 120 and 121 from 83 may be reversible.  
In the context of [4+2] cycloaddtion chemistry, Hayashi evaluated the 
relationship between the catalyst activity and the nature of the ligand on the 
transition metal. He demonstrated that a rhodium-diene complex is much more 
active than its rhodium-bisphosphine counterpart as a catalyst.155 His 
quantitative evaluation of several ligands in a rhodium catalysed intramolecular 
[4+2] cycloaddition reaction was carried out in a kinetic study and it was found 
that the reaction catalysed by the Rh-COD complex proceeded very fast while 
rhodium-dppe and rhodium-dppb catalysts counterparts (dppe = 1,2-
bis(diphenylphosphanyl)ethane; dppb = 1,2-bis(diphenylphosphanyl)butane) 
were at least twenty times slower.  
To verify that achiral species 121 gives indeed the racemic product, the same 
Me2Zn addition reaction was run using this time [Rh(Cl)COD]2 as a catalyst, in 
the absence of any ligand (Scheme 46). 
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Scheme 46: Effect of racemisation caused by achiral catalytic species 
     Rh(Me)(COD). 
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As expected, the reaction afforded the racemic product which confirmed our 
hypothesis regarding the consequences of the generation of 121, namely a 
racemisation process. The ratio ligand/metal being fixed to 1:1 in 83, we 
thought that a trivial solution to solve the problem would be to modify this 
ratio by increasing the amount of ligand. This way, the presence of deliberately 
added free excess (R,R)-MeDuPHOS would convert any achiral species 121 
directly into 120. Also, to diminish the formation of 121, it was decided to 
replace the COD coligand with a bis(ethylene) analogue since the latter is 
known for being a better leaving group. Unlike COD (or COE) which is a high 
boiling point liquid (b.p. = 150 °C), ethylene has the advantage of being a gas; 
therefore, when ethylene is displaced by the methyl group (or maybe the 
solvent, THF), the process is not reversible as ethylene gas cannot be 
coordinated back to rhodium. In the case of the COD group (83), the same 
process is reversible to some extent (slower exchange metal-coligand) which 
makes it less labile and eventually allows generation of a certain amount of 
highly active achiral species 121. By using the highly labile bis(ethylene) 
coligand, it is inferred that the possible rhodium catalytic species reacting with 
Me2Zn (to obtain 120) is [(R,R)-Me DuPHOS Rh(Cl)]2 123 (Figure 23). The 
formation of another species, 124, could also be envisaged; this latter being a 
Rh atom substituted with four phospholanes would be catalytically inactive as 
all sites on Rh are occupied. 
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Figure 23: Possible rhodium species generated in the catalytic process. 
 
 
To verify the outcome of the above-mentioned hypothesis, the catalytic system 
was therefore altered by using chlorobis(ethylene)rhodium(I) dimer as a 
catalyst and an excess of (R,R)-Me DuPHOS ligand (Scheme 47). 
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Scheme 47: Me2Zn addition reaction carried out with [Rh(Cl)(C2H4)2]2 as a 
      catalyst. 
 
The reproducibility of the transformation was checked by running the reaction 
twice in the very same conditions, and with different ratios ligand/metal in 
order to compare results obtained with the duplicates (Graph 6). As it can be 
clearly seen, on the one hand when the ligand and the metal are used in 
equimolar proportions (L*/Rh = 1.0), a significant gap is visible between the 
enantioselectivity reached between duplicates of the same reaction. A 
remarkable example is  the case of the p-fluoro benzaldimine 36 in which the 
enantioselectivities obtained in the two duplicates show a gap of 22% whilst a 
120  
slight increase of 0.1 mol% of ligand (i.e. L*/Rh = 1.1) reduces this gap down 
to 1%, thus making a valuable difference. 
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Graph 6: Effect of the L*/Rh ratio on the reproducibility of the Me2Zn 
    addition reaction. Comparison of duplicates. 
 
 
A noteworthy trend is the fact that increasing the amount of ligand does 
increase the enantioselectivity. In the case of the p-trifluorobenzaldimine 35, 
the e.e. evolves progressively from 33% to 62% and 82% with respective 
L*/Rh ratios of 1.0, 1.1 and 1.4. The fact that our rhodium catalysed system 
exhibits ligand retarded catalysis, this increase has its limits since an excessive 
amount of ligand reduces the activity. These results supported strongly and 
confirmed our hypothesis expounded earlier. Consequently, we decided to keep 
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the new catalytic system which has an excess of ligand, for further 
optimisation. 
 
5.2.2  Effect of the reaction scale 
The influence of another parameter of the reaction, the scale on which it was 
performed, was tested. The reaction was scaled up by a factor 2 from 0.30 
mmol (usual scale) to 0.60 mmol. Four substrates were tested and the variation 
of the enantioselectivity in two different ligand/catalyst ratios measured  
(Table 20). 
 
Table 20: Effect of the reaction scale on the reproducibility of the 
    enantioselectivity. 
 
 
 
 
 
 
 
Entry Ar e.e. (%)a 
[0.30 mmol scale] [0.60 mmol scale] 
L*/cat.  
= 1.4 
L*/cat.  
= 1.6 
L*/cat.  
= 1.4 
L*/cat.  
= 1.6 
1 Ph 27 97 81 93 93 
2 4-CH3-Ph 32 89 81 93 93 
3 4-CF3-Ph 35 75 75 86 86 
4 4-F-Ph 36 86 88 89 90 
 
 (a) Determined by GC after derivatisation. 
 
 
Results show that on a 0.30 mmol scale, the variability of the enantioselectivity 
can still be significant in some cases (Entries 1-2) or minor in others (Entries 3-
4). On the other hand, on a 0.60 mmol scale, not only the steadiness of the 
reproducibility is increased (highest variation is 1% e.e – entry 4), but the 
Ar
N P
O
Ph
Ph Me2Zn
THF, reflux,  3 h
Ar
HN P
O
Ph
Ph
Me(5.8 mol% Rh)
(8.1 - 9.3 mol%)54
125
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enantioselecivity as a whole is also increased from 2% (Entry 4) to 15% 
(Entries 1-2-3). 
It is assumed that the explanation of this finding is merely due to the fact that 
the instrumental level of accuracy of the amounts of chemicals weighed out on 
the balance, is higher when the reaction is scaled-up. Indeed, the amount of 
catalyst and ligand goes up from 3.4 mg and 9.6 mg to 6.8 mg and 19.2 mg 
when shifting from a 0.30 to a 0.60 mmol scale respectively. 
 
5.3 Formation of the reduction product 
5.3.1 Meerwein-Ponndorf-Verley rearrangement 
The formation of an unusual byproduct which could be detected by 1H NMR 
spectroscopy drew our attention during the optimisation stage of the Me2Zn 
reaction. The identification of this byproduct was carried out by means of 
spectroscopic data and it turned out to be the product resulting from the 
reduction of the substrate. This identification was confirmed by synthesing the 
reduction product and by comparing the spectroscopic data which perfectly 
matched. 
Initially, the formation of the reduction product puzzled us since unlike Et2Zn, 
no β hydride elimination can take place with Me2Zn. This option being ruled 
out, the other most likely reaction that could generate a reduction product was a 
Meerwein-Ponndorf-Verley (MPV) rearrangement. In this reaction  
(Scheme 48) the rhodium-catalyzed hydride shift from the α carbon of amine 
2’ to the C=N bond of the imine proceeds via a six-membered transition state. 
This transition state gives rise to two compounds, the MPV reduction product 
2’ and the Oppenauer oxidation product ketimine 5’. 
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Scheme 48: Meerwein-Ponndorf-Verley reduction occurring as a side 
    reaction in the Me2Zn addition reaction. 
 
The metal promoting the formation of the six-membered transition state could 
possibly not be rhodium as it is suggested in the above-mentioned scheme. A 
basic experimental attempt to determine the nature of the coordinating metal in 
3’ was undertaken. It was found that the absence of either the Rh catalyst or 
Me2Zn resulted in the total recovery of the starting material; a result which 
could not contribute to the mechanistic understanding of the process taking 
place. 
Unfortunately, the hypothesis that the MPV reduction reaction is taking place 
has not been proven yet. In fact, generation of the Oppenauer oxidation product 
5’ was not experimentally observed; none of its possible decomposition 
products due to its hydrolytic unstability were observed either by NMR 
spectroscopy which may suggest that 5’ undergoes another unidentified 
reaction. 
 
In order to minimise or inhibit the formation of the MPV product it was 
necessary to gain insight into which parameters could affect the formation of 
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this byproduct. Two parameters were identified in our study: the catalyst 
coligand (Table 22) and the ligand/metal ratio (cf. 5.2.5, table 22). Indeed, it 
was found that the nature of the catalyst coligand which may seem to be a non 
significant factor could favour substantially the formation of the MPV product 
126.  
 
Table 22: Influence of the catalyst coligand on the formation of the MPV 
   reduction product 126. 
 
Cl
N PPh2
O
Cl
HN PPh2
O
Me2Zn
(5.8 mol% Rh)
No ligand
THF, reflux, 3 h
Me +
Cl
HN PPh2
O
51 126
Cat.
37
100 % conv.
(rac)
 
 
Entry Catalyst 51:126  
ratio a 
 
1 
      
Rh Rh
Cl
Cl
      125 
 
10 : 90 
 
2 
 
Rh Rh
Cl
Cl
  122 
 
54 : 46 
 
(a) Determined by 1H NMR spectroscopy. 
 
 
This was realised when catalysts 125 and 122 were employed under the same 
conditions in the Me2Zn addition reaction. Surprisingly, although both catalysts 
have the same acitivity, 125 which has an ethylene coligand and 122 which has 
a COD coligand afforded a 10:90 (Entry 1) and 54:46 (Entry 2) methyl 
addition product:MPV product ratio respectively. 
 
5.3.2 Effect of BozPHOS 
As presented in the introduction (cf. 1.3.2.2.2, Scheme 7), in the Cu(I)-
catalysed Me2Zn addition reaction developed by Charette et al.,39,40,41 it was 
found that the Me-DuPHOS monoxide ligand (or BozPHOS) was performing 
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better than the Me-DuPHOS ligand. Charette and coworkers also found that the 
genuine catalyst participating in the reaction is actually not Cu-DuPHOS, but 
Cu-BozPHOS which is formed by an in situ oxidation.156 Consequently, this 
interesting fact encouraged us to evaluate the effect of BozPHOS both as a 
ligand and as an additive on the Me2Zn addition reaction to p-Cl-benzaldimine 
37 (Table 23). 
 
Table 23: Effect of BozPHOS as ligand and additive on the Me2Zn addition 
  reaction. 
 
Cl
N PPh2
O
Cl
HN
PPh2
O
Me2Zn
(5.8 mol% Rh)
Ligand
THF, reflux, 3 h
Me +
Cl
HN PPh2
O
51 126
(5.2-17.4 mol %)
37
RhCat. = Rh Cl
Cl
125
Cat.
 
 
 
Entry 
 
L*/Rh 
ratio 
 
Ligand 
 
Additive 
Results 
Conv.a 
(%) 
Ratio a 
51:126 
e.e. b 
(%) 
1 0 none none 100 10 : 90 0 
       2  
0.9 
 
(R,R)-Me-
DuPHOS 
none 100 67 : 33 86-91 
3 BozPHOSc 100 91 : 9 90 
4 BozPHOS none 100 84 : 16 85 
       5 
1.8 
(R,R)-Me-
DuPHOS 
none 100 95 : 5 86-90 
6 BozPHOSd 100 96 : 4 87 
7 1,5-CODe 100 95 : 5 88 
8 BozPHOS none 100 92 : 8 91 
 9 1.4 (R,R)-Me-
DuPHOS 
 
none 
100 92 : 8 82 
10 2.2 86 94 : 6 80 
11 3.0 11 72 : 28 78 
 
(a) Determined by 1H NMR spectroscopy. 
(b) Determined by GC after derivatisation. 
(c) Loading = 5 mol%. 
(d) Loading = 2 mol%. 
(e) Loading = 10 mol%. 
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Three elements were measured: conversion, enantioselectivity and methyl 
addition product/reduction product ratio. In the absence of ligand, the reaction 
affords the racemic product (as expected) and mainly the MPV product (Entry 
1). When the reaction is run with a 0.9 L*/cat. ratio, addition of BozPHOS as 
an additive with DuPHOS seems to be effective to reduce the formation of the 
MPV product (Entries 2-3). However under this ratio, when BozPHOS is used 
as the main ligand (Entry 4) a greater amount of  MPV product is generated 
while the enantioselectivity does not vary substantially (85-91% e.e, entries 2-
4). Nevertheless, no solid finding can be drawn from such results since it is 
known that a problem of reproducibility does exist when the ligand/metal ratio 
is low. When the reaction is run with a 1.8 L*/cat. ratio, the amount of MPV 
product is very small (relative amount : 4-5%, entries 5-7). Under this ratio, the 
absence or presence of BozPHOS as an additive (Entries 5-6) is not detrimental 
since identical values of conversion, e.e. and methyl addtion product/reduction 
product ratio are measured. However when BozPHOS is the main ligand (Entry 
8) a slight increase in enantioselectivity (91% e.e.) can be measured. The effect 
of the addition of free 1,5-COD was also tested (Entry 7); interestingly, the 
presence of 10 mol% of free 1,5-COD does not affect the outcome of the 
reaction since the results obtained in the presence or absence of this additive 
are almost identical. Based on Scheme 41, the addition of 1,5-COD should 
favour the formation of active achiral Rh catalyst bearing the COD group as a 
coligand. Unfortunately, this hypothesis could not be verified by this single test 
reaction. Finally, the reaction was run with a 1.4, 2.2 and 3.0 L*/Rh ratios 
(Entries 9-11) in order to observe the trend obtained with the increase of 
amount of ligand. As anticipated, a drop of the activity and of the selectivity 
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was observed when the amount of ligand was excessively high (Entries 10-11) 
since the present transformation corresponds to a ligand-retarded catalysis. 
 
5.4  Effect of various optimisation parameters 
5.4.1  Effect of substrate scope 
Once the parameters related to the non-reproducibility, namely the ligand/metal 
ratio and the reaction scale, were identified and successfully solved, the 
reaction reached a good level of optimisation and it was therefore decided to 
test the newly developed conditions on seven substrates (Table 21). 
 
Table 21: Me2Zn addition reaction carried out on optimised conditions. 
 
 
 
 
Entry Ar e.e. a (%) 
1 Ph 27       97 (R) 
2 4-Cl-Ph 37 90 
3 4-Br-Ph 40 90 
4 4-CF3-Ph 35 89 
5 3-Me-Ph 33 92 
6 2-Me-Ph 34 91 
7 2-Cl-Ph 39 > 99 
   
 (a) Determined by GC after derivatisation. 
  
 
The level of enantioselectivity reached with the new conditions where the 
ligand/metal ratio is 1.8 and the reaction scale 0.60 mmol, was outstanding. 
Indeed, the range of substrates which was tested afforded enantioselectivites in 
the range 90-99% e.e. The e.e. value reached with 27 increased from 93% to 
Ar
N P
O
Ph
Ph Me2Zn
THF, reflux,  3 h Ar
HN P
O
Ph
Ph
Me(5.8 mol% Rh)
(10.4 mol%)54
[0.60 mmol scale]
125
128  
97% (Entry 1), from 84% to 90% (Entry 2) with 37, and from 62% to 90% 
(Entry 3) with 40. 
 
 
5.4.2  Effect of catalyst loading 
The catalyst loading of the Me2Zn addition reaction which was set to 5.8 mol% 
for all reactions carried out in the study presented in this thesis. Obviously this 
loading is viable on a laboratory scale but very problematic on the industrial 
scale because of the price of rhodium which is fairly expensive. Consequently 
it was decided to test the reaction with a loading of Rh catalyst of 3.0 mol%, 
almost half of the usual loading (Table 24). 
 
Table 24: Influence of the catalyst loading on performance of the reaction. 
 
N
PPh2
O
HN
PPh2
O
Me
Me2Zn  (2 equ.)
THF, reflux, 3 h
L*/Rh = 1.8
RhCat. = Rh
Cl
Cl
P MeMe
P MeMe
L* =
125 54
27 44
 
  
Entry Cat. loading 
(mol% of Rh) 
Conv. a 
(%) 
e.e. b 
(%) 
1 5.8 98 97 
2 3.0 95 97 
  
(a) Determined by 1H NMR spectroscopy. 
(b) Determined by GC after derivatisation. 
 
 
129  
Under this lower catalyst loading both activity and selectivity remained 
constant which shows that catalyst 125 is not used up to its highest limit and 
that a smaller amount could be successfully run. 
 
 
5.4.3  Effect of free DuPHOS 
As mentioned earlier, during the course of this study on the Me2Zn addition 
reaction, it was found that the ligand/metal ratio was essential to get a good 
reproducibility and a good selectivity (cf. 5.2.2.1 - Graph 6). This discovery led 
us to use the couple (R,R)-Me-DuPHOS/[RhCl(C2H4)2]2 with a ratio of 1.8 
instead of (R,R)-Me-DuPHOS Rh(COD)]BF4 83. The positive effect of the 
excess of ligand being successfully demonstrated, an attempt to prove that this 
same excess could also be beneficial to the couple (R,R)-Me-DuPHOS/83
 
was 
carried out. Therefore the Me2Zn addition reaction was run with substrate 37, 
catalyst 83, and a sufficient amount of free DuPHOS ligand so that the overall 
ligand/metal ratio was equal to 1.8 (Table 25). 
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Table 25: Effect of free DuPHOS when combined with catalyst 83. 
 
Cl
N PPh2
O
Cl
HN PPh2
O
Me2Zn
(5.8 mol% Rh)
THF, reflux, 3 h
Me +
Cl
HN PPh2
O
51 126
Cat.
37
P RR
P RR
Rh
BF4
83
Cat. =
 
 
 
Entry 
 
Additive 
 
Ratio 
L*/cat. 
Results 
Conv. a 
(%) 
51:126 
ratio a 
e.e. b  
(%) 
1 none 1.0 100 90 : 10 82 
2 (R,R)-Me-DuPHOSc 1.8 21 88 : 12 64 
 
(a) Determined by 1H NMR spectroscopy. 
(b) Determined by GC after derivatisation. 
(c) Loading = 4.6 mol%. 
 
 
When catalyst 83 is used in the absence of free DuPHOS ligand which means 
that the ligand/metal ratio is equal to 1.0, a complete conversion and reasonable 
selectivity is obtained (Entry 1). But surprisingly, in the presence of 4.6 mol% 
of excess free DuPHOS ligand (ligand/metal = 1.8), a dramatic drop in the 
activity and in enantioselectivity is observed (Entry 2). Finally, no significant 
change in the amount of reduced byproduct 126 was observed. A possible 
explanation for the unexpected poor performance caused by the addition of free 
DuPHOS ligand in the present system could be that the Rh catalyst gets 
converted into an inactive species such as 124, in which the Rh atom is 
tetrasubstituted with phospholanes, thus having all sites blocked.  
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5.4.4  Effect of time and temperature 
When the problem of reproducibility first arose, different parameters were 
studied; among them two were related to the formation of the catalytic 
complex: the reaction time and the temperature. To this end two different 
reaction conditions were tested: 
- Conditions A:  reaction run on a 0.60 mmol scale, ligand and catalyst 
stirred at room temperature for 90 min. 
- Conditions B:  reaction run on a 0.60 mmol scale, ligand and catalyst 
stirred at 60 oC for 110 min. 
The influence on the enantioselectivity was then measured for both conditions 
and for two different ligand/Rh ratios (Table 26). 
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Table 26: Influence of time and temperature on the enantioselectivity. 
N
PPh2
O
HN
PPh2
O
Me
Me2Zn  (2 equ)
THF, reflux, 3 h
RhCat. = Rh
Cl
Cl
P MeMe
P MeMe
L* =
125 54
R R
Cat. (5.8 mol%)
 
 
Entry 
 
R 
e.e. (%) a 
Conditions Ab Conditions Bc 
L*/Rh 
 = 1.4 
L*/Rh 
= 1.6 
L*/Rh 
 = 1.4 
L*/Rh 
= 1.6 
1 H 27 81 67 90 89 
2 CF3 35 84 82 85 85 
3 F 36 72 72 62 88 
 
(a) Determined by GC after derivatisation. 
(b) Reaction run on a 0.60 mmol scale, ligand and catalyst stirred at room 
  temperature for 90 min. 
(c) Reaction run on a 0.60 mmol scale, ligand and catalyst stirred at 60oC for 110 
  min. 
 
 
For a ligand/metal ratio of 1.6, the enantioselectivity is higher when the 
reaction is run under conditions B; for instance, in the case of substrate 27 
(Entry 1), conditions A afford a 67% e.e. while conditions B afford a 89% e.e. 
Also, under conditions A the e.e. tends to decrease when switching from ratio 
1.4 to ratio 1.6 while this decrease is not observed under conditions B. 
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Conclusion 
 
In conclusion, the goals and objectives of this research project have been 
successfully reached though further studies would be beneficial to bring more 
potential to the methodology which we have developed.  
 
On the one hand, an effective iridium(I) catalytic system in the AlMe3 (or 
DABAL-Me3) addition reaction was identified. We showed that, in this system, 
addition of other organoaluminium nucleophiles such as the alkenyl group or 
the alkynyl group was suitable with the reaction conditions. Screening of 
different ligands to make the reaction enantioselective showed little success as 
the best result of this screening was obtained with 78 with only 36% e.e. The 
different screenings which were carried out led us to develop a new method for 
the measurement of the enantiomeric excess taking advantage of the presence 
of 31P atom on the substrate. This 31P NMR based technique was found to not 
be as accurate as chromatographic separation techniques such as HPLC or GC; 
nonetheless it is much more time saving in the identification of leads in high 
throughput screening. 
 
On the other hand, the second goal achieved in this investigation was to 
identify another catalytic system enabling the effective and enantioselective 
addition of Me2Zn to diphenylphosphinoyl protected imines. This new system 
catalysed by a rhodium(I) preformed catalyst, [(R,R)-Me-DuPHOS 
Rh(COD)]BF4 83 proved to be effective as it affords the methylated amine with 
very high conversion (~ 100%) and high e.e. (up to > 99%). A comprehensive 
screening of other rhodium and iridium preformed catalysts found that 83 was 
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the most enantioselective. A single attempt to carry out a Et2Zn addition 
reaction in the conditions found with 83 proved unsuccessful, thus suggesting 
that a β hydride elimination is taking place with such alkyl groups and that the 
present rhodium-catalysed system requires further elaboration to increase the 
scope of nucleophiles. The Rh-catalysed methylation reaction was then 
improved by replacing catalyst 83 with [RhCl(C2H4)]2 and (R,R)-Me-DuPHOS 
ligand, to get good reproducibility. 
 
It should be noted that the two catalytic systems developed in this investigation 
both use commercially available catalysts and organometallic reagents, which 
is quite a substantial advantage compared to other similar transformations 
reported by other groups. Regarding the future work, some findings such as the 
effect of the ligand bite angle which have not been investigated thoroughly 
because of lack of time need further attention in order to find a highly 
performant catalyst. If the testing of BPM ligand 109, which has been 
suggested earlier because of its small bite angle, is positive, the design and the 
synthesis of an entire family of derived ligands could be envisaged. Last but 
not least, the fact that the diphenylphosphinoyl protected amine product can be 
recrystallised smoothly (in CH2Cl2/hexanes) is a great advantage since it 
enables access to virtually enantiopure chiral amines. 
 
Finally, once all the methodology is fully developed and optimised, a number 
of biologically active compounds featuring a chiral amine moiety could be 
easily synthesised, thus illustrating the usefulness of our novel reactions. 
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Experimental procedures 
 
7.1  Synthesised compounds 
7.2  General methods 
7.3  General procedures 
7.4  Synthesis of aldimine susbstrates 
7.5  Synthesis of racemates 
7.6  Synthesis of trifluoroacetamides and acetamides 
7.7  Deprotection and isolation of amines 
7.8  Synthesis of ligands and catalysts 
7.9  Synthesis of oximes 
7.10  Synthesis of sulfonyl adducts 
7.11  Synthesis of the allyl and propargyl addition products 
7.12  Miscellaneous 
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7.1  Synthesised compounds 
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7.2  General methods 
 
All reactions were run under an argon atmosphere with rigid exclusion of 
moisture from the glassware using standard Schlenk techniques on a dual 
manifold. Reaction solvents were dried and freshly distilled from suitable 
drying agents prior to use. THF was distilled from sodium-benzophenone ketyl. 
Dichloromethane was distilled from calcium hydride. Thin layer 
chromatography (TLC) was performed on Merck silica gel 60 F254+366 pre-
coated plates (0.25 mm) silica. The plates were visualised by the use of a 
combination of ultraviolet light (254 and 366 nm) and/or aqueous potassium 
permanganate with heating.  
Liquid chromatography was by forced flow (flash chromatography) with the 
solvent systems indicated using silica gel 60 (220-240 mesh) supplied by 
Fluka. Nuclear magnetic resonance spectra (1H, 13C, 31P, 19F) were recorded 
either on a JEOL EX270, Bruker DPX400, Bruker AV400 and Bruker 
AV(III)400 spectrometers, using Me4Si as an internal reference. For all 
samples δ values were referenced to residual CHCl3. Data are reported as 
follows: chemical shift in ppm, multiplicity (s = singlet, d = doublet, t = triplet, 
q = quartet, qn = quintet, sept = septet, m = multiplet and br = broad), coupling 
constant in Hz, integration, and assignment. Infrared absorption spectra were 
recorded on a Nicolet Avatar 320 FT-IR, a Perkin Elmer 1600 Series FTIR and 
a Bruker Tensor 27 machine. Mass spectra (MS) were recorded at high 
resolution (HRMS) on a Bruker ApexIV FT-ICR mass spectrometer using 
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Electrospray (ES) or electron impact (EI) techniques. Optical rotations were 
measured using a Bellingham Stanley ADP440 digital polarimeter at ambient 
temperature in units of 10-1 o cm2 g-1 (c in g/100 cm3). Enantioselectivities were 
determined by 31P NMR spectroscopy, chiral GC or chiral HPLC. GC analyses 
were performed on a Varian 3380 gas chromatograph using a Chiracil-dex CB, 
lipodex A and 2,6-γ columns under the conditions given. Chiral HPLC used 
Daicel Chiracel OD-H (250 mm) and Chiracel AD-H (250 mm) stationary 
phase columns on rigorously purified samples. 
The dimethylzinc samples used were commercial products from the following 
sources: ZnMe2 (2.0 M toluene solution; Fluka or Aldrich). (R,R)-Me-
DUPHOS used in the synthesis of BozPHOS was provided by Chirotech Ltd 
(Dow Pharma) and was used as received. The ligands 70-80 and preformed 
catalysts 81-83, 95-108, 110-115 were generously offered by Chirotech Ltd (Dr 
Reddy’s), and were used as received. 
 
 
7.3  General procedures 
 
7.3.1  Methylation of imines with AlMe3 in the screening of copper and 
iridium catalysts (Table 9, conditions C,D,E; Table 10, conditions F,G,H) 
 
In a 20 mL flame dried Schlenk tube purged under argon and equipped with a 
magnetic stirrer bar, was successively charged the ligand (0.025 mmol, 5 
mol%), the catalyst (0.025 mmol, 5 mol%) and 4.5 mL of dry solvent. The 
solution was stirred for about 30 min before introducing the imine substrate 
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(0.50 mmol, 1 eq.) and stirring for another 15 min. Next, dropwise addition of 
a 2M AlMe3 solution in hexanes (0.50 mL, 2 eq.) was carried out and the 
solution was left under stirring and under argon at the appropriate temperature 
for 24 h, upon which time the solution was quenched by cautious addition of 
MeOH. The mixture was filtered through a small pad of Celite and the solvent 
evaporated off. Conversion was measured by 1H NMR spectroscopy analysis 
using deuterated chloroform deactivated by passage through basic alumina (to 
remove HCl and water). Enantiomeric excess was measured by chiral HPLC 
using an AD-H column. 
 
7.3.2  Methylation of imines using AlMe3 and Ni(acac)2 (Fujisawa’s 
conditions – Table 8, conditions A) 
In a 20 mL flame dried Schlenk tube purged under argon and equipped with a 
magnetic stirrer bar, was dissolved Ni(acac)2 (0.025 mmol, 5 mol%) and 2 mL 
of dry THF at 0 °C. In the meantime, in a 10 mL flame dried round-bottom 
flask under argon, were dissolved the triphenylphosphine (0.050 mmol, 10 
mol%) and the imine substrate (0.50 mmol, 1 eq.) in 3 mL of dry THF. Next, 
the two solutions were mixed in the Schlenk tube, at 0 °C, for 10 min. Then, 
after the dropwise addition of a 2M AlMe3 solution in hexanes (0.50 mL, 2 
eq.), the mixture was stirred overnight at 0 °C. Acidic workup with MeOH, 
filtration on Celite and evaporation of the solvent afforded a product which was 
analysed by 1H NMR spectroscopy. 
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7.3.3  Methylation of imines using Me2Zn and (CuOTf)2 (Charette’s 
conditions - Table 9, conditions C) 
In the same flask, BozPHOS ligand (8.1 mg, 0.025 mmol, 5 mol%) and 
(CuOTf)2•toluene (12.6 mg, 0.025 mmol, 5 mol%) were dissolved in toluene 
(1.5 mL). The resulting heterogeneous solution was stirred for 1 h at room 
temperature. 
A 2M dimethylzinc solution (0.75 mL, 1.5 mmol, 3 eq.) was added at room 
temperature and the resulting yellow/green suspension was stirred for an 
additional 30 min before the imine (0.50 mmol, 1 eq.) in toluene (3 mL and 1.5 
mL) was transferred (with a cannula or a syringe) to the catalyst solution. After 
stirring for 48 h at room temperature, the reaction was quenched with saturated 
NH4Cl and the aqueous layer was extracted rapidly with CH2Cl2 (3 times). The 
combined organic layers were dried over Na2SO4. Conversion was measured 
by 1H NMR spectroscopy. 
 
7.3.4  Ligand screening of the iridium catalysed AlMe3 addition to 
benzaldimine 27 
In a 20 mL flame dried Schlenk tube purged under argon and equipped with a 
magnetic stirrer bar, was successively charged the ligand (0.015 mmol, 5 
mol%), the catalyst (0.015 mmol, 5 mol%) and 4.0 mL of dry solvent. The 
solution was stirred for about 5-10 min before introducing the imine substrate 
(0.30 mmol, 1 eq.), 1.0 mL of dry solvent and being left to stir for another 10 
min. Next, dropwise addition of a 2M AlMe3 solution in hexanes (0.60 mmol, 
2 eq.) was carried out and the solution was left under stirring and under argon 
at the appropriate temperature and time. The reaction mixture was finally 
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quenched by cautious addition of NH4Cl. The mixture was extracted 3 times 
with CH2Cl2 and the organic layer was dried over Na2SO4, filtered through 
cotton wool and the solvent was evaporated. Conversion was measured by 1H 
NMR spectroscopy analysis using deuterated chloroform deactivated by 
passage through basic alumina (to remove HCl and water). Enantiomeric 
excess was measured by chiral HPLC and/or by 31P NMR spectroscopy using 5 
equivalents of (1S)-10-camphorsulfonic acid. 
 
7.3.5  Preformed catalysts screening in the Me2Zn addition to 
benzaldimine 27 
In a 20 mL flame dried Schlenk tube purged under argon and equipped with a 
magnetic stirrer bar, was charged the preformed catalyst (5.8 mol%) and 4.0 
mL of dry THF. The solution was stirred for about 1 min upon which time was 
introduced the imine substrate (0.30 mmol, 1 eq.) and 1.0 mL of dry THF. The 
mixture was left under stirring for 10 min at room temperature. Next, dropwise 
addition of a 2M Me2Zn solution in toluene (0.30 mL, 0.60 mmol, 2 eq.) was 
carried out and the solution was left under stirring and under argon at the 
appropriate temperature and time. The reaction mixture was finally quenched 
by cautious addition of NH4Cl. The mixture was extracted 3 times with CH2Cl2 
and the organic layer was dried over Na2SO4, filtered through cotton wool and 
the solvent was evaporated. Conversion was measured by 1H NMR 
spectroscopy analysis using deuterated chloroform deactivated by passage 
through basic alumina. Finally, the product was isolated by preparative TLC 
(EtOAc/CH2Cl2 1:1) and analysed by chiral SFC or chiral HPLC for e.e. 
determination. 
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7.3.6  Optimised conditions for the [RhCl(C2H4)2]2 catalysed Me2Zn 
addition reactions 
In a 20 mL flame dried Schlenk tube purged under argon and equipped with a 
magnetic stirrer bar, was successively charged the [RhClbis(ethylene)] dimer 
(7.8 mg, 17.4 mol, 5.8 mol% Rh), (R,R)-Me-DuPHOS (19.2 mg, 62.6 mol, 
10.4 mol%) and 4.0 mL of dry THF. The solution was stirred for about 30 min 
at room temperature upon which time was introduced the imine substrate (0.60 
mmol, 1 eq.) and 1.0 mL of dry solvent. The mixture was left under stirring for 
10 min. Next, dropwise addition of a 2M Me2Zn solution in toluene (0.60 mL, 
1.20 mmol, 2 eq.) was carried out and the solution was left under stirring and 
under argon at reflux temperature for 3 hours. The reaction mixture was finally 
quenched by cautious addition of NH4Cl. The mixture was extracted three 
times with CH2Cl2 and the organic layer was dried over Na2SO4, filtered 
through cotton wool and the solvent was evaporated. Conversion was measured 
by 1H NMR spectroscopy analysis using deuterated chloroform deactivated by 
passage through basic alumina. Finally, the product was isolated by flash 
chromatography (EtOAc/CH2Cl2 1:1) and derivatised for chiral GC assay. 
 
7.3.7  Protecting group exchange – conversion of methylated products into 
trifluoroacyl or acyl derivatives 
A 10 mL vial equipped with a magnetic stirrer was charged with the pure 
protected secondary amine (c.a. 30 mg) and trifluoroacetic anhydride (50 eq.) 
or acetyl chloride (50 eq.) with DMAP (7 mol%). The suspension was stirred 
for 30 min before the slow and cautious addition of 2 drops of distilled water, 
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(EXOTHERMIC!). The resulting solution was stirred overnight and the 
reaction mixture was transferred in a larger container before quenching it 
cautiously with NaHCO3 (30 mL, EXOTHERMIC!). The mixture was 
extracted with CH2Cl2 (3 x 20 mL), dried over Na2SO4, filtered and evaporated 
to dryness. Finally, the crude mixture was purified by filtration over a pad of 
silica or by flash chromatography with elution with CH2Cl2. Samples were 
assessed pure by 1H NMR spectroscopy and were used directly for e.e. 
determination by chiral GC.  
 
7.3.8  Enantiomeric excess determination by 31P NMR spectroscopy 
A sample of crude methylated protected amine was dissolved in CDCl3 and 
placed in a vial. Solid (1S)-10-camphorsulfonic acid (4.0 eq.) was added and 
the suspension was shaken and filtered. The filtrate was then collected in 5 mm 
NMR tube which was capped for NMR analysis. The 31P NMR were acquired 
under standard conditions and the relative enantiomeric composition 
determined by integration of the two main signals corresponding to the 
enantiomers. This technique was found to be of sufficient accuracy (± 6%) to 
allow preliminary screening by 31P NMR spectroscopy to be carried out. 
 
7.3.9  Synthesis of diphenylphosphinoyl protected benzaldimines 
The approach of Scheidt157 proving to be the most reliable it was employed 
with the following modifications. A mixture of Ph2P(O)(NH2) (5.43 g, 25.0 
mmol), aldehyde (2.95 mL, 25.0 mmol) and NEt3 (12.3 mL, 87.5 mmol) in 
CH2Cl2 (250 mL) was cooled to 0 oC and TiCl4 (12.5 mmol) in 
dichloromethane (12.5 mL) added over 5 mins. The reaction was stirred for 1 h 
150  
at 0 oC and 1-4 h at room temperature (depending on the substrate as 
recommended by Jennings). The reaction mixture was promptly filtered 
through Celite with a dichloromethane wash (3 x 5 mL) and evaporated to a 
white solid.  The crude product (which is not fully soluble in the initial 
chromatographic eluent) was transferred as a suspension to the top of a 4 cm 
diameter x 9 cm high silica column using 7:3 EtOAc:light petroleum (b.p. 40-
60 oC). Elution with the same solvent system (300-400 mL) gave residual 
aldehyde. Continued elution with 1:1 EtOAc:CH2Cl2 (300 mL) gave the imine 
product as a white solid. Yields obtained were within the range 40-70%. Lower 
yields were associated with slower elution of the products and occasional 
batches of over activated silica. 
 
7.3.10  Racemic methylation of imines with MeMgBr 
A flame dried Schlenk tube was charged with the desired imine substrate (3.13 
mmol) in dried Et2O (20 mL). The suspension was cooled down to 0 oC, 
addition of a minimum amount of dichloromethane was carried out (c.a. 10 
mL) to solubilise the compound. Finally, MeMgBr (3.1 mL of 3.0 M Et2O 
solution, 9.39 mmol) was slowly added to the solution. The reaction mixture 
was stirred first at 0 oC for 30 min and next at room temperature for 1 h after 
which time it was quenched at 0oC with water (20 mL). The product was 
extracted into dichloromethane (3 x 20 mL), the combined organic extracts 
were washed successively with water (50 mL) and brine (50 mL), dried over 
Na2SO4 and the solvent removed in vacuo to afford the crude amine. 
Purification by flash chromatography (silica; EtOAc:CH2Cl2 1:1) gave the pure 
protected secondary amine (80-90%).  
151  
 
7.3.11  Preparation of diphenylphosphinoyl protected imines 
In a 250 mL flame-dried three-neck round-bottomed flask purged with argon,  
P,P-diphenylphosphinic amide (5.00 g, 23.0 mmol, 1.0 eq.), aldehyde (72.0  
mmol, 3.1 eq.), triethylamine (19.2 mL, 138 mmol, 7.0 eq.), dichloromethane 
(90 mL) and molecular sieves were added and the flask was cooled to 0 °C. 
Then, titanium tetrachloride (1.50 mL, 13.8 mmol, 0.6 eq.) was introduced 
dropwise into the solution. The reaction mixture was stirred for another 30 min 
at 0 °C, warmed to room temperature, stirred overnight, poured into anhydrous 
ether (200 mL) and filtered through a pad of a 1:1 mixture of Florisil and 
Celite. The filtrate was evaporated under reduced pressure to give a yellow 
powder which was directly purified by flash chromatography [CH2Cl2/EtOAc] 
to yield a solid compound which was immediately dried and kept under inert 
atmosphere. 
 
7.3.12  Deprotection of diphenyphosphinoyl protected methylation 
products158 
To a solution of diphenyphosphinoyl protected amine in CH2Cl2 (3 mL) under 
argon at 0 °C, was added MeOH (5 mL) and BF3Et2O (excess). The solution 
was then stirred overnight after which time H2O (2 mL) was added and the 
solution was extracted with CH2Cl2 (3 x 5 mL), basified with NaHCO3 and 
then extracted with further portions of CH2Cl2 (3 x 5 mL). The organic layers 
were combined, washed with brine (5 mL), dried (Na2SO4), filtered, and the 
solvent removed in vacuo to yield the free amine. 
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7.3.13  Synthesis of oximes159 
In a 100 mL round-bottomed flask was prepared a solution of aldehyde (17.7 
mmol) in THF (30 mL). Hydroxylamine hydrochloride (1.39 g, 20.0 mmol, 1.2 
eq.) was dissolved in H2O (10.0 mL) and added to the stirring solution of 
aldehyde. Sodium carbonate (1.00 g, 10.0 mmol, 0.6 eq.) was dissolved in H2O 
(10.0 mL) and added to the reaction mixture. The reaction was completed in 1 
hour as monitored with thin-layer chromatography. The organic and aqueous 
layers were separated; then, the aqueous layer was extracted twice with ethyl 
acetate. The combined organic layers were washed with water and brine and 
dried over MgSO4. After filtering, the solvent was concentrated to give a 
yellow sticky oil. The reaction mixture was purified by flash silica 
chromatography; however, the cis- and trans-isomers could not be separated. 
 
7.3.14  Synthesis of sulfinic acid adducts160 
A 250 mL three-necked round-bottomed flask equipped with a magnetic 
stirring bar was charged with diphenylphosphinic amide (1.91 g, 8.79 mmol). 
Dichloromethane (15 mL) and diethylether (73 mL) were added successively 
into the flask. The resulting suspension was stirred for 5 min and the aldehyde 
(13.19 mmol, 1.5 eq.) was added dropwise. p-Toluenesulfinic acid (2.06 g, 
13.19 mmol, 1.5 eq.) was then added in one portion at room temperature. The 
reaction mixture was capped and allowed to stir for 48 hours during which time 
a white precipitate was slowly formed. The reaction mixture was filtered 
through a sintered glass funnel and the white solid was washed with 
diethylether (20 mL) and dried under vacuum to afford the sulfonyl adduct. 
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7.4  Synthesis of aldimine substrates 
 
N-Benzylidene-4-methylbenzenesulfonamide (28)161 
N
S
O
O
CH3
H
 
In a 250 mL flame-dried three-neck round-bottom flask purged with argon, p-
toluenesulfonamide (3.08 g, 18 mmol, 1.0 eq.), benzaldehyde (1.8 mL, 18 
mmol, 1.0 eq.), triethylamine (15.0 mL, 108 mmol, 7.0 eq.), dichloromethane 
(85 mL) were added and the flask was cooled to 0 °C. Then, titanium 
tetrachloride (1.20 mL, 10.8 mmol, 0.6 eq.) was introduced dropwise into the 
solution. The reaction mixture was stirred for another 30 min at 0 °C, warmed 
to room temperature, stirred overnight, poured into anhydrous ether (160 mL) 
and filtered through a pad of a 1:1 mixture of Florisil and Celite. The filtrate 
was evaporated under reduced pressure to give a yellow powder which was 
directly purified by flash chromatography on silica gel (Petrol/EtOAc 8:2) to 
afford 3.32 g (71%) of a shiny white solid; m.p. 111-112 °C; Lit.161 108-114 
°C; 1H NMR (CDCl3, 400 MHz) δH 9.05 (s, 1H, HC=N), 7.90 (d, 2H, J = 8.4 
Hz, Ar), 7.62 (t, 1H, J
 
= 7.6 Hz, Ar), 7.94 (d, 2H, J
 
= 8.4 Hz, Ar), 7.50 (t, 2H, J 
= 7.6 Hz, Ar), 7.37 (d, 2H, J =  8.0 Hz, Ar), 2.45 (s, 3H, CH3); 13C NMR 
(CDCl3, 100 MHz) δC 170.2, 144.6, 135.2, 135.0, 132.4, 131.4, 129.9, 129.2, 
128.2, 21.7; IR υmax (CHCl3)/ cm-1 1596, 1450, 1318, 1223, 1156, 1088, 867, 
782, 754; Rf  0.30 Petrol/EtOAc 8:2). 
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N-Benzylidene(phenyl)methanamine (29)162 
N
H
 
In a 250 mL flame-dried three-neck round-bottom flask purged with argon, 
benzylamine (1.1 mL, 10 mmol, 1.0 eq.), benzaldehyde (1.0 mL, 10  mmol, 1.0 
eq.), triethylamine (8.4 mL, 60 mmol, 7.0 eq.), dichloromethane (50 mL) were 
added and the flask was cooled to 0 °C. Then, titanium tetrachloride (0.66 mL, 
6 mmol, 0.6 eq.) was introduced dropwise into the solution. The reaction 
mixture was stirred for another 30 min at 0 °C, warmed to room temperature, 
stirred overnight, poured into anhydrous ether (90 mL) and filtered through a 
pad of a 1:1 mixture of Florisil and Celite. The filtrate was evaporated under 
reduced pressure to give 1.74g (89%) of an yellow oil which did not need 
further purification; 1H NMR (CDCl3, 400 MHz) δH 8.27 (s, 1H, HC=N), 7.69-
7.73 (m, 2H, Ar), 7.10- 7.40 (m, 8H, Ar), 4.73 (s, 2H, CH2 benzyl); 13C NMR 
(CDCl3, 100 MHz); δC 162.1, 139.5, 137.3, 130.9, 128.8, 128.7, 128.4, 128.2, 
127.2, 65.2; IR υmax (CHCl3)/ cm-1 2847, 1957, 1889, 1816, 1702, 1644, 1580, 
1496, 1343, 1027, 858. 
 
N-Benzylidene-o-anisidine (30)163 
N
H
O
 
In a 100 mL flame-dried three-neck round-bottom flask purged with argon, o-
anisidine (1.7 mL, 15 mmol, 1.0 eq.), benzaldehyde (1.5 mL, 15  mmol, 1.0 
eq.), triethylamine (12.6 mL, 90 mmol, 7.0 eq.), dichloromethane (60 mL) 
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were added and the flask was cooled to 0 °C. Then, titanium tetrachloride (1.0 
mL, 9 mmol, 0.6 eq.) was introduced dropwise into the solution. The reaction 
mixture was stirred for another 30 min at 0 °C, warmed to room temperature, 
stirred overnight, poured into anhydrous ether (130 mL) and filtered through a 
pad of a 1:1 mixture of Florisil and Celite. The filtrate was evaporated under 
reduced pressure to give 2.68 g (85%) of a thick dark orange oil which did not 
need further purification; 1H NMR (CDCl3, 400 MHz) 8.49 (s, 1H, HC=N), 
7.96 (m, 2H, Ar), 7.30-7.85 (m, 7H, Ar), 3.89 (s, 3H, CH3); 13C NMR (CDCl3, 
100 MHz) δC 161.4, 152.3, 141.9, 137.4, 131.4, 129.8, 129.1, 129.0, 128.8, 
128.7, 126.8, 55.9; IR υmax (CHCl3)/ cm-1 2838, 1702, 1629, 1579, 1496, 1177, 
1116, 1027, 975, 880. 
 
tert-Butyl benzylidenecarbamate (31)164 
N
H
O
O
 
In a 100 mL flame dried round-bottom flask under argon, sodium 
benzenesulfinate (4.10 g, 25 mmol, 2.5 eq.) and tert-butyl carbamate (1.17 g, 
10 mmol, 1.0 eq.) were dissolved in a mixture of water (20 mL) and methanol 
(10 mL). Then, benzaldehyde (2.0 mL, 20 mmol, 2.0 eq.) was introduced to the 
mixture before to acidify it with concentrated formic acid to pH 2-3, and the 
mixture was stirred for 24 hours. After cooling at 0 °C, the resulting solid was 
separated by filtration, rinsed with water and petroleum ether, solubilised in 
CH2Cl2 (30 mL) and the organic layer was dried over Na2SO4. After 
concentration in vacuo, 2.95 g (85%) of crude tert-butyl phenyl 
(phenylsulfonyl)methylcarbamate was obtained. Finally, this intermediate 
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sulfone (764  mg, 2.20 mmol, 1.0 eq.) was treated with anhydrous potassium 
carbonate (1.80 g, 13 mmol, 5.9 eq.) in refluxing THF (40 mL) for 24 hours. 
Filtration through Celite and concentration in vacuo afforded 351 mg (78%) of 
pure imine; m.p. 165-166 °C; 1H NMR (CDCl3, 400 MHz) δH 8.85 (s, 1H, 
HC=N), 7.91-7.87 (m, 2H, Ar), 7.56-7.50 (m, 1H, Ar), 7.46-7.42 (m, 2H, Ar), 
1.57 (s, 9H, CH3); 13C NMR (CDCl3, 100 MHz) δC 169.9, 162.9, 134.3, 133.8, 
130.4, 129.0, 82.5, 28.2; IR υmax (CHCl3)/ cm-1 3428, 2904, 1964, 1732, 1644, 
1498, 1365, 1185, 1002, 848. 
 
N-Benzylidene-P,P-diphenylphosphinic amide (27)169 
N
O
H
PPh2
 
Preparation according to general procedure 7.3.9 performed on a 25 mmol 
scale gave title compound as a white solid (6.69 g, 88%). m.p. 136-137 °C; 
Lit.163 134-141 °C; 1H NMR (CDCl3, 270 MHz) δH 9.33 (d, 1H, JPH = 32.0 Hz, 
HC=N), 7.90-8.10 (m, 6H, Ar), 7.45-7.66 (m, 9H, Ar); 13C NMR (CDCl3, 100 
MHz) δC 174.1 (d, J = 8 Hz), 136.1 (d, J = 25 Hz), 134.0, 133.2 (d, J = 127 
Hz), 132.1 (d, J = 3 Hz), 131.9 (d, J = 10 Hz), 130.5, 129.3, 128.8 (d, J = 12 
Hz); 31P NMR (CDCl3, 162MHz) δP 25.7; IR υmax (CHCl3)/ cm-1 2990, 1625, 
1578, 1443, 1198, 1127, 846, 832, 736; HRMS [found (ESI) MH+  307.1038 
C19H16NOP requires M  307.1042]; Rf 0.30 (EtOAc/Pet. Ether 40-60 °C 7:3). 
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N-(4-Methylbenzylidene)-P,P-diphenylphosphinic amide (32)165 
N
O
H
PPh2
 
Preparation according to general procedure 7.3.9 performed on a 25 mmol 
scale gave title compound as a white solid (6.42 g, 80%). m.p. 153-155 °C; 
Lit.165 154 °C; 1H NMR (400 MHz, CDCl3) δH 9.29 (d, JPH = 32.0 Hz, 1H, 
HC=N), 7.88-7.99 (m, 6H, Ar), 7.40-7.54 (m, 6H, Ar), 7.32 (s, 1H, Ar), 7.30 (s, 
1H, Ar), 2.44 (s, 3H, Ar); 13C NMR (100 MHz, CDCl3) δC 173.9 (d, J = 8 Hz), 
145.0, 133.9 (d, J = 49 Hz), 133.3 (d, J = 125 Hz), 132.0 (d, J = 3 Hz), 131.9 
(d, J = 9 Hz), 130.6, 130.0, 128.7 (d, J = 12 Hz), 22.2; 31P NMR (162 MHz, 
CDCl3) δP 24.8; IR υmax (CHCl3)/ cm-1 2989, 1618, 1605, 1571, 1439, 1185, 
1126, 1107, 861, 838 cm-1; HRMS [found (ESI) MH+  320.1188 C20H18NOP 
requires M  320.1199]; Rf 0.32 (CH2Cl2/EtOAc 1:1). 
 
N-(3-Methylbenzylidene)-P,P-diphenylphosphinic amide (33)166 
N
O
H
PPh2
 
Preparation according to general procedure 7.3.9 performed on a 17 mmol 
scale gave title compound a white solid (2.25 g, 41%). m.p. 114-118 oC; Lit.166 
116-118 °C; 1H NMR (400 MHz, CDCl3) δH 9.30 (d, JPH = 32.0 Hz, 1H, 
HC=N), 7.99.-7.97 (m, 1H, Ar), 7.970-7.954 (m, 1H, Ar), 7.954-7.940 (m, 1H, 
Ar), 7.94-7.92 (m, 1H, Ar), 7.84 (s, 1H, Ar), 7.83-7.77 (m, 1H, Ar), 7.59-7.37 
(m, 6H, Ar), 7.41 (s, 1H, Ar), 7.39 (s, 1H, Ar), 2.45 (s, 3H, CH3); 13C NMR 
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(100 MHz, CDCl3) δC 174.5, 139.1, 136.3, 134.9, 133.4 (d, J = 125 Hz), 132.1 
(d, J = 3 Hz), 131.9 (d, J = 9 Hz), 130.6, 129.2, 128.8 (d, J = 13 Hz), 128.2, 
21.6; 31P NMR (162 MHz, CDCl3) δP 24.9; IR υmax (CHCl3)/ cm-1 2989, 1623, 
1601, 1585, 1438, 1187, 1126, 1108, 842; HRMS [found (ESI) MH+  320.1195 
C20H18NOP requires M 320.1199]; Rf 0.22 (EtOAc/CH2Cl2 8:2). 
 
N-(2-Methylbenzylidene)-P,P-diphenylphosphinic amide (34)167 
N
O
H
PPh2
 
Preparation according to general procedure 7.3.9 performed on a 23 mmol 
scale gave title compound as a white solid (4.23 g, 58%); m.p.168 102 oC; 1H 
NMR (400 MHz, CDCl3) δH 9.65 (d, JPH = 32.0 Hz, 1H, HC=N), 8.18 (dd, J = 
7.6 Hz, J = 1.2 Hz, Ar), 8.030-8.005 (m, 1H, Ar), 8.005-7.990 (m, 1H , Ar), 
7.990-7.975 (m, 1H, Ar), 7.975 (m, 1H, Ar), 7.55-7.43 (m, 7H, Ar), 7.35 (t, J = 
7.6 Hz, 1H, Ar), 7.29 (s, 1H, Ar), 2.70 (s, 3H, CH3); 13C NMR (100 MHz, 
CDCl3) δC 172.8 (d, J = 8.0 Hz), 141.4, 134.1 (d, J = 2.0 Hz), 133.9, 133.5 (d,  
J = 123 Hz), 133.5, 132.0 (d, J = 3.0 Hz), 131.9 (d, J = 9.0 Hz), 130.1, 128.8 
(d, J = 13.0 Hz), 126.7, 20.0; 31P NMR (162 MHz, CDCl3) δP 24.8; IR υmax 
(CHCl3)/ cm-1 2989, 1617, 1597, 1571, 1439, 1186, 1125, 1107, 849; HRMS 
[found (ESI) MH+  320.1195 C20H18NOP requires M  320.1199]; Rf 0.25 
(EtOAc/CH2Cl2 8:2). 
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N-(4-Chlorobenzylidene)-P,P-diphenylphosphinic amide (37)169 
N
O
H
PPh2
Cl
 
Preparation according to general procedure 7.3.9 performed on a 8.76 mmol 
scale gave title compound as a white solid (1.86 g, 62%); m.p. 127-128 °C; 
Lit.163 122-130 °C; 1H NMR (400 MHz, CDCl3) δH 9.28 (d, JPH = 31.6 Hz, 1H, 
HC=N), 7.98-7.88 (m, 6H, Ar), 7.50 (m, 8H, Ar); 13C NMR (100 MHz, CDCl3) 
δC 172.6 (d, J = 8 Hz), 140.3, 134.5 (d, J = 25 Hz), 133.7 (d, J = 129 Hz), 
133.6, 132.3, 132.2 (d, J = 2 Hz), 132.2, 131.8 (d, J = 10 Hz), 131.6, 129.6, 
128.8 (d, J = 12 Hz);31P NMR (162 MHz, CDCl3) δP 25.0; IR υmax (CHCl3)/ 
cm-1 2991, 1621, 1595, 1569, 1489, 1439, 1191, 1126, 1092, 833; HRMS 
[found (ESI) MH+ 340.0657 C19H15ClNOP requires M  340.0653]; Rf 0.25 
(EtOAc/CH2Cl2 8:2). 
 
N-(3-Chlorobenzylidene)-P,P-diphenylphosphinic amide (38)169,170 
N
O
H
PPh2
Cl
 
Preparation according to general procedure 7.3.9 performed on a 13.2 mmol 
scale gave title compound as a sticky off-white solid (941 mg, 21%). m.p.168 
116 °C; 1H NMR (400 MHz, CDCl3) δH 9.28 (d, JPH = 32.0 Hz, 1H, HC=N), 
8.06 (br s, 1H, Ar), 7.97 (br s, 1H, Ar), 7.95 (d, J = 1.6 Hz, 1H, Ar), 7.94 (br s, 
1H, Ar), 7.92 (d, J = 1.2 Hz, 1H, Ar), 7.82 (d, J = 7.8 Hz, 1H, Ar), 7.58-7.42 
(m, 8H, Ar); 13C NMR (100 MHz, CDCl3) δC 172.4 (d, J = 7 Hz), 137.6 (d, J = 
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25 Hz), 135.5, 133.7, 132.8 (d, J = 127 Hz), 132.2 (d, J = 3 Hz), 131.8 (d, J = 9 
Hz), 130.5, 129.3, 129.1, 128.8 (d, J = 12 Hz); 31P NMR (162 MHz, CDCl3) δP 
25.1; IR υmax (CHCl3)/ cm-1 3631, 2993, 2945, 2839, 1625, 1438; HRMS 
[found (ESI) MH+ 340.0640 C19H15ClNOP requires M 340.0653; Rf 0.32 
(EtOAc/CH2Cl2 8:2). 
 
N-(2-Chlorobenzylidene)-P,P-diphenylphosphinic amide (39) 41 
N
O
H
PPh2
Cl
 
Preparation according to general procedure 7.3.9 performed on a 23 mmol 
scale gave title compound as a white solid (3.07 g, 39%). m.p. 109-110 °C; 
Lit.41 109-111; 1H NMR (400 MHz, CDCl3) δH 9.76 (d, JPH = 31.0 Hz, 1H, 
HC=N), 8.31 (d, J = 7.6 Hz, 1H, Ar), 8.000-7.975 (s, 1H, Ar), 7.975-7.959 (s, 
1H, Ar), 7.959-7.943 (s, 1H, Ar), 7.943-7.910 (s, 1H, Ar), 7.56-7.43 (m, 8H, 
Ar), 7.43-7.36 (t, J = 7.2 Hz, 1H, Ar); 13C NMR (100 MHz, CDCl3) δC 170.7 
(d, J = 7 Hz), 138.6, 134.7, 133.2 (d, J = 128 Hz), 132.4, 132.3 (d, J = 3 Hz), 
132.0 (d, J = 9 Hz), 130.8, 129.7, 128.9 (d, J = 12 Hz), 127.4; 31P NMR (162 
MHz, CDCl3) δP 25.1; IR υmax (CHCl3)/ cm-1 2992, 1614, 1592, 1439, 1273, 
1192, 1125, 1107, 835; HRMS [found (ESI) MH+ 340.0654 C19H15ClNOP 
requires M  340.0653]; Rf 0.23 (EtOAc/CH2Cl2 9:1). 
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N-(4-Fluorobenzylidene)-P,P-diphenylphosphinic amide (36)171 
N
O
H
PPh2
F
 
Preparation according to general procedure 7.3.9 performed on a 43.1 mmol 
scale gave title compound as a white solid (8.81 g, 63%). 1H NMR (300 MHz, 
CDCl3) δH 9.93 (d, JPH = 31.8 Hz, 1H, HC=N), 8.09-7.87 (m, 6H, Ar), 7.55-
7.36 (m, 6H, Ar), 7.18 (t, J = 8.7 Hz, 2H, Ar); 13C NMR (100 MHz, CDCl3) δC 
173.9 (d, J = 8 Hz), 134.9 (d, J = 213 Hz), 133.3 (d, J = 127 Hz), 132.1 (d, J = 
3 Hz), 131.9 (d, J = 9 Hz), 131.0 (d, J = 24 Hz), 129.2 (d, J = 50 Hz), 128.9 (d, 
J = 12 Hz), 126.9, 125.5, 124.4; 31P NMR (121 MHz, CDCl3) δP 26.1; 19F 
NMR (282 MHz, CDCl3) δF -104.3; IR υmax (CHCl3)/ cm-1 2990, 1621, 1595, 
1569, 1439, 1190, 1126, 1091, 833; HRMS [found (ESI) MH+ 324.0955 
C19H15FNOP requires M 324.0948]; Rf 0.30 (EtOAc/CH2Cl2 1:1). 
 
N-(4-Bromobenzylidene)-P,P-diphenylphosphinic amide (40)172,173 
N
O
H
PPh2
Br
 
Preparation according to general procedure 7.3.9 performed on a 25 mmol 
scale gave title compound as a white solid (6.98 g, 59%). 1H NMR (400 MHz, 
CDCl3) δH 9.29 (d, JPH = 32.0 Hz, 1H, HC=N), 7.980-7.955 (m, 2H, Ar), 
7.955-7.938 (m, 2H, Ar), 7.938-7.925 (m, 1H, Ar), 7.925-7.900 (m, 1H, Ar), 
7.55-7.42 (m, 8H, Ar); 13C NMR (100 MHz, CDCl3) δC 172.6 (d, J = 7 Hz), 
140.3, 134.6 (d, J = 25 Hz), 133.0 (d, J = 127 Hz), 132.2 (d, J = 2 Hz), 131.9 
162  
(d, J = 9 Hz), 131.6, 129.7, 128.9 (d, J = 13 Hz); 31P NMR (162 MHz, CDCl3) 
δP 25.0; IR υmax (CHCl3)/ cm-1 2991, 1621, 1589, 1567, 1439, 1190, 1125, 
1069, 831; HRMS [found (ESI) MH+ 384.0146 C19H15BrNOP requires M  
384.0147]; Rf 0.30 (EtOAc/CH2Cl2 1:1). 
 
N-(4-(Trifluoromethyl)benzylidene)-P,P-diphenyl-phosphinic amide 
(35)169,172 
N
O
H
PPh2
F3C
 
Preparation according to general procedure 7.3.9 performed on a 8.8 mmol 
scale gave title compound as a white solid (861 mg, 36%). m.p. 127-128 °C; 
Lit.169 124-126 °C; 1H NMR (300 MHz, CDCl3) δH 9.39 (d, JPH = 31.6 Hz, 1H, 
HC=N), 8.13 (s, 1H, Ar), 8.11 (s, 1H, Ar), 7.97 (m, 1H, Ar), 7.96 (m, 1H, Ar), 
7.94 (m, 1H, Ar), 7.92 (m, 1H, Ar), 7.77 (s, 1H, Ar), 7.75 (s, 1H, Ar), 7.56-7.40 
(m, 6H, Ar); 13C NMR (100 MHz, CDCl3) δC 172.5 (d, J = 7 Hz), 138.8 (d, J = 
25 Hz), 135.0 (d, J = 33 Hz), 133.2, 132.4 (d, J = 2 Hz), 131.7 (d, J = 131 Hz), 
131.9 (d, J = 10 Hz), 128.9 (d, J = 13 Hz), 126.2 (q, J = 4 Hz), 125.2, 122.5, 
53.7; 19F NMR (282 MHz, CDCl3) δF -63.1; 31P NMR (121 MHz, CDCl3) δP 
26.5; IR υmax (CHCl3)/ cm-1 2992, 1627, 1582, 1484, 1324, 1175, 1128, 1066, 
830; HRMS [found (ESI) MH+ 374.0917 C20H15F3NOP requires M  374.0916]; 
Rf 0.26 (EtOAc/CH2Cl2 7:3). 
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N-(4-Methoxybenzylidene)-P,P-diphenylphosphinic amide (43)169 
N
O
H
PPh2
MeO
 
Preparation according to general procedure 7.3.9 performed on a 8.8 mmol 
scale gave title compound as a white solid (2.23 g, 72%). m.p. 145-146 °C; 
Lit.169 147-149 °C; 1H NMR (400 MHz, CDCl3) δH 9.23 (d, JPH = 32.0 Hz, 1H, 
HC=N), 8.00-7.97 (m, 1H, Ar), 7.97-7.95 (m, 1H, Ar), 7.95-7.94 (m, 1H, Ar), 
7.94-7.92 (m, 1H, Ar), 7.92-7.90 (m, 1H, Ar), 7.51-7.40 (m, 6H, Ar), 7.00 (s, 
1H, Ar), 6.98 (s, 1H, Ar), 3.87 (s, 3H, CH3); 13C NMR (100 MHz, CDCl3) δC 
172.9 (d, J = 7 Hz), 132.7, 132.5 (d, J = 126 Hz), 132.0, 131.9 (d, J = 3 Hz), 
131.8 (d, J = 9 Hz), 128.8, 128.7, 114.7, 55.9; 31P NMR (162 MHz, CDCl3) δP 
24.8; IR υmax (CHCl3)/ cm-1 2987, 1619, 1572, 1513, 1259; HRMS [found 
(ESI) MH+ 336.1140 C20H18NO2P requires M 336.1148]; Rf 0.25 (EtOAc/ Pet. 
ether 40-60 °C 7:3). 
 
N-(Naphthalen-2-ylmethylene)-P,P-diphenylphosphinic amide (41) 169 
N
O
H
PPh2
 
Preparation according to general procedure 7.3.9 performed on a 24.3  mmol 
scale gave title compound as a white solid (5.16 g, 60%). m.p. 172-173 °C; 
Lit.169 172-174 °C; 1H NMR (400 MHz, CDCl3) δH 9.48 (d, JPH = 32.0 Hz, 1H, 
HC=N), 8.35 (s, 1H, Ar), 8.23 (dd, J = 8.8 Hz, J = 1.6 Hz, Ar), 8.04-7.96 (m, 
5H, Ar), 7.94 (d, J = 8.8 Hz, 1H, Ar), 7.90 (d, J = 8.0 Hz, 1H, Ar), 7.62 (td, J = 
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7.0 Hz, J = 1.4 Hz, 1H, Ar), 7.58 (td, J =  7.0 Hz, J = 1.4 Hz, 1H, Ar), 7.55-
7.43 (m, 6H, Ar); 13C NMR (100 MHz, CDCl3) δC 173.6 (d, J = 8 Hz), 145.9, 
134.8, 133.5, 132.8 (d, J = 125 Hz), 132.2, 132.0 (d, J = 9 Hz), 129.8, 129.2, 
129.1, 128.8 (d, J = 20 Hz), 128.3, 127.3, 125.4, 124.1; 31P NMR (162 MHz, 
CDCl3) δP 25.0; IR υmax (CHCl3)/ cm-1 2990, 1615, 1439, 1188, 1126, 1107, 
843; HRMS [found (ESI) MH+ 365.1188 C23H18NOP requires M  365.1199]; 
Rf 0.29 (EtOAc/CH2Cl2 1:1). 
 
N-(Naphthalen-1-ylmethylene)-P,P-diphenylphosphinic amide (42)169 
N
O
H
PPh2
 
Preparation according to general procedure 7.3.9 performed on a 8.8 mmol 
scale gave title compound as a white solid (1.52 g, 49%). m.p. 121-122 °C; 
Lit.169 118-120 °C; 1H NMR (400 MHz, CDCl3) δH 9.94 (d, JPH = 33.2 Hz, 1H, 
HC=N), 9.28 (d, J = 8.4 Hz, 1H, Ar), 8.22 (dd, J = 7.2 Hz, J = 0.8 Hz, 1H, Ar), 
8.09-7.99 (m, 5H, Ar), 7.92 (d, J =  8.0 Hz, 1H, Ar), 7.73-7.66 (ddd, J = 7.2 
Hz, J = 1.4 Hz, Ar), 7.63-7.55 (m, 2H, Ar), 7.55-7.43 (m, 6H, Ar); 13C NMR 
(100 MHz, CDCl3) δC 173.9 (d, J = 8 Hz), 134.9, 134.1 (d, J = 15 Hz), 133.8, 
133.4 (d, J = 130 Hz), 132.7, 132.1 (d, J = 3 Hz), 131.8 (d, J = 9 Hz), 131.0 (d, 
J = 24 Hz), 129.2, 128.9 (d, J = 20 Hz), 128.7, 126.9, 125.5, 124.4; 31P NMR 
(162 MHz, CDCl3) δP 25.1; IR υmax (CHCl3)/ cm-1 3673, 3063, 2990, 1674, 
1607, 1587, 1462; HRMS [found (ESI) MH+ 365.1190 C23H18NOP requires M  
365.1199]; Rf 0.30 (EtOAc/Pet.Ether 7:3). 
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7.5  Synthesis of racemates 
 
(±)-P,P-Diphenyl-N-(1-phenylethyl)phosphinic amide (44)41 
HN
O
PPh2
 
In a 200 mL flame dried round-bottom flask under argon, was prepared a 
solution of methylbenzylamine (2.0 mL, 15.7 mmol, 1.0 eq.) and triethylamine 
(4.4 mL, 31.4 mmol, 2.0 eq.) in CH2Cl2 (75 mL). This solution was cooled at  
0 °C before the dropwise addition of diphenylphosphinic chloride. The 
resulting mixture was stirred at room temperature overnight, poured into an 
equal volume of saturated aqueous ammonium chloride and extracted with 
CH2Cl2 (3×40 mL). The combined organic extracts were dried over Na2SO4 
and concentrated in vacuo to give 4.54 g (90%) of a white solid; m.p. 150-152 
°C; Lit.41 147-149 °C; 1H NMR (CDCl3, 270 MHz) δH 7.95-7.60 (m, 4H, Ar), 
7.60-7.10 (m, 11H, Ar), 4.40 (q, 1H, J
 
= 7.7 Hz, CH), 3.22 (m, 1H, NH), 1.58 
(d, 3H, J
 
= 7.7 Hz, CH3); 13C NMR (CDCl3, 100 MHz) δC 145.0 (d, J = 6.7 
Hz), 133.2 (d, J = 128 Hz), 132.4 (d, J = 9.4 Hz), 132.1 (d, J = 129 Hz), 131.9 
(d, J = 9.5 Hz), 131.8 (d, J = 3.6 Hz), 131.7 (d, J = 2.6 Hz), 128.5, 128.5 (d, J = 
12.4 Hz), 128.3 (d, J = 12.5 Hz), 127.1, 125.9, 51.0, 25.9 (d, J = 3.1 Hz); 31P 
NMR (CDCl3, 162MHz) δP 21.9; IR υmax (CHCl3)/ cm-1 3150, 1436, 1179, 
1125, 1036; HRMS [found (ESI) MH+ 322.1342 C20H20NOP requires M 
322.1355]; Rf 0.17 (EtOAc/Pet. Ether 8:2). 
The HPLC assay: Chiralcel AD-H, isocratic (n-Hexane:i-PrOH 85:15, 1.0 
mL/min), λ
 
 = 280 nm,  t1 = 13.4 min (R), t2 = 15.8 min (S). 
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(±)-P,P-Diphenyl-N-(1-p-tolylethyl)phosphinic amide (48)174 
HN
O
PPh2
 
Preparation according to general procedure 7.3.10 performed on a 1.8 mmol 
scale gave title compound as a white solid (520 mg, 86%). m.p.168 121 °C; 1H 
NMR (400 MHz, CDCl3) δH 7.87-7.92 (m, 2H, Ar), 7.80-7.87 (m, 2H, Ar), 
7.40-7.50 (m, 4H, Ar), 7.33-7.40 (m, 2H, Ar), 7.17 (d, 2H, J = 8.0 Hz, Ar), 7.11 
(d, 2H, J = 8.0 Hz, Ar), 4.35 (m, 1H, CHα), 3.21 (dd, 1H, J = 7.0 Hz, J = 3.6 
Hz, NH), 2.96 (s, 3H, CH3Ar), 1.55 (d, 3H, J = 7.8 Hz, CH3β) 13C NMR (100 
MHz, CDCl3) δC 142.1 (d, J = 7.0 Hz), 136.7, 132.4 (d, J = 9.4 Hz), 131.9 (d, J 
= 9.4 Hz), 131.8 (d, J = 2.7 Hz), 131.7 (d, J = 2.7 Hz), 129.2, 128.4 (d, J = 12.6 
Hz), 128.3 (d, J = 12.4 Hz), 125.8, 50.8, 25.9 (d, J = 3.0 Hz), 21.0; 31P NMR 
(162 MHz, CDCl3) δP 22.4; IR υmax (CHCl3)/ cm-1 3380, 2982, 1515, 1439, 
1185; HRMS [found (ESI) MH+ 337.1498 C21H22NOP requires M 337.1512]; 
Rf 0.29 (EtOAc/Pet. ether 7:3). 
The HPLC assay: Chiralcel OD-H column, isocratic (n-Hexane/i-PrOH 95:5, 
1.0 mL/min), λ
 
 = 240 nm, t1 = 14.0 min, t2 = 18.9 min. 
 
(±)-P,P-Diphenyl-N-(1-m-tolylethyl)phosphinic amide (49)41 
HN
O
PPh2
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Preparation according to general procedure 7.3.10 performed on a 3.1 mmol 
scale gave title compound as a white solid (840 mg, 80%). m.p.168 130-131 °C; 
1H NMR (400 MHz, CDCl3) δH 7.96-7.88 (dd, J = 7.0 Hz, J = 11.8 Hz, 2H, 
Ar), 7.88-7.79 (dd, J = 7.0 Hz, J = 11.8 Hz, 2H, Ar), 7.54-7.41 (m, 4H, Ar), 
7.41-7.35 (m, 2H, Ar), 7.25-7.18 (m, 1H, Ar), 7.13-7.08 (m, 1H, Ar), 7.08-7.03 
(m, 2H, Ar), 4.37 (dd, J = 7.8 Hz, J = 2.8 Hz, 1H, CHα), 3.16 (dd, J = 7.4 Hz,  
J = 2.8 Hz, 1H, NH), 2.33 (s, 3H, CH3Ar), 1.57 (d, J = 7.8 Hz, 3H, CH3α); 13C 
NMR (100 MHz, CDCl3) δC 145.0 (d, J = 6.1 Hz), 138.2, 133.3 (d, J = 128 
Hz), 132.6 (d, J = 9.1 Hz), 132.2 (d, J = 130 Hz), 132.0 (d, J = 9.1 Hz), 131.9, 
131.8, 128.6 (d, J = 12.2 Hz), 128.6, 128.4, 128.0, 126.8, 123.0, 51.2, 26.1 (d, J 
= 3.0 Hz), 21.6; 31P NMR (162 MHz, CDCl3) δP 22.4; IR υmax (CHCl3)/ cm-1 
3381, 2982, 1592, 1439, 1185, 1124; HRMS [found (ESI) MH+ 337.1505 
C21H22NOP requires M 337.1512]; Rf 0.29 (EtOAc/Pet. ether 7:3). 
 
(±)-P,P-Diphenyl-N-(1-m-tolylethyl)phosphinic amide (50)  
HN
O
PPh2
 
Preparation according to general procedure 7.3.10 performed on a 3.0 mmol 
scale gave title compound as a white solid (932 mg, 93%). m.p. 139-142 °C; 
1H NMR (400 MHz, CDCl3) δH 7.98-7.92 (m, 1H, Ar), 7.92-7.87 (m, 1H, Ar), 
7.81-7.76 (m, 1H, Ar), 7.76-7.71 (m, 1H, Ar), 7.55-7.49 (m, 1H, Ar), 7.49-7.40 
(m, 4H, Ar), 7.37-7.30 (2H, m, Ar), 7.30-7.23 (m, 1H, Ar), 7.16 (dt, J = 7.6Hz, 
J = 1.2 Hz, 1H, Ar), 7.09-7.03 (m, 1H, Ar), 4.62 (dq, J = 7.8 Hz, J = 3.2 Hz, 
1H, CHα), 3.30 (dd, 1H, J = 5.6 Hz, J = 3.2 Hz, NH), 2.02 (s, 3H, CH3), 1.51 
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(d, J = 6.4 Hz, 3H, CH3); 13C NMR (100 MHz, CDCl3) δC 143.7 (d, J = 7.0 
Hz), 133.3 (d, J = 150 Hz), 132.4 (d, J = 9.7 Hz), 131.8 (d, J = 9.4 Hz), 131.8 
(d, J = 2.4 Hz), 131.7 (d, J = 2.7 Hz), 130.3, 128.4 (d, J = 12.5 Hz), 128.2 (d, J 
= 12.7 Hz), 126.8, 126.5, 124.7, 47.1, 26.0 (d, J = 3.0 Hz), 18.8; 31P NMR 
(162 MHz, CDCl3) δP 22.6; IR υmax (CHCl3)/ cm-1 2981, 1439, 1184, 1125, 
1086, 958, 852; HRMS [found (ESI) MH+ 337.1509 C21H22NOP requires M 
337.1512]; Rf 0.35 (EtOAc/Pet. ether 7:3). 
 
(±)-N-(1-(4-Chlorophenyl)ethyl)-P,P-diphenylphosphinic amide (54)174 
HN
O
PPh2
Cl
 
Preparation according to general procedure 7.3.10 performed on a 3.1 mmol 
scale gave title compound as a white solid (149 mg, 91%). m.p.168 176-177 °C; 
1H NMR (400 MHz, CDCl3) δH 7.86-7.96 (m, 2H, Ar), 7.76-7.85 (m, 2H, Ar), 
7.42-7.55 (m, 4H, Ar), 7.34-7.42 (m, 2H, Ar), 7.25-7.31 (m, 2H, Ar), 7.20-7.25 
(m, 2H, Ar), 4.38 (dq, J = 7.4 Hz, J = 3.2 Hz, 1H, CH), 3.20 (dd, J = 5.6 Hz,  
J = 4.0 Hz, 1H, NH), 1.56 (d, J = 7.8 Hz, 3H, CH3); 13C NMR (100 MHz, 
CDCl3) δC 143.5 (d, J = 6.1 Hz), 132.8 (d, J = 127 Hz), 132.7, 132.3 (d, J = 9.6 
Hz), 132.0 (d, J = 129 Hz), 131.9, 131.9 (d, J = 9.5 Hz), 131.8, 128.6, 128.5 (t, 
J = 11.9 Hz), 127.4, 50.4, 25.8 (d, J = 3.9 Hz); 31P NMR (162 MHz, CDCl3) δP 
22.5; IR υmax (CHCl3)/ cm-1 3378, 2983, 1493, 1439, 1261, 1096; HRMS 
[found (ESI) MH+ 357.0966 C20H19ClNOP requires M 357.0963]; Rf 0.25 
(100% EtOAc). 
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The HPLC assay: Chiralcel OD-H column, isocratic (n-Hexane/ 
i-PrOH 95:5, 1.0 mL/min), λ
 
 = 240 nm, t1 = 16.2 min, t2 = 19.0 min. 
 
(±)-N-(1-(3-Chlorophenyl)ethyl)-P,P-diphenylphosphinic amide (56) 
HN
O
PPh2
Cl
 
Preparation according to general procedure 7.3.10 performed on a 1.0 mmol 
scale gave title compound as a white solid (300 mg, 84%). m.p. 182-184 °C; 
1H NMR (400 MHz, CDCl3) δH 7.99-7.87 (m, 2H, Ar), 7.87-74 (m, 2H, Ar), 
7.57-7.42 (m, 4H, Ar), 7.42-7.32 (m, 2H, Ar), 7.30-7.13 (m, 4H, Ar), 4.45-4.30 
(m, 1H, CHα), 3.32 (dd, J = 5.6 Hz, J = 9.6 Hz, 1H, NH), 1.57 (d, J = 6.8 Hz, 
3H, CH3); 13C NMR (100 MHz, CDCl3) δC 147.1, 134.3, 132.3 (d, J = 9.6 Hz), 
132.0, 131.8 (d, J = 9.5 Hz), 131.9 (d, J = 2.8 Hz), 129.8, 128.5 (t, J = 12.9 
Hz), 127.2, 126.1, 124.3, 50.6, 25.8 (d, J = 3.5 Hz); 31P NMR (162 MHz, 
CDCl3) δP 22.7; IR υmax (CHCl3)/ cm-1 3692, 2984, 2361, 1600, 1452, 1119, 
1124; HRMS [found (ESI) MH+ 357.0977 C20H19ClNOP requires M 
357.0966]; Rf 0.25 (100% EtOAc). 
 
 (±)-N-(1-(2-Chlorophenyl)ethyl)-P,P-diphenylphosphinic amide (57) 
HN
O
PPh2
Cl
 
Preparation according to general procedure 7.3.10 performed on a 2.8 mmol 
scale gave title compound as a free flowing white powder (986 mg, 99%). m.p. 
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189-190 °C; 1H NMR (400 MHz, CDCl3) δH 7.950-7.915 (d, J = 1.2 Hz, 1H, 
Ar), 7.915-7.898 (d, J = 1.6 Hz, 1H, Ar), 7.898-7.884 (d, J = 0.8 Hz, 1H, Ar), 
7.884-7.850 (d, J = 1.2 Hz, 1H, Ar), 7.82-7.79 (s, 1H, Ar), 7.790-7.773 (d, J = 
1.2 Hz, 1H, Ar), 7.768 (s, 1H, Ar), 7.759-7.730 (d, 1H, J = 1.6 Hz, Ar), 7.55-
7.48 (m, 1H, Ar), 7.48-7.41 (m, 3H, Ar), 7.41-7.38 (m, 1H, Ar), 7.38-7.31 (m, 
2H, Ar), 7.31-7.24 (m, 2H, Ar), 7.24-7.15 (m, 1H, Ar), 4.75 (m, J = 7.8 Hz, 1H, 
CHα), 3.49 (dd, J = 5.6 Hz, J = 9.6 Hz, 1H, NH), 1.57 (d, J = 7.8 Hz, 3H, CH3); 
13C NMR (100 MHz, CDCl3) δC 142.3 (d, J = 5.6 Hz), 132.9 (d, J = 127 Hz), 
132.3 (d, J = 9.6 Hz), 131.9, 131.8 (d, J = 9.4 Hz), 131.7 (d, J = 2.8 Hz), 131.1, 
129.8, 128.4 (d, J = 12.4 Hz), 128.2 (d, J = 12.5 Hz), 128.1, 127.4, 127.1, 49.1, 
25.0 (d, J = 3.7 Hz); 31P NMR (162 MHz, CDCl3) δP 22.8; IR υmax (CHCl3)/ 
cm-1 3694, 2983, 1602, 1439, 1187, 1108, 958; HRMS [found (ESI) MH+ 
357.0969 C20H19ClNOP requires M 357.0966]; Rf 0.28 (EtOAc/Pet. ether 7:3). 
 
(±)-N-(1-(4-Fluorophenyl)ethyl)-P,P-diphenylphosphinic amide (53)174  
HN
O
PPh2
F
 
Preparation according to general procedure 7.3.10 performed on a 3.1 mmol 
scale gave title compound as a white solid (953 mg, 90%). m.p. 158-160 °C; 
Lit.175 157-159 °C; 1H NMR (400 MHz, CDCl3) δH 7.83-7.98 (m, 2H, Ar), 
7.75-7.83 (m, 2H, Ar), 7.42-7.58 (m, 4H, Ar), 7.35-7.42 (m, 2H, Ar), 7.30-7.35 
(m, 4H, Ar), 4.38 (dq, J = 7.8 Hz, CHbenzyl), 3.34 (m, 1H, NH), 1.57 (d, 3H, 
CH3); 13C NMR (100 MHz, CDCl3) δC 161.8 (d, J = 244 Hz), 140.8 (d, J = 3.0 
Hz), 132.3 (d, J = 9.4 Hz), 131.9 (d, J = 9.1 Hz), 131.8 (d, J = 1.9 Hz), 128.4 (t, 
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J = 12.1 Hz), 127.6 (d, J = 8.0 Hz), 115.2 (d, J = 21.3 Hz), 50.3, 25.9 (d, J = 
2.5 Hz); 31P NMR (162 MHz, CDCl3) δP 22.5; IR υmax (CHCl3)/ cm-1 3377, 
2894, 1493, 1439, 1187; HRMS [found (ESI) MH+ 340.1261 C20H19FNOP 
requires M 340.1257]; Rf 0.25 (100% EtOAc). 
The HPLC assay: Chiralcel OD-H column, isocratic (n-Hexane/i-PrOH 95:5, 
1.0 mL/min), λ
 
 = 240 nm, t1 = 15.0 min, t2 = 18.5 min. 
 
(±)-N-(1-(4-Bromophenyl)ethyl)-P,P-diphenylphosphinic amide (58)176 
HN
O
PPh2
Br
 
Preparation according to general procedure 7.3.10 performed on a 2.6 mmol 
scale gave title compound as a white solid (920 mg, 88%). m.p.168 172 °C; 1H 
NMR (400 MHz, CDCl3) δH 7.95-7.90 (m, 1H, Ar), 7.90-7.86 (m, 1H, Ar), 
7.84-7.80 (m, 1H, Ar), 7.80-7.76 (m, 1H, Ar), 7.55-7.44 (m, 4H, Ar), 7.44-7.42 
(m, 1H, Ar), 7.42-7.40 (m, 1H, Ar), 7.40-7.34 (m, 2H, Ar), 7.20-7.17 (m, 1H, 
Ar
 
), 7.17-7.14 (m, 1H, Ar), 4.36 (dq, J = 7.8 Hz, J = 3.2 Hz, 1H, CHα), 3.15 
(dd, J = 5.4 Hz, J = 4.0 Hz, 1H, NH), 1.55 (d, J = 7.8 Hz, 3H, CH3); 13C NMR 
(100 MHz, CDCl3) δC 144.0 (d, J = 6.0 Hz), 132.8 (d, J = 127 Hz), 132.3 (d, J 
= 9.7 Hz), 132.0 (d, J =129 Hz), 131.9 (d, J = 9.4 Hz), 131.8, 128.5 Hz (d, J = 
11.9 Hz), 128.4 (d, J = 12.5 Hz), 127.8, 120.9, 50.4, 25.8 (d, J = 3.8 Hz); 31P 
NMR (162 MHz, CDCl3) δP 22.6; IR υmax (CHCl3)/ cm-1 2984, 1412, 1195, 
1124, 647; HRMS [found (ESI) MH+ 400.0465 C20H19BrNOP requires M 
400.0460]; Rf 0.25 (100% EtOAc). 
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The HPLC assay: Chiralcel OD-H column, isocratic (n-Hexane/i-PrOH 95:5, 
1.0 mL/min), λ
 
 = 240 nm, t1 = 16.7 min, t2 = 19.6 min. 
 
(±)-P,P-Diphenyl-N-(1-(4-(trifluoromethyl)phenyl)ethyl)phosphinic amide 
(55)177 
HN
O
PPh2
F3C
 
Preparation according to general procedure 7.3.10 performed on a 5.4 mmol 
scale gave title compound as a white solid (1.90 g, 91%). m.p.168 185 °C; 1H 
NMR (400 MHz, CDCl3) δH 7.85-7.98 (m, 2H, Ar), 7.72-7.83 (m, 2H, Ar), 
7.49-7.61 (m, 3H, Ar), 7.42-7.49 (m, 3H, Ar), 7.30-7.42 (m, 4H, Ar), 4.46 (dq, 
J = 7.8 Hz, J = 2.8 Hz, 1H, CH), 3.25 (dd, J = 5.6 Hz, J = 3.6 Hz, 1H, NH), 
1.58 (d, J = 7.8 Hz, 3H, CH3); 13C NMR (100 MHz, CDCl3) δC 148.9 (d, J = 
5.6 Hz), 132.7 (d, J = 127 Hz), 132.3 (d, J = 9.6 Hz), 132.0 (d, J = 2.8 Hz), 
131.9 (d, J = 9.3 Hz), 131.9 (d, J = 2.9 Hz), 131.8 (d, J = 129 Hz), 129.5, 
129.2, 128.6 (d, J = 12.6 Hz), 128.4 (d, J = 12.6 Hz), 126.4, 125.5 (q, J = 3.8 
Hz), 50.6, 25.8 (d, J = 4.1 Hz); 31P NMR (162 MHz, CDCl3) δP 22.69; IR υmax 
(CHCl3)/ cm-1 3339, 2984, 1621, 1439, 1327, 1126; HRMS [found (ESI) 
MNa+ 412.1049 C21H19F3NOP requires M 412.1048]; Rf 0.25 (100% EtOAc). 
The HPLC assay: Chiralcel OD-H column, isocratic (n-Hexane/i-PrOH 95:5, 
1.0 mL/min), λ
 
 = 240 nm, t1 = 14.7 min, t2 = 17.2 min. 
 
(±)-N-(1-(4-Methoxyphenyl)ethyl)-P,P-diphenylphosphinic amide (59)174 
173  
HN
O
PPh2
MeO
 
Preparation according to general procedure 7.3.10 performed on a 0.16 mmol 
scale gave title compound as a white solid (50.1 mg, 91%). m.p.168 139-141 
°C; 1H NMR (300 MHz, CDCl3) δH 8.02-7.77 (m, 4H, Ar), 7.56-7.29 (m, 6H, 
Ar), 7.23 (d, J =  8.7 Hz, 2H, Ar), 6.87 (d, J = 8.7 Hz, 2H, Ar), 4.47-4.27 (m, 
1H, CHα), 3.12 (dd, J = 5.7 Hz, J = 9.3 Hz, 1H, NH), 1.57 (d, J = 6.9 Hz, 3H, 
CH3), 31P NMR (121 MHz, CDCl3) δP 23.6. This data was in accordance with 
literature reports. 
The HPLC assay: Chiralcel OD-H column, isocratic (n-Hexane/i-PrOH 95:5, 
1.0 mL/min), λ
 
 = 240 nm, t1 = 20.1 min, t2 = 23.2 min. 
 
(±)-N-(1-(Naphthalen-2-yl)ethyl)-P,P-diphenylphosphinic amide (60)178 
HN
O
PPh2
 
Preparation according to general procedure 7.3.10 performed on a 3.1 mmol 
scale gave title compound as a white solid (1.12 g, 97%). Found C 76.49, H 
5.90; N 3.64%. Calc. For C24H22NOP C 77.61; H 5.90; N 3.64%; m.p.168 100-
102 °C; 1H NMR (400 MHz, CDCl3) δH 7.89-7.98 (m, 2H, Ar), 7.73-7.88 (m, 
5H, Ar), 7.66 (s, 1H, Ar), 7.39-7.55 (m, 7H, Ar), 7.29-7.38 (m, 2H, Ar), 4.57 
(m, J = 7.8 Hz, 1H, CHα), 3.31 (dd, J = 5.6 Hz, J = 9.2 Hz, 1H, NH), 1.67 (d, J 
= 7.8 Hz, 3H, CH3); 13C NMR (100 MHz, CDCl3) δC 142.3 (d, J = 6.7 Hz), 
133.2, 133.1 (d, J = 127 Hz), 132.4 (d, J = 9.6 Hz), 132.6, 132.0 (d, J = 130 
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Hz), 131.9 (d, J = 9.4 Hz), 131.8, 131.7 (d, J = 2.4 Hz), 131.4, 128.4 (t, J = 
12.2 Hz), 127.8, 127.6, 126.1, 125.8, 124.5, 124.3, 51.1, 25.9 (d, J = 3.1 Hz); 
31P NMR (162 MHz, CDCl3) δP 22.6; IR υmax (CHCl3)/ cm-1 3380, 2982, 1439, 
1185, 1125; HRMS [found (ESI) MH+ 372.1506 C24H22NOP requires M 
372.1512]; Rf 0.25 (100% EtOAc). 
The HPLC assay: Chiralcel OD-H column, isocratic (n-Hexane/i-PrOH 95:5, 
1.0 mL/min), λ
 
 = 240 nm, t1 = 16.3 min, t2 = 19.2 min. 
 
(±)-N -(1-(Naphthalen-1-yl)ethyl)-P,P-diphenylphosphinic amide (61)179 
HN
O
PPh2
 
Preparation according to general procedure 7.3.10 performed on a 0.15 mmol 
scale gave title compound as a white solid (30.5 mg, 55%). m.p. 160-161 °C; 
Lit.180 163-164 oC; 1H NMR (400 MHz, CDCl3) δH 7.84-8.03 (m, 4H, Ar), 
7.73-7.84 (m, 3H, Ar), 7.61-7.69 (m, 1H, Ar), 7.35-7.58 (m, 7H, Ar), 5.26 (m, 
1H, CHα), 3.37 (m, 1H, NH), 1.72 (d, J = 7.6 Hz, 3H, CH3); 13C NMR (100 
MHz, CDCl3) δC 142.6 (d, J = 6.7 Hz), 133.2, 133.0 (d, J = 125 Hz), 132.6 (d, 
J = 9.6 Hz), 132.5, 132.1 (d, J = 128 Hz), 131.9 (d, J = 9.4 Hz), 131.6, 131.5 
(d, J = 2.4 Hz), 131.4, 128.4 (t, J = 12.2 Hz), 127.8, 127.6, 126.1, 125.8, 124.5, 
123.9, 51.3, 26.0 (d, J = 3 Hz); 31P NMR (162 MHz, CDCl3) δP 23.4; IR υmax 
(CHCl3)/ cm-1 3690, 3606, 2982, 2338, 1602, 1439, 1239, 1124; HRMS [found 
(ESI) MH+ 372.1512 C24H22NOP requires 372.1512; Rf 0.25 (100% EtOAc). 
The HPLC assay: Chiralcel OD-H column, isocratic (n-Hexane/i-PrOH 95:5, 
1.0 mL/min), λ
 
 = 240 nm, t1 = 18.9 min, t2 = 27.1 min. 
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(±)-4-Methyl-N-(1-phenylethyl)benzenesulfonamide (220)181,182 
HN
S
O
O
 
Preparation according to Fujisawa’s procedure described in 7.2.2. The product 
was obtained as a colourless oil which solidified upon standing (0.35 mmol 
scale, 92 mg, 97% yield); m.p. 77-80 °C; Lit.181,182 79-82 °C; 1H NMR 
(CDCl3, 400 MHz) δH 7.75-7.05 (m, 9H, Ar), 4.94 (d, 1H, J = 7.8 Hz, NH), 
4.46 (dq, 1H, J = 7.8 Hz, J = 7.8 Hz, CH), 2.39 (s, 3H, CH3tosyl), 1.42 (d, 3H,  
J = 7.8 Hz, CH3); 13C NMR (CDCl3, 100 MHz) δC 142.9, 142.2, 137.7, 129.7, 
128.6, 127.5, 127.2, 127.1, 53.4, 23.5,  21.4; HRMS [found (ESI) MH+ 
298.0877 C15H17NO2S requires 298.0872]; Rf 0.33 (EtOAc/Pet. ether 2:8). 
 
 (±)-N-Benzyl-1-phenylethanamine (226)183 
HN
 
In a 250 mL flame-dried two-neck round-bottom flask purged with argon,  
(±)-α-methylbenzylamine (1.90 mL, 15 mmol, 1.0 eq.) is diluted in DMF (75 
mL). Next, cesium carbonate (4.90 g, 15 mmol, 1.0 eq.) was introduced 
forming a white suspension which was stirred for 30 min at room temperature. 
Finally, benzyl bromide (2.15 mL, 18 mmol, 1.0 eq.) was added dropwise and 
the reaction mixture was stirred overnight, quenched with 2M NaOH and 
extracted with ethyl acetate. Purification by flash chromatography on silica gel 
(Petrol/EtOAc 8:2) afforded 2.24 g (70%) of a light yellow liquid; 1H NMR 
176  
(CDCl3, 400 MHz) δH 7.50-7.10 (m, 10H, Ar), 3.87 (q, 1H, J = 7.6 Hz, CH), 
3.68 (d, 2H, J = 8.0 Hz, CH2), 1.78 (s, 1H, NH), 1.42 (d, 3H, J = 7.6 Hz, CH3); 
13C NMR (CDCl3, 100 MHz) δC 145.8, 140.9, 128.8, 128.7, 128.4, 127.2, 
127.1, 127.0, 57.8, 51.9, 24.8; IR υmax (CHCl3)/ cm-1 3330, 2846, 2797, 1952, 
1813, 1602, 1495, 1370, 1111, 1071, 1028, 827; Rf 0.23 (Petrol/EtOAc 8:2). 
 
 
7.6  Synthesis of trifluoroacetamides and acetamides 
 
(±)-2,2,2-Trifluoro-N-(1-phenylethyl)acetamide (227)184 
HN CF3
O
 
White solid. m.p. 65-66 °C; Lit.184 65-66 °C; 1H NMR (400 MHz, CDCl3) δH 
7.44-7.37 (m, 2H, Ar), 7.37-7.30 (m, 3H, Ar), 7.55 (s, 1H, NH), 5.16 (dq, 1H,  
J = 7.1 Hz, J = 7.6 Hz, CHα), 1.60 (d, 3H, J = 7.1 Hz, CH3); 13C NMR (100 
MHz, CDCl3) δC 156.6 (d, J = 36 Hz), 141.2, 129.4, 128.5, 126.5, 116.1 (d, J = 
36 Hz), 50.1, 21.4; 19F NMR (376 MHz, CDCl3) δF -75.9; IR υmax (CHCl3)/ 
cm-1 3429, 2984, 1724, 1530, 1171; HRMS [found (ESI) MNa+ 240.0600 
C10H10F3NO requires M 240.0607]; Rf 0.38 (EtOAc/Pet.Ether 7:3). (R) 
enantiomer: [α]D25 = 65.4 (c 1.24, CH2Cl2); Lit.185 [α]D20 = 115.3 (c 1.24, 
CH2Cl2). 
The GC assay: 25 m CP-Chiracil-Dex CB column, 100 °C (isothermal), He 
carrier gas, 12 psi, (R) 27.5 min, (S) 27.3 min. 
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(±)-2,2,2-Trifluoro-N-(1-p-tolylethyl)acetamide (209)186 
HN CF3
O
 
White solid. 1H NMR (270 MHz, CDCl3) δH 7.35-7.10 (m, 4H, Ar), 6.40 (br s, 
1H, NH), 5.15 (q, J =  7.0 Hz, 1H, CHα), 2.36 (s, 3H, CH3Ar), 1.62 (d, J = 7.0 
Hz, 3H, CH3α); 19F NMR (376 MHz, CDCl3) δF -75.9; Rf 0.36 (CH2Cl2/Pet. 
Ether 6:4). This compound was synthesised solely for GC assay purposes and 
its data was sufficient to compare with literature. 
 
(±)-2,2,2-Trifluoro-N-(1-m-tolylethyl)acetamide (210) 
HN CF3
O
 
White solid. 1H NMR (400 MHz, CDCl3) δH 7.25-7.32 (m, 1H, Ar), 7.10-7.18 
(m, 1H, Ar), 7.55 (s, 1H, NH), 5.12 (dq, J = 7.4 Hz, 1H, CHα), 2.38 (s, 3H, 
CH3Ar), 1.59 (d, J = 7.8 Hz, CH3α); 13C NMR (100 MHz, CDCl3) δC 156.2 (q, J 
= 37 Hz), 140.8, 138.8, 128.9, 128.9, 127.0, 123.1, 115.8 (q, J = 287 Hz), 49.9, 
21.4, 21.1; 19F NMR (376 MHz, CDCl3) δF -75.9; IR υmax (CHCl3)/ cm-1 3422, 
2983, 1722, 1529, 1171; HRMS [found (ESI) MNH4+ 249.1199 C11H12F3NO 
requires M 249.1209]; Rf 0.35 (CH2Cl2/Pet. Ether 6:4). This compound was 
synthesised solely for GC assay purposes and its data was sufficient to compare 
with literature. 
The GC assay: 25 m 2,6-γ-cyclodextrin column, 70 °C (isothermal), He carrier 
gas, 12 psi, t1 = 115.0 min, t2 = 115.1 min. 
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(±)-2,2,2-Trifluoro-N-(1-o-tolylethyl)acetamide (211) 
HN CF3
O
 
White solid. 1H NMR (400 MHz, CDCl3) δH 7.31-7.19 (m, 4H), 6.37 (br s, 
1H),  5.34 (quintet, J = 7.2 Hz, 1H), 2.37 (s, 3H), 1.58 (d, J = 7.2 Hz); 13C 
NMR (100 MHz, CDCl3) δC  156.1 (q, J = 36.8 Hz), 138.8, 136.0, 131.1, 
128.1, 126.6, 124.6, 115.8 (q, J = 286.3 Hz), 46.3, 20.5, 19.0; 19F NMR (376 
MHz, CDCl3) δF -75.8; IR υmax (CHCl3)/ cm-1 3428, 3012, 1723, 1528, 1171; 
Rf 0.37 (CH2Cl2/Pet. ether 6:4); HRMS [found (ESI) MH+ 232.0943 
C11H9F6NO requires M 232.0944]. This compound was synthesised solely for 
GC assay purposes and its data was sufficient to compare with literature. 
The GC assay: 25 m CP-Chiracil-Dex CB column, 100 °C (isothermal), He 
carrier gas, 12 psi, t1 = 31.7 min, t2 = 32.5 min. 
 
(±)-N-(1-(4-Fluorophenyl)ethyl)-2,2,2-trifluoroacetamide (212) 
HN CF3
O
F
 
White solid. 1H NMR (400 MHz, CDCl3) δH 7.40-7.20 (m, 2H, Ar), 7.20-7.00 
(m, 2H, Ar), 6.45 (br s, 1H, NH), 5.15 (q, J = 7.0 Hz, 1H, CHα), 1.59 (d, J = 7.0 
Hz, 3H, CH3); 13C NMR (100 MHz, CDCl3) δC 162.4 (d, J = 245.5 Hz), 156.3 
(d, J = 37.1 Hz), 136.7 (d, J = 10.6 Hz), 127.9 (d, J = 8.2 Hz), 115.9 (d, J = 
21.5 Hz), 115.7 (d, J = 286.2 Hz), 49.1, 21.1; 19F NMR (377 MHz, CDCl3) δF -
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75.9, -113.8; IR υmax (CHCl3)/ cm-1 3450, 3100, 2254, 1724, 1400, 1200; 
HRMS [found (ESI) MNa+ 258.0520 C10H9F4NO requires M 258.0512]; Rf 
0.35 (CH2Cl2/Pet. Ether 6:4). This compound was synthesised solely for GC 
assay purposes. 
The GC assay: 25 m CP-Chiracil-Dex CB column, 100 °C (isothermal), He 
carrier gas, 12 psi, t1 = 32.4 min, t2 = 35.2 min. 
 
(±)-N-(1-(4-Chlorophenyl)ethyl)-2,2,2-trifluoroacetamide (213) 
HN CF3
O
Cl
 
White solid. 1H NMR (400 MHz, CDCl3) δH 7.38-7.33 (m, 2H, Ar), 7.29-7.25 
(m, 2H, Ar), 7.49 (s, 1H, NH), 5.12 (dq, 1H, J = 7.0 Hz, CHα), 1.58 (d, 3H, J = 
7.0 Hz, CH3); 13C NMR (100 MHz, CDCl3) δC 156.4 (q, J = 37.1 Hz), 139.5, 
134.1, 129.2, 127.7, 114.4, 49.3, 21.1; 19F NMR (376 MHz, CDCl3) δF -75.9; 
IR υmax (CHCl3)/ cm-1 3429, 3011, 1726, 1529, 1495, 1169; HRMS [found 
(ESI) MNa+ 274.0217 C10H9ClF3NO requires M 274.0217]; Rf 0.35 
(CH2Cl2/Pet. Ether 6:4). This compound was synthesised solely for GC assay 
purposes and its data was sufficient to compare with literature. 
The GC assay: 25 m CP-Chiracil-Dex CB column, 120 °C (isothermal), He 
carrier gas, 12 psi, t1 = 35.9 min, t2 = 37.0 min. 
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(±)-N-(1-(3-Chlorophenyl)ethyl)-2,2,2-trifluoroacetamide (214)  
HN
Cl
CF3
O
 
White solid. 1H NMR (400 MHz, CDCl3) δH 7.550-7.515 (m, 1H, Ar), 7.515-
7.490 (m, 1H, Ar), 7.230-7.207 (m, 1H, Ar), 7.207-7.180 (m, 1H, Ar), 7.42 (br 
s, 1H, NH), 5.11 (dq, J = 7.8 Hz, J = 7.4 Hz, 1H, CHα), 1.58 (d, J = 7.8 Hz, 
1H); 13C NMR (100 MHz, CDCl3) δC 156.5 (q, J = 37.1 Hz), 143.0, 134.9, 
130.4, 128.4, 126.4, 124.5, 115.8 (q, J =
 
286.0 Hz), 49.4, 21.1; 19F NMR (376 
MHz, CDCl3) δF -75.9; IR υmax (CHCl3)/ cm-1 3429, 3050, 2254, 1726, 1210, 
1170, ; HRMS [found (ESI) MNa+ 274.0213 C10H9ClF3NO requires M 
274.0217]; Rf 0.35 (CH2Cl2/Pet. Ether 6:4). This compound was synthesised 
solely for GC assay purposes and its data was sufficient to compare with 
literature. 
The GC assay: 25 m CP-Chiracil-Dex CB column, 115 °C (isothermal), He 
carrier gas, 12 psi, t1 = 82.5 min, t2 = 84.7 min. 
 
(±)-N-(1-(2-Chlorophenyl)ethyl)-2,2,2-trifluoroacetamide (215) 
HN
Cl
O
CF3
 
White solid. 1H NMR (400 MHz, CDCl3) δH 7.46-7.38 (m, 1H, Ar), 7.37-7.30 
(m, 1H, Ar), 7.30-7.23 (m, 2H, Ar), 7.78 (br s, 1H, NH), 5.44 (dq, J = 7.8 Hz,  
J = 7.2 Hz, CHα), 1.61 (d, J = 7.8 Hz, 3H, CH3); 13C NMR (100 MHz, CDCl3) 
δC 156.1 (q, J = 37.1 Hz), 138.0, 133.0, 130.5, 129.3, 127.4, 127.4, 115.8 (q, J 
181  
= 286.2 Hz), 48.2, 20.2; 19F NMR (376 MHz, CDCl3) δF -75.9; IR υmax 
(CHCl3)/ cm-1 3691, 3432, 2950, 2360, 1728, 1602, 1529, 1170, 660; HRMS 
[found (ESI) MNa+ 274.0202 C10H9ClF3NO required M 274.0217]; Rf 0.35 
(CH2Cl2/Pet. Ether 6:4). This compound was synthesised solely for GC assay 
purposes and its data was sufficient to compare with literature. 
The GC assay: 25 m CP-Chiracil-Dex CB column, 120 °C (isothermal), He 
carrier gas, 12 psi, t1 = 18.2 min, t2 = 20.0 min. 
 
(±)-N-(1-(4-Bromophenyl)ethyl)-2,2,2-trifluoroacetamide (216)187 
HN
Br
O
CF3
 
White solid. 1H NMR (400 MHz, CDCl3) δH 7.52-7.55 (m, 1H, Ar), 7.48-7.55 
(m, 1H, Ar), 7.21-7.24 (m, 1H, Ar), 7.17-7.21 (m, 1H, Ar), 7.40 (s, 1H, NH), 
5.11 (m, 1H, CH
 benzyl), 1.58 (d, J = 7.2 Hz, 3H, CH3); 13C NMR (100 MHz, 
CDCl3) δC 156.4 (q, J = 37.1 Hz), 140.0, 132.2, 128.0, 122.2, 117.2, 114.4, 
111.5, 49.3, 21.1; 19F NMR (376 MHz, CDCl3) δF -75.9; IR υmax (CHCl3)/ cm-
1
 3429, 3011, 1726, 1530, 1492, 1170; HRMS [found (ESI) MNa+ 317.9701 
C10H9BrF3NO requires M 317.9712]; Rf 0.35 (CH2Cl2/Pet. Ether 6:4). This 
compound was synthesised solely for GC assay purposes and its data was 
sufficient to compare with literature. 
The GC assay: 25 m CP-Chiracil-Dex CB column, 115 to 125 °C at 0.2 °C/min 
+ 15 min at 125 °C (ramp), He carrier gas, 12 psi, t1 = 57.0 min, t2 = 58.0 min. 
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(±)-2,2,2-Trifluoro-N-(1-(4-(trifluoromethyl)phenyl)ethyl)acetamide 
(217)187 
HN
F3C
O
CF3
 
White solid. 1H NMR (400 MHz, CDCl3) δH 7.65 (s, 1H, Ar), 7.63(s, 1H, Ar), 
7.45 (s, 1H, Ar), 7.43 (s, 1H, Ar), 7.61(s, 1H, NH), 5.19 (dq, J = 7.2 Hz, 1H, 
CHα), 1.61 (d, J = 7.2 Hz, 3H, CH3); 13C NMR (100 MHz, CDCl3) δC 156.7, 
156.3, 145.0, 130.6, 130.3, 126.5, 126.1, 126.1, 126.0, 126.0, 122.6, 117.2, 
114.3, 111.5, 49.5, 21.2; 19F NMR (376 MHz, CDCl3) δF -62.5, -75.8; IR υmax 
(CHCl3)/ cm-1 3430, 3011, 1728, 1622, 1531, 1327, 1171; HRMS [found (ESI) 
MNH4+ 303.0928 C11H9F6NO requires M 303.0927]; Rf 0.35 (CH2Cl2/Pet. 
Ether 6:4). This compound was synthesised solely for GC assay purposes and 
its data was sufficient to compare with literature. 
The GC assay: 25 m CP-Chiracil-Dex CB column, 100 °C (isothermal), He 
carrier gas, 12 psi, t1 = 45.4 min, t2 = 47.6 min. 
 
(±)-N-(1-p-Tolylethyl)acetamide (218)188 
HN
O
 
Pale yellow solid. 1H NMR (270 MHz, CDCl3) δH 7.30-7.00 (m, 4H, Ar), 6.15 
(br s, 1H, NH), 5.07 (q, J = 7.1 Hz, 1H, CHα), 2.33 (s, 3H, CH3Ar), 1.95 (s, 3H, 
COCH3), 1.47 (d, J = 7.1 Hz, 3H, CH3); 13C NMR (68 MHz, CDCl3) δC 169.4, 
140.6, 137.2, 129.5, 126.4, 48.7, 23.6, 22.0, 21.3; IR υmax (CHCl3)/ cm-1 3441, 
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3050, 2987, 2400, 2253, 1663, 1509, 1373; HRMS [found (ESI) MNa+ 
200.1041 C11H15NO requires M 200.1046]; Rf 0.30 (100% EtOAc). This 
compound was synthesised solely for GC assay purposes. 
The GC assay: 25 m CP-Chiracil-Dex CB column, 165 °C (isothermal), He 
carrier gas, 12 psi, t1 = 9.0 min, t2 = 9.3 min. 
 
(±)-N-(1-(Naphthalen-2-yl)ethyl)acetamide (219)189 
HN
O
 
White solid. 1H NMR (270 MHz, CDCl3) δH 7.90-7.70 (m, 4H, Ar), 7.60-7.35 
(m, 3H, Ar), 5.87 (br s, 1H, NH), 5.32 (q, J = 7.0 Hz, 1H, CHα), 2.02 (s, 3H, 
COCH3), 1.59 (d, J = 7.0 Hz, 3H, CH3α); 13C NMR (68 MHz, CDCl3) δC 
169.1, 140.5, 133.3, 132.7, 128.6, 127.8, 127.6, 126.2, 125.9, 124.7, 124.5, 
48.8, 23.5, 21.6; IR υmax (CHCl3)/ cm-1 3645, 3441, 3000, 2253, 1665, 1382; 
HRMS [found (ESI) MNa+ 236.1040 C14H15NO requires M 236.1046]; Rf 0.30 
(100% EtOAc).  This compound was synthesised solely for GC assay purposes 
and its data was sufficient to compare with literature. 
The GC assay: 25 m CP-Chiracil-Dex CB column, 160 °C (isothermal), He 
carrier gas, 12 psi, t1 = 21.9 min, t2 = 22.9 min. 
 
 
7.7  Deprotection and isolation of amines 
 
 (±)-1-Phenylethanamine (45)190 
184  
NH2
 
Preparation according to general procedure 7.3.12 gave title compound as a 
colourless liquid. 1H NMR (CDCl3, 400 MHz) δH 7.62-7.32 (m, 4H, Ar), 7.31-
7.20 (m, 1H, Ar), 4.13 (q, J = 6.8 Hz, 1H, CHα), 1.51 (br s, 2H, NH2), 1.41 (d, J 
= 6.8 Hz, CH3); 13C NMR (CDCl3, 100 MHz) δC 148.0, 128.7, 127.0, 125.9, 
51.5, 29.8; IR υmax (CHCl3)/ cm-1 3376, 2965, 2493, 1584, 1493, 1452, 1373; 
HRMS [found (ESI) MNa+ 144.0767 C8H11N requires M 144.0784]. 
 
(±)-1-p-Tolylethanamine (204)191,192 
NH2
 
Preparation according to general procedure 7.3.12 gave title compound as a 
colourless liquid. 1H NMR (CDCl3, 400 MHz) δH 7.28 (d, J = 8.0 Hz, 2H, Ar), 
7.20 (d, J = 8.0 Hz, 1H, Ar), 4.12 (q, J = 6.8 Hz, 1H, CHα), 2.39 (s, 3H, CH3Ar), 
1.96 (br s, 2H, NH2), 1.43 (d, J = 6.8 Hz, 3H, CH3α); 13C NMR (CDCl3, 100 
MHz) δC 144.8, 136.4, 129.5, 122.8, 51.1, 25.7, 21.1; IR υmax (CHCl3)/ cm-1 
3667, 3374, 2965, 2337, 1677, 1607, 1514, 1451, 1372; HRMS [found (ESI) 
MH+ 136.1105 C9H13N requires M 136.1121]. 
 
(±)-1-(4-Fluorophenyl)ethanamine (205)193 
NH2
F
 
Preparation according to general procedure 7.3.12 gave title compound as a 
colourless liquid. 1H NMR (CDCl3, 400 MHz) δH 7.30 (m, 2H, Ar), 7.00 (m, 
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2H, Ar), 4.10 (q, J = 6.4 Hz, 1H, CHα), 1.93 (br s, 2H, NH2), 1.35 (d, J = 6.4 
Hz, 3H, CH3); 13C NMR (CDCl3, 100 MHz) δC 161.8 (d, J = 232 Hz), 143.5, 
127.4, 115.4, 50.8, 25.2; 19F NMR (376 MHz, CDCl3) δF -116.3; IR υmax 
(CHCl3)/ cm-1 3667, 3376, 2966, 2337, 1888, 1603, 1510, 1373, 1240, 1157; 
HRMS [found (ESI) MH+ 140.0854 C8H10FN requires M 140.0870]. 
 
(±)-1-(4-Methoxyphenyl)ethanamine (206)191 
NH2
MeO
 
Preparation according to general procedure 7.3.12 gave title compound as a 
colourless liquid. 1H NMR (CDCl3, 400 MHz) δH 7.23 (d, J = 8.6 Hz, 1H, Ar), 
6.83 (d, J = 8.6 Hz, 1H, Ar), 4.02 (q, J = 6.6 Hz, 1H, CHα), 3.73 (s, 3H, CH3Ar), 
1.60 (br s, 2H, NH2), 1.33 (d, J = 6.6 Hz, CH3); 13C NMR (CDCl3, 100 MHz) 
δC 158.3, 139.9, 126.7, 113.7, 55.0, 50.5, 25.6; IR υmax (CHCl3)/ cm-1 3666, 
3374, 2962, 2492, 2056, 1883, 1611, 1513, 1464, 1373; HRMS [found (ESI) 
MH+ 152.1061 C9H13NO requires M 152.1070]. 
 
(±)-1-(Naphthalen-2-yl)ethanamine (207)194 
NH2
 
Preparation according to general procedure 7.3.12 gave title compound as a 
white solid. 1H  NMR (CDCl3, 400 MHz) δH 7.84 (d, J = 3.6 Hz, 3H, Ar), 7.79 
(s, 1H, Ar), 7.53-7.42 (m, 3H, Ar), 4.30 (q, 6.6 Hz, 1H, CHα), 1.61 (s, 2H, 
NH2), 1.49 (d, J = 6.6 Hz, 3H, CH3); 13C NMR (CDCl3, 100 MHz) δC 145.5, 
133.8, 132.9, 128.5, 128.1, 127.9, 126.3, 125.8, 124.9, 124.0, 51.7, 26.0; IR 
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υmax (CHCl3)/ cm-1 3661, 3061, 2965, 1601, 1508, 1376, 1127; HRMS [found 
(ESI) MH+ 172.1109 C12H13N requires M 172.1121]. 
 
(±)-1-(Naphthalen-2-yl)ethanamine (208)195 
NH2
 
Preparation according to general procedure 7.3.12 gave title compound as a 
colourless liquid. 1H NMR (CDCl3, 400 MHz) δH 8.16 (d, J = 8.4 Hz, 1H, Ar), 
7.90 (d, J = 7.6, J = 1.6 Hz, 1H, Ar), 7.77 (d, J = 8.0 Hz, 1H, Ar), 7.68 (d, J = 
6.8 Hz, 1H, Ar), 7.59-7.54 (m, 1H, Ar), 7.54-7.47 (m, 2H, Ar), 4.97 (q, J = 6.8 
Hz, 1H, CHα), 1.72 (br s, 1H, NH), 1.58 (d, J = 6.8 Hz, 3H, CH3); 13C NMR 
(CDCl3, 100 MHz) δC 143.6, 134.2, 131.0, 129.2, 127.5, 126.2, 125.9, 125.7, 
123.2, 121.6, 46.8, 25.1; IR υmax (CHCl3)/ cm-1 3666, 3377, 2996, 1597, 1511, 
1449, 1396; HRMS [found (ESI) MH+ 172.1112 C12H13N requires M 
172.1121]. 
 
7.8  Synthesis of ligands and catalysts 
 
O-O’-(S)-(1,1’-Dinaphthyl-2-2’-diyl)-N,N’-di-(S,S)-1-phenylethyl 
phosphoramidite (64)196 
O
P
O
N
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In a 50 mL round-bottomed flask the amine hydrochlorate salt was dissolved in 
a minimum amount of CH2Cl2 and basified with an even amount of a 2M 
NaOH solution. The solution was stirred for approximately 1 h before isolating 
the free amine (colourless liquid) by extraction with CH2Cl2 followed by a 
drying over Na2SO4 and concentration in vacuuo. In a 250 mL two neck round-
bottomed flask under argon equipped with a magnetic stirrer and fitted with an 
inert atmosphere filtration tube was introduced PCl3 (8.6 mmol, 0.75 mL), 
Et3N (17.2 mmol, 2.40 mL) and toluene (10 mL). The mixture was cooled 
down to -60 °C. Next was added a warm solution (60 °C) of (S)-2,2’-
binaphthol (1 eq., 8.6 mmol, 2.46 g) in toluene (40 mL) by means of a cannula, 
over 10 min. The resulting mixture was stirred for 2 h, warmed to room 
temperature, filtered under argon atmosphere and the filtrate was treated with 
Et3N (8.32 mmol, 1.18 mL) and the freshly isolated free secondary amine (7.32 
mmol, 1.65 g) at -40 °C. After 16 h at room temperature the reaction mixture 
was filtered to give the crude product as a yellow oil which was immediately 
purified by flash chromatography on silica gel (Pet. ether/CH2Cl2 3:1) and 
recrystallisation in Et2O/CH2Cl2. Finally, 1.58 g (40%) of a white foam was 
obtained. [α]D20 = +46.0, (c = 0.79, CHCl3); Lit.197 +11198 (c = 0.79, CHCl3); 
m.p. 86-87 °C; Lit196 87-89; 1H NMR (CDCl3, 400 MHz) δH 8.09 (d, 1H, J = 
8.8 Hz, Ar), 8.01 (d, 1H, J = 8.0 Hz, Ar), 7.91 (d, 1H, J = 9.2 Hz, Ar), 7.66 (d, 
1H, 8.8 Hz), 7.40-7.55 (m, 5H, Ar), 7.15-7.40 (m, 13H, Ar), 4.50 (q, J = 7.2 
Hz, 2H, CH), 1.78 (d, J = 7.2 Hz, 6H, CH3); 13C NMR (CDCl3, 100 MHz) δC 
150.9, 150.8, 150.1, 143.4, 133.2, 133.1, 131.7, 130.8, 130.7, 129.9, 128.6, 
128.4, 128.3, 128.1, 127.6, 127.5, 127.0, 127.4, 127.2, 125.1, 124.7, 122.9, 
122.7, 54.9, 54.8, 23.4, 23.3; 31P (CDCl3, 162 MHz) δP 151.3; IR υmax 
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(CHCl3)/ cm-1 3568, 3050, 2361, 1592, 1507,1437, 1328, 1070, 949; HRMS 
[found (ESI) MH+ 540.2058 C36H30NO2P requires M  540.2087]; Rf 0.30 (Pet. 
ether/CH2Cl2 3:1). 
 
(2R,5R)-1-{2[(2R,5R)2,5-Dimethylphospholan-1-yl]phenyl}-2,5 
dimethylphospholane 1-oxide (BozPHOS)  (60)41 
P
P
O
 
To a solution of (R,R)-Me-DUPHOS (500 mg, 1.63 mmol, 1.0 equiv) in THF 
(16 mL, 0.1 M) was added BH3•DMS (10 M, 180 mL, 1.80 mmol, 1.1 equiv) at 
0 °C. The mixture was stirred 45 min at this temperature and treated with H2O2 
(30% (v/v) 2.0 mL, 19.60 mmol, 12.0 eq.). After 45 min of additional stirring 
at room temperature, the reaction was quenched with saturated Na2SO3 (until 
basic pH) at 0 °C. Aqueous layers were extracted with EtOAc (3x20 mL), dried 
over Na2SO4, filtered and evaporated under reduced pressure. The crude 
product was immediately dissolved in toluene (16 mL, 0.1 M) and treated with 
DABCO (275 mg, 2.45 mmol, 1.5 eq.) at 50 °C. The reaction mixture was 
further stirred for 5 h at 50 °C, evaporated under reduced pressure and directly 
purified on silica gel [EtOAc/MeOH 95:5] to afford 431 mg (83%) of a white 
air-stable solid; [α]D20 = -134.3, (c = 0.67, benzene); Lit.41 -250.5 (c = 0.65, 
benzene); m.p. 124-125 °C; Lit.41 123-125 °C; 1H NMR (C6D6, 400 MHz) δH 
7.59 (m, 1H, Ar), 7.43 (m, 1H, Ar), 7.21-7.13 (m, 2H, Ar), 2.94-2.68 (m, 2H, 
CH-PO, 2.63-2.52 (m, 1H, CH-P), 2.20-1.93 (m, 5H, CH2 and CH3-CHPO), 
1.92-1.70 (m, 2H, CH2), 1.50-1.26 (m, 4H, CH and CH3), 1.20-1.03 (m, 7H, 
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CH, CH3-CHP and CH3-CHPO), 0.95 (dd, 3H, JPH = 17.6 Hz, J = 7.6 Hz, CH3-
CHP); 13C NMR (C6D6, 100 MHz) δC 144.0, 139.1, 134.2, 130.5, 128.3, 37.9, 
37.6, 37.1, 34.8, 34.6, 31.9, 31.7, 31.5, 20.1, 18.3, 17.4, 12.8; 31P NMR (C6D6, 
162MHz) δP 63.4, 9.7; IR υmax (CHCl3)/ cm-1 2918, 2858, 1447, 1160, 757, 
736, 677; HRMS [found (ESI) MH+ 323.1691 C18H28OP2 requires M 
323.1688]; Rf 0.20 (100% EtOAc). 
 
Tetrakis acetonitrile copper(I) tetrafluoroborate (221)199 
Cu
N
NN
N
Me
Me
Me
Me
BF4
 
In a 100 mL Erlenmeyer flask fitted with a magnetic stirrer, copper(I) oxide 
(1.00 g, 13.56 mmol, 1.0 eq.) was dissolved in acetonitrile (25 mL). Next, 48% 
HBF4 (5.0 mL, 38.3 mmol, 2.8 eq.) was slowly added to the resulting 
suspension and the mixture was heated up to 75 °C until complete dissolution 
had occured. Then the solution was hot filtered and the filtrate was collected 
into a hot Erlenmeyer flask before to be left to cool to room temperature, time 
during which few crystals of the complex appear. Finally, recrystallisation at 0 
°C was carried out for one hour until a large crop of crystals had formed. Quick 
filtration and washings with dry ether afforded 3.13 g (73%) of colourless 
crystals; (Found C 27.48; H 3.42; N 17.50%. Calc. For C8H12BCuF4N4200 C 
30.55; H 3.85; N 17.81%); m.p. 155-160 °C; Lit.199 159-161 °C; 1H NMR 
(C2D6O, 400 MHz) δH 2.07 (s, 12H, CH3); 13C NMR (C2D6O, 100 MHz) δC 
117.9, 1.0; IR υmax (CHCl3)/ cm-1 2945, 2303, 2274, 1417, 1366, 1284. 
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Tris(acetylacetonate) iridium(III) (222)201 
O O
O
OO
O Ir
 
In a 10 mL Schlenck tube equipped with a magnetic stirrer bar, iridium (III) 
chloride trihydrate (0.142 mmol, 50.0 mg) was dissolved in distilled water (3.0 
mL). The solution was warmed up to 70 °C to reach complete solubilisation. 
Next, acetylacetonate (0.568 mmol, 58 L) was introduced and the solution 
was stirred for 15 min after which time a small amount of a saturated solution 
of NaHCO3 (1 mL) was added to get a neutral pH. Then, the reaction vessel 
was fitted with a condenser and the mixture was heated at 70 °C for 48 h 
during which time the colour of the reaction solution lightened considerably. 
An orange-yellow solid was collected by vacuum filtration and recristallised 
from boiling methanol. The purified product was obtained as a bright yellow 
powder (25.7 mg, 37%). m.p. 268-269 °C; Lit.202 269-271 °C; 1H NMR 
(C2D6SO, 400 MHz) δH 5.50 (s, 1H, CHenol), 1.88 (s, 6H, CH3); 13C NMR 
(C2D6SO, 100 MHz) δC 185.3, 101.8, 27.0; IR υmax (CHCl3)/ cm-1 3566, 3004, 
1556, 1524, 1392.
 
 
Di--chloro-bis(1,5-cyclooctadiene)-diiridium(I) (65)203 
IrIr Cl
Cl
 
In a 100 mL Schlenk flask equipped with a magnetic stirrer and purged with 
argon, iridium trichloride trihydrate (1.0 g, 2.84 mmol, 1.0 eq.) was dissolved 
in 15 mL of degassed distilled water, to which a mixture of degassed 
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isopropanol (30 mL) and 1,5-cyclooctadiene (3.0 mL, 24.45 mmol, 8.6 eq.) 
was added portion wise and stirred at reflux temperature for about 18 hours. 
This resulted in a colour change from brown toward red. The resulting solution 
was concentrated to about 50% of its original volume by distillation of the 
solvent under argon. Upon slow cooling to room temperature, dark brown 
crystals precipitated, which were filtered, washed with cold methanol and dried 
under vacuum to afford 518 mg (27%) of the complex; m.p. 202-205 °C (dec.); 
Lit.204,205 > 200 °C (dec.); 1H NMR (C2D6SO, 270 MHz) δH 4.19 (d, J = 2.0 
Hz, 8H, CH), 2.36-2.12 (m, 8H, CH2), 1.92-1.70 (m, 8H, CH2); 13C NMR 
(C2D6SO, 100 MHz) δC 74.0, 30.7; IR υmax (CHCl3)/ cm-1 2977, 2965, 2934, 
2934, 2830, 2337, 1506, 1472, 1448, 1323, 1010, 979, 904.
 
 
Di--methoxy-bis(1,5-cyclooctadiene)-diiridium(I) (66) 
IrIr Cl
O
Me
 
A 100mL round-bottom flask equipped with a magnetic stirrer and purged with 
argon was charged with a solution of potassium hydroxide (25 mg, 0.445 
mmol, 2.0 eq.) in degassed methanol (5 mL). Addition of a suspension of 
[IrCl(1,5-COD)]2 (149 mmol, 0.222 mmol, 1.0 eq.) in methanol turns the 
colour of the initially orange-black suspension to dark yellow. After being 
stirred for 30 minutes at room temperature, 40 mL of degassed distilled water 
were added, changing the colour of the solution to bright yellow. Finally, the 
yellow-green precipitate was collected by filtration, using a fine sintered-glass 
filter, washed with water (6×5 mL), and vacuum dried over phosphorus(V) 
oxide to give 108 mg (73%) of the black/orange complex; (Found: C, 30.69; H, 
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4.15%. Calc. For C17H27ClIr2O C, 30.60; H, 4.08%); m.p. 192-193 °C (dec.);  
1H NMR (CDCl3, 400 MHz) δH 3.62-3.45 (m, 8H, CH), 3.25 (s, 3H, CH3), 
2.40-2.10 (m, 8H, CH2), 1.50-1.20 (m, 8H, CH2); 13C NMR (CDCl3, 100 MHz) 
δC 57.4, 54.2, 31.4; IR υmax (CHCl3)/ cm-1 2878, 2344, 1562, 1446, 1321, 1054, 
1002, 969. 
 
Di--chlorotetrakis(cyclooctene)diiridium(I) (68)204 
IrIr Cl
Cl
 
In a 10 mL flame dried Schlenk tube equipped with a magnetic stirrer and 
purged with argon, iridium trichloride trihydrate (1.00 g, 2.84 mmol, 1.0 eq.) 
was dissolved in 11 mL of degassed isopropanol (HPLC grade) and 4 mL of 
degassed distilled water before adding cyclooctene (2.0 mL, 5.4 eq.). The 
reaction mixture was stirred at room temperature for 5 minutes and then 
refluxed for 3 hours under a low stream of argon passing through the system. 
During this reflux, the initially dark green solution turned yellow-orange. 
Finally, the reaction mixture was cooled down to room temperature, filtered 
through a glass sinter, and then dried with high vacuum overnight to remove 
residual cyclooctene. 843 mg (66%) of the complex were obtained as a yellow-
orange solid; (Found: C, 41.90; H, 7.21%. Calc. For C32H56Cl2Ir2 C, 42.89; H, 
7.30%); m.p. 160-162 °C (dec.); Lit.206 160-165 °C (dec.); 1H NMR (CDCl3, 
270 MHz) δH 2.30-2.60 (m, 6H, 3x CH2), 1.2-1.9 (m, 8H, 3x CH2, 2x CH); 13C 
NMR (C6D6, 100 MHz) δC 64.3, 31.1, 30.8, 27.2, 2.0; IR υmax (CHCl3)/ cm-1 
2925, 2853, 1588, 1466. 
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1,2-bis((2R,5R)-2,5-Dimethylphospholano) benzene) (1,5-
cyclooctadiene)rhodium(I) triflate (118) 
P MeMe
P MeMe
Rh
OTf
 
A 50 mL flame dried Schlenck tube fitted with a stirring bar was purged under 
argon and then charged with (1,5-cycloocatadiene)(acetylacetonato)rhodium(I) 
(7.00 g, 19.34 mmol), degassed THF (4.6 mL) and MTBE (23 mL). This 
mixture was stirred at -50 °C until all material was dissolved. Another 50 mL 
flame dried Schlenck tube purged under argon was charged with degassed 
isopropanol (9.3 mL – HPLC grade) and triflic acid (2.10 mL, 23.73 mmol) 
was slowly added whilst maintaining a temperature of -78 °C. 
In a third 50 mL flame dried Schlenck tube purged under argon (R,R)-Me-
DuPHOS (5.93 g, 19.35 mmol) was introduced and dissolved in degassed THF 
(12 mL). The triflic acid solution in isopropanol was added continuously over 
25 minutes whilst maintaining a gentle reflux by means of a dosing pump to 
give a transparent yellow/brown homogeneous solution. The mixture was 
stirred at reflux temperature for approximately 20 minutes. The (R,R)-Me-
DuPHOS solution in THF was once again added continuously over 25 minutes 
whilst maintaining a gentle reflux by means of the dosing pump. This addition 
caused almost immediate precipitation of the crystalline product. Finally, the 
reaction mixture was cooled down to room temperature and filtered under 
argon. The filter and the Schlenck tube were rinsed twice with degassed 
isopropanol and the residual solvent removed under vacuum. The filter cake 
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was finally rinsed three times with a degassed 3:2 THF/MTBE solution and 
vacuum dried to constant to afford 11.38 g (88%) of a red shiny solid; [α]D =  
-46.39, (c = 0.53, CHCl3); m.p. 147-151 °C (dec.); 1H NMR (CDCl3, 400 
MHz) δH 7.70 (m, 4H, , CHaryl DuPHOS), 5.62 (s, 2H, =CHCOD), 5.05 (s, 2H, 
=CHCOD), 2.58-2.80 (m, 4H, CH2 DuPHOS), 2.30-2.56 (m, 8H, CH2 COD), 1.82-
2.00 (m, 2H, CH
 DuPHOS), 1.50-1.62 (m, 2H, CH DuPHOS), 1.40-1.50 (m, 6H, CH3 
DuPHOS), 0.98-1.10 (m, 6H, CH3 DuPHOS); 13C NMR (CDCl3, 100 MHz) δC 133.1, 
133.0, 132.6, 107.9, 93.6, 93.5, 60.2, 45.5, 41.2, 38.9, 37.9, 37.3, 37.1, 34.7, 
32.6, 31.0, 28.7, 28.3, 17.7, 14.3; 31P NMR (CDCl3, 162 MHz) 77.5, 75.6; 19F 
NMR (CDCl3, 377 MHz) -153.0; IR υmax (CHCl3)/ cm-1 3696, 3605, 2947, 
1602, 1455, 1288, 1088, 1031, 996. 
 
 
7.9 Synthesis of oximes 
 
Oximes were synthesised according to general procedure 7.3.13. 
 
Benzaldehyde oxime (191)207 
N OH
 
Purification by flash chromatography afforded one fraction of 1:1 cis/trans 
isomers and another fraction containing exclusively the cis isomer. Both 
fractions were clear yellowish oils. 
Cis isomer: 1H NMR (CDCl3, 400 MHz) δH 9.40 (s, 1H, OH), 8.23 (s, 1H, 
HC=N), 7.63 (m, 2H, Ar), 7.42 (m, 3H, Ar). Cis/trans mixture of isomers: 
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1H NMR (CDCl3, 400 MHz) δH 9.51 (s, 2H, OH), 8.23 (s, 2H, HC=N), 7.63 
(m, 4H, Ar), 7.42 (m, 6H, Ar); 13C NMR (CDCl3, 100 MHz) δC 150.8, 132.1, 
130.6, 130.2, 129.1, 127.1; IR υmax (CHCl3)/ cm-1 3579, 3315, 2909, 1955, 
1895, 1493, 1451, 1304, 1263, 949; HRMS [found (ESI) MNa+ 144.0422 
C7H7NO requires M 144.0420]; Rf cis 0.62, Rf trans 0.72 (CHCl3/EtOAc 1:1). 
 
Cyclohexanecarbaldehyde oxime (193)208 
N OH
 
Purification by flash chromatography afforded a colourless oil that was an 
inseparable mixture of cis-oxime/trans-oxime/hydroxylamine in a 50:21:29 
ratio. 13C NMR (CDCl3, 100 MHz) δC 157.7, 157.2, 38.8, 37.3, 34.1, 30.5, 
29.7, 27.2, 25.7, 25.5; IR υmax (CHCl3)/ cm-1 3669, 3587, 3312, 3011, 2935, 
2856, 1653, 1450, 1309, 964; HRMS [found (EI) M+ 127.1129 C7H13NO 
requires M 127.0992]; Rf 0.72 (CHCl3/EtOAc 1:1). 
Cis-oxime isomer: 1H NMR (CDCl3, 400 MHz) δH 9.28 (s, 1H, OH), 7.31 (d, 
1H, J = 7.0 Hz, HC=N), 2.20 (m, 1H, CHα), 1.05-1.82 (m, 10H, CH2). Trans-
oxime isomer: 1H NMR (CDCl3, 400 MHz) δH 9.28 (s, 1H, OH), 7.52 (d, 1H, 
J = 7.6 Hz, HC=N), 2.20 (m, 1H, CHα), 1.05-1.82 (m, 10H, CH2); 
Hydroxylamine isomer: 1H NMR (CDCl3, 400 MHz) δH 9.28 (s, 2H, 
NH+OH), 2.96 (m, 1H, C=CH), 1.05-1.82 (m, 10H, CH2) 
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2-Phenylacetaldehyde oxime (192)208 
N OH
 
Purification by flash chromatography afforded two fractions of cis/trans 
isomers in 98:2 ratio (crystalline needles) and 94:6 ratio (waxy bright brown 
solid) respectively. IR υmax (CHCl3)/ cm-1 3751, 3587, 3328, 3011, 1558, 1454, 
1420, 1357, 1310, 895; HRMS [found (ESI) MH+ 137.0747. C8H9NO requires 
M 137.0757]; Rf 0.11 (Hexane/EtOAc 90:10). Cis-isomer: m.p. 97-98 °C, 
Lit.209 99 °C; 1H NMR (CDCl3, 400 MHz) δH 8.95 (s, 1H, OH), 7.33-7.40 (m, 
2H, Ar), 7.26-7.33 (m, 3H, Ar), 7.96 (t, 1H, J = 5.6 Hz, HC=N), 3.80 (d, 2H, J 
= 5.6 Hz, CH2); 13C NMR (CDCl3, 100 MHz) δC 151.2, 137.0, 129.2, 129.10, 
127.0, 32.0. Trans-isomer: 1H NMR (CDCl3, 400 MHz) δH 8.80-10.60 (s, 1H, 
OH), 7.26-7.40 (m, 5H, Ar), 7.60(t, 1H, J = 7.4 Hz, HC=N), 3.60 (d, 2H, J = 
7.4 Hz, CH2); 13C NMR (CDCl3, 100 MHz) δC 151.0, 137.3, 129.11, 129.06, 
127.3, 127.2, 37.2. 
 
Butyraldehyde oxime (194)210 
N OH
 
Was afforded as an inseparable 1:1 mixture of cis/trans isomers. Colourless oil. 
IR υmax (CHCl3)/ cm-1  3668, 3588, 3289, 3011, 2968, 2876, 1720, 1656, 1462; 
HRMS [found (EI) MNa+ 87.1077 C4H9NO requires M 87.0679]; Rf 0.81 
(CHCl3/EtOAc 1:1). 
Cis isomer: 1H NMR (CDCl3, 400 MHz) δH 9.78 (s, 1H, OH), 7.41 (t, 1H, J = 
7.4 Hz, HC=N), 2.35 (tq, 2H, J = 7.2 Hz, J = 7.6 Hz, CH2β), 1.50 (tq, 2H, J = 
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7.4 Hz, J = 7.6 Hz, CH2α), 0.96 (t, 3H, J = 7.2 Hz, CH3); 13C NMR (CDCl3, 
100 MHz) δC 153.0, 31.7, 20.2, 14.1. Trans isomer: 1H NMR (CDCl3, 400 
MHz) δH 9.42 (s, 1H, OH), 7.41 (t, 1H, J = 5.4 Hz, HC=N), 2.35 (dt, 2H, J = 
7.2 Hz, J = 7.4 Hz, CH2β), 1.50 (tq, 2H, J = 7.4 Hz, J = 5.4 Hz, CH2α), 0.94 (t, 
3H, J = 7.2 Hz, CH3); 13C NMR (CDCl3, 100 MHz) δC 152.4, 27.2, 19.7, 13.9. 
 
7.10  Synthesis of sulfonyl adducts 
 
Sulfonyl adducts were prepared according to general procedure 7.2.14. Most of 
them were obtained as crude mixtures which could not be succesfully purified 
by recrystallisation. Therefore, with the exception of 203, only the IR data is 
reported in Table 26 for these compounds.  
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Table 26: Comparison of IR data of synthetised crude sulfonyl adduct 
   compounds. 
 
Entry Compound IR υmax (CHCl3)/ cm-1 
 
 
 
1 
P, P-Diphenyl-N-(phenyl 
(tosyl)methyl)-phosphinic amide 
S
HN
PPh2
O
O
O
 
195 
3692, 3009, 1624, 
1600, 1454, 1191, 
1129 
 
 
2 
P,P-Diphenyl-N-(p-tolyl 
(tosyl)methyl)-phosphinic amide 
S
HN
PPh2
O
O
O
 
196 
3688, 3008, 1604, 
1439, 1181, 1131 
 
 
3 
P,P-Diphenyl-N-((4-fluorophenyl) 
(tosyl)methyl)-phosphinic amide 
S
HN
PPh2
O
O
O
F
 
197 
3689, 2998, 1601, 
1510, 1439, 1192, 
1131, 950 
 
 
4 
P,P-Diphenyl-N-((4-chlorophenyl) 
(tosyl)methyl)-phosphinic amide 
S
HN
PPh2
O
O
O
Cl
 
198 
3691, 2989, 2948, 
1711, 1600, 1439, 
1182, 1132, 950 
 
 
5 
P,P-Diphenyl-N-((2-chlorophenyl) 
(tosyl)methyl)-phosphinic amide 
S
HN PPh2
O
Cl
O
O
 
200 
3688, 3009, 1602, 
1439, 1191, 1132, 951 
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6 
P,P-Diphenyl-N-((4-methoxyphenyl) 
(tosyl)methyl)-phosphinic amide 
S
HN PPh2
O
MeO
O
O
 
199 
3693, 3000, 1600, 
1572, 1439, 1180, 
1132, 950 
 
 
7 
P,P-Diphenyl-N-((2-methoxyphenyl) 
(tosyl)methyl)-phosphinic amide 
S
HN PPh2
O
OMe
O
O
 
201 
3690, 3009, 1602, 
1439, 1177, 1132, 950 
 
 
8 
P,P-Diphenyl-N-(cyclohexyl 
(tosyl)methyl)-phosphinic amide 
S
HN PPh2
O
O
O
 
202 
3691, 3061, 2937, 
2859, 1707, 1599, 
1439, 1176, 1132, 950 
 
 
P,P-Diphenyl-N-(2-phenyl-1-tosylethyl)phosphinic amide (203) 
S
HN PPh2
O
O
O
 
Purification by washing with water (2x20 mL) and recrystallisation in  
CHCl3/Et2O afforded the title compound as a white solid with 94% purity by 
1H NMR spectroscopy. 1H NMR (CDCl3, 400 MHz) δH 7.88-7.91 (d, 2H, J = 
12.4 Hz, Ar), 7.32-7.60 (m, 3H, Ar), 7.20-7.32 (m, 14H, Ar), 4.74 (m, 1H, 
CHα), 3.86 (t, 1H, J = 10.4 Hz, CHβ), 3.60 (dd, 1H, J = 2.6 Hz, J = 14.2 Hz, 
CHβ), 3.13 (dd, 1H, J = 9.2 Hz, J = 14.4 Hz, NH); 13C NMR (CDCl3, 100 
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MHz) δC 145.4, 144.6, 135.3, 132.4, 132.3, 132.20, 132.16, 132.10, 132.06, 
130.6, 130.1, 130.04, 129.97, 129.4, 129.0, 128.9, 128.8, 128.6, 128.5, 127.7, 
125.3, 73.9, 37.8, 22.1, 21.8; 31P NMR (CDCl3, 162 MHz) δP 23.9; IR υmax 
(CHCl3)/ cm-1 3610, 3050, 2338, 1596, 1456, 1302, 1124; HRMS [found (ESI) 
MH+ 477.1457 C27H26NO3PS requires M 477.1444]. 
 
7.11  Synthesis of the allyl and propargyl addition products 
 
(±)-P,P-Diphenyl-N-(1-phenylundec-2-enyl)phosphinic amide (86) 
HN P
O
Ph
Ph
C8H17
 
In a 50 mL flame dried round-bottom flask equipped with a magnetic stirrer 
and purged with argon, was introduced 1-decyne (0.54 mL, 3.00 mmol) and 
anhydrous hexane (3.0 mL). Next, after cooling down the solution to 0 °C, neat 
diisobutylaluminium hydride (0.51 mL, 3.60 mmol) was added while stirring. 
Finally, the reaction mixture was warmed up to 55 °C and stirred at this 
temperature for 4 hours to form dibutyl(dec-1-enyl)aluminium 
(iBu)2Al(CH)2C8H17. In another 10 mL flame dried Schlenck tube under argon, 
di--chlorotetrakis(cyclooctene)diiridium(I) (5.2 mg, 5.75 mol) was dissolved 
in THF (2.0 mL) and diphenylphosphinoyl benzaldimine (37.0 mg, 0.115 
mmol) was added after complete dissolution. Then, previously synthesised 
dibutyl(dec-1-enyl)aluminium (64.5 mg, 0.230 mmol) was added slowly into 
the solution at room temperature. The reaction mixture was then allowed to be 
stirred overnight, at 55 °C. Purification by flash chromatography on silica gel 
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(Petroleum ether/EtOAc 8:2) afforded 18.4 mg (36%) of a colourless liquid; 1H 
NMR (CDCl3, 270 MHz) δH 7.80-8.00 (m, 4H, Ar), 7.60-7.20 (m, 11H, Ar), 
5.58-5.72 (dd, J = 6 Hz, J = 15 Hz, 1H, CHvinyl), 5.43-5.58 (m, 1H, CHvinyl), 
4.73-4.88 (m, 1H, CHbenzyl), 3.21-3.34 (m, 1H, NH), 1.90-2.05 (m, 1H, 
CH2allyl), 1.10-1.40 (s, 12H, CH2octyl), 0.88 (m, 3H, CH3); 13C NMR (CDCl3, 
100 MHz) δC 132.9, 132.7, 132.6, 132.4, 129.0, 128.8, 128.6, 128.0, 127.5, 
127.3, 57.3, 32.5, 32.2, 29.7, 29.6, 29.5, 29.3 (d, J = 3 Hz), 23.0, 14.4; 31P 
NMR (CDCl3, 162 MHz) δP 23.5; IR υmax (CHCl3)/ cm-1 3366, 2993, 1439, 
1184; HRMS [found (ESI) MNa+ 468.2422. C29H36NOP requires M 
468.2447]; Rf 0.30 (Petroleum ether/EtOAc 8:2). 
 
(±)-P,P-Diphenyl-N-(1-phenyloct-2-ynyl)phosphinic amide (92) 
HN
P
O
Ph
Ph
C5H11
 
A 20 mL flame dried Schlenck tube under argon was charged with a 2M 
solution of AlMe3 in toluene (1.5 mL, 3.0 mmol). Then, triethylamine (42 L, 
0.3 mmol) was added and the mixture was stirred at room temperature for 10 
minutes. Finally, 1-heptyne (435 L, 3.3 mmol) was added and the mixture 
was heated up to 60 °C for 6 hours. The product (hept-1-
ynyldimethylaluminum) was stored overnight under argon, and kept away from 
light. The next day, in 20 mL flame dried Schlenck tube under argon, di--
chlorotetrakis(cyclooctene)diiridium(I) (13.4 mg, 15 mol) was dissolved in 
THF (4.0 mL) and diphenylphosphinoyl benzaldimine (91.6 mg, 0.30 mmol) 
was added with another portion of THF (1.0 mL) after complete dissolution. 
Then, previously synthesised hept-1-ynyldimethylaluminum (0.30 mL, 0.6 
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mmol) was added slowly into the solution at room temperature, causing a 
change of colour from orange to dark. The reaction mixture was then heated to 
reflux temperature for 3 hours. Purification by flash chromatography on silica 
gel (Petrol. ether/EtOAc 4:6) afforded 77.0 mg (64%) of a colourless liquid; 1H 
NMR (CDCl3, 270 MHz) δH 8.20-8.00 (m, 2H, Ar), 7.90-7.75 (m, 2H, Ar), 
7.70-7.55 (m, 2H, Ar), 7.55-7.00 (m, 9H, Ar), 5.14 (m, 1H, CH), 3.53 (m, 1H, 
NH), 2.30-2.10 (m, 2H, CH2propargyl), 1.50-1.10 (m, 6H, CH3), 1.00-0.60 (m, 
3H, CH3); 13C NMR (CDCl3, 100 MHz) δC 141.3 (d, J = 5 Hz), 133.0 (d, J =  
126 Hz), 132.2 (d, J = 7 Hz), 132.2 (d, J = 9 Hz), 128.8 (d, J = 2 Hz), 128.6, 
128.0, 127.6, 86.6, 80.0 (d, J = 9 Hz), 47.1, 31.4, 28.6, 22.5, 19.1, 14.3; 31P 
NMR (CDCl3, 162 MHz)  23.2; IR υmax (CHCl3)/ cm-1 3388, 3046, 1602, 
1439, 1186, 1125; HRMS [found (ESI) MH+ 402.1980. C26H28NOP requires M 
402.1981]; Rf 0.32 (Petrol. ether/EtOAc 4:6). 
 
 
7.12  Miscellaneous 
 
P,P-Diphenylphosphinic amide (223)169 
P
O
NH2
 
In a 1 L two-neck round-bottom flask equipped with a magnetic stirring bar, to 
a solution of diphenylphosphinic chloride (5.0 mL, 27.2 mmol) in THF (70 
mL) was slowly added 35% aqueous solution of ammonia (3.6 mL, 65.5 
mmol). The resulting white cloudy mixture was allowed to be stirred for 2 
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hours, upon which time the suspension was filtered through a glass sinter, dried 
over Na2SO4, filtered again and evaporated to dryness under reduced pressure 
to give a white solid (98%) which could be recrystallised in hot toluene to give 
4.32 g (76%) of the product. m.p. 160-161 °C; Lit.16 160-161 °C; 1H NMR 
(CDCl3, 270 MHz) δH 7.87-7.82 (m, 4H, Ar), 7.36-7.40 (m, 6H, Ar), 3.51 (s, 
2H, NH2); 13C NMR (CDCl3, 100 MHz) δC 133.8 (d, J = 130 Hz), 132.1 (d, J = 
14 Hz), 132.0 (d, J = 5 Hz), 128.7 (d, J = 19 Hz); 31P NMR (CDCl3, 162 MHz) 
δP 23.2; IR υmax (CHCl3)/ cm-1 1560, 1438, 1172, 1125, 1108, 894, 757, 737, 
720; HRMS [found (TOF) M-H 217.0585 C12H12NOP requires M 217.0584]; 
Rf 0.38 (EtOAc:MeOH 94:6). 
 
(S)-P,P-Diphenyl-N-(1-phenylpropyl)phosphinic amide (224)41 
HN
O
PPh2
 
In a 200 mL round-bottomed flask under argon was prepared a solution of  
(S)-1-phenylpropylamine (2.0 mL, 13.76 mmol) and Et3N (3.8 mL, 27.24 
mmol, 2 eq.) in dichloromethane (75 mL). This solution was cooled down to 0 
°C before the dropwise addition of diphenylphosphinic chloride (2.6 mL, 13.62 
mmol, 1 eq.). The resulting mixture was stirred at room temperature overnight, 
poured into an equal volume of saturated aqueous NH4Cl and extracted with 
CH2Cl2 (3 x 40 mL). The combined organic extracts were dried over Na2SO4 
and concentrated in vacuo to give 4.54 g (99%) of a white solid. m.p. 118-120 
°C; Lit.41 118-119 °C; 1H NMR (CDCl3, 400 MHz) δH 7.92 (m, 1H, Ar), 7.90 
(m, 1H, Ar), 7.89 (m, 1H, Ar), 7.87 (m, 1H, Ar), 7.82-7.78 (m, 1H, Ar), 7.78-
7.74 (m, 1H, Ar), 7.54-7.48 (m, 1H, Ar), 7.48-7.41 (m, 3H, Ar), 7.38-7.31 (m, 
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3H, Ar), 7.31-7.29 (m, 1H, Ar), 7.29-7.22 (m, 1H, Ar), 7.22-7.18 (m, 1H, Ar), 
7.18-7.15 (m, 1H, Ar), 4.19-4.06 (m, 1H, CHα), 3.28 (dd, J = 6.4 Hz, J = 9.6 
Hz, NH), 2.10-1.97 (m, 1H, CHβ), 1.94-1.80 (m, 1H, CHβ), 0.80 (t, J = 7.5 Hz, 
3H, CH3); 13C NMR (CDCl3, 100 MHz) δC 139.8 (d, J = 8 Hz), 132.5 (d, J = 
129 Hz), 132.3 (d, J = 9 Hz), 132.0 (d, J = 2 Hz), 128.7 (d, J = 3 Hz), 128.6, 
127.9, 127.5, 44.8; 31P NMR (162 MHz, CDCl3) δP 22.5; IR υmax (CHCl3)/ cm-
1 3383, 2976, 1454, 1409, 1186, 1124, 1109; HRMS [found (ESI) MH+ 
336.1503 C21H22NOP requires M 336.1512]; [α]D20 = -45.94, (c = 2.54, 
MeOH); Lit.41 -53.1 (c = 2.54, MeOH); Rf 0.45 (100% EtOAc). 
 
N,N-Dimethyl-1-phenylethanamine (47)123 
N
 
In a 50 mL non-flame dried round-bottomed flask fitted with a magnetic stirrer 
was introduced (±)-α-methylbenzylamine (1.9 mL, 15.1 mmol). Then, a 
dropwise addition of aqueous formaldehyde solution (37% - 5.2 mL) was 
followed by a dropwise addition of aqueous formic acid solution (90% - 6 mL). 
The resulting mixture was heated for 24 h, cooled down to room temperature, 
basified with NaOH pellets and extracted with Et2O (3x20 mL). The combined 
Et2O layers were dried (MgSO4), filtered and then concentrated under reduced 
pressure to give a light yellow oil. This oil was distilled in vacuo to give 1.96 g 
of a colourless oil (87%). 1H NMR (CDCl3, 400 MHz) δH 7.21-7.37 (m, 5H, 
Ar), 3.26 (q, J = 7.8 Hz, 1H, CHα), 2.21 (s, 6H, N-CH3), 1.39 (d, J = 7.8 Hz, 
3H, CH3α); 13C NMR (CDCl3, 100 MHz) δC 144.2, 128.5, 128.4, 127.7, 67.2, 
43.4, 20.5; IR υmax (CHCl3)/ cm-1 2981, 2865, 2823, 2780, 1680, 1452; HRMS 
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[found (ESI) MH+ 150.1269 C10H15N requires 1503.1277; Rf 0.22 
(EtOAc/CH2Cl2 7:3). 
 
p-Toluenesulfinic acid (225)39 
S
O
OH
 
A 200 mL Erlenmeyer flask containing a 10% vol/vol HCl solution was heated 
to 65 °C. Meanwhile a 100 mL Erlenmeyer flask containing the sodium p-
toluenesulfinate salt (7.98 g, 44.9 mmol) was kept under stirring and heated at 
the same temperature. Then, addition of hot HCl into the salt was carried out 
slowly until the resulting pH became lower than 3 and the salt was completely 
dissolved. Finally the solution was allowed to recrystallise at 4 °C and the 
precipitate was filtered and dried under vacuum to afford 4.31 g of white 
crystals (61%); m.p. 84-85 °C; Lit.211 85 °C; 1H NMR (CDCl3, 400 MHz) δH 
7.58 (d, 2H, J = 8.4 Hz, Ar), 7.31 (d, 2H, J = 8.4 Hz, Ar), 7.49 (s, 1H, OH), 
2.41 (s, 3H, CH3); 13C NMR (CDCl3, 100 MHz) δC 143.6, 143.0, 130.0, 125.4, 
21.8; IR υmax (CHCl3)/ cm-1 3671, 3242, 3043, 2989, 2926, 1596, 1327, 1144; 
HRMS [found (ESI) MNa+ 179.0127. C7H8O2S requires M 179.0137]; Rf 0.18 
(EtOAC/MeOH 80:20). 
 
N-Benzyl-P,P-diphenylphosphinic amide (94) 
HN PPh2
O
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White yellowish solid. m.p. 111-113 °C; Lit.212 110-112 °C; 1H NMR (CDCl3, 
400 MHz) δH 8.00-7.87 (m, 4H, Ar), 7.52-7.34 (m, 8H, Ar), 7.34-7.26 (m, 2H, 
Ar), 7.26-7.20 (m, 1H, Ar), 4.10 (t, J = 7.6 Hz, 2H, CH2), 3.54 (m, 1H, NH); 
13C NMR (CDCl3, 100 MHz) δC 139.9 (d, J = 8 Hz), 132.5 (d, J = 129 Hz), 
132.3 (d, J = 9 Hz), 132.0 (d, J = 2 Hz), 128.7 (d, J = 3 Hz), 128.6, 127.9, 
127.5, 44.8; 31P NMR (162 MHz, CDCl3) δP 23.7; IR υmax (CHCl3)/ cm-1 3372, 
2986, 1439, 1183, 1125; HRMS [found (ESI) MH+ 308.1209. C19H18NOP 
requires M 308.1199]; Rf  0.35 (EtOAc/CH2Cl2 1:1). 
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